0001071739-24-000157.txt : 20240726 0001071739-24-000157.hdr.sgml : 20240726 20240725180554 ACCESSION NUMBER: 0001071739-24-000157 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 66 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240726 DATE AS OF CHANGE: 20240725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 041406317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 241143106 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 10-Q 1 cnc-20240630.htm 10-Q cnc-20240630
0001071739--12-312024Q2FALSExbrli:sharesiso4217:USDiso4217:USDxbrli:sharesiso4217:GBPxbrli:purecnc:positioncnc:segment00010717392024-01-012024-06-3000010717392024-07-2400010717392024-06-3000010717392023-12-310001071739us-gaap:HealthCarePremiumMember2024-04-012024-06-300001071739us-gaap:HealthCarePremiumMember2023-04-012023-06-300001071739us-gaap:HealthCarePremiumMember2024-01-012024-06-300001071739us-gaap:HealthCarePremiumMember2023-01-012023-06-300001071739us-gaap:ServiceMember2024-04-012024-06-300001071739us-gaap:ServiceMember2023-04-012023-06-300001071739us-gaap:ServiceMember2024-01-012024-06-300001071739us-gaap:ServiceMember2023-01-012023-06-3000010717392024-04-012024-06-3000010717392023-04-012023-06-3000010717392023-01-012023-06-300001071739us-gaap:CommonStockMember2023-12-310001071739us-gaap:CommonStockMember2024-06-300001071739us-gaap:CommonStockMember2024-03-310001071739us-gaap:TreasuryStockCommonMember2023-12-310001071739us-gaap:TreasuryStockCommonMember2024-03-310001071739us-gaap:TreasuryStockCommonMember2024-06-300001071739us-gaap:AdditionalPaidInCapitalMember2023-12-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001071739us-gaap:RetainedEarningsMember2023-12-310001071739us-gaap:NoncontrollingInterestMember2023-12-310001071739us-gaap:RetainedEarningsMember2024-01-012024-03-310001071739us-gaap:NoncontrollingInterestMember2024-01-012024-03-3100010717392024-01-012024-03-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001071739us-gaap:CommonStockMember2024-01-012024-03-310001071739us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001071739us-gaap:TreasuryStockCommonMember2024-01-012024-03-310001071739us-gaap:AdditionalPaidInCapitalMember2024-03-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001071739us-gaap:RetainedEarningsMember2024-03-310001071739us-gaap:NoncontrollingInterestMember2024-03-3100010717392024-03-310001071739us-gaap:RetainedEarningsMember2024-04-012024-06-300001071739us-gaap:NoncontrollingInterestMember2024-04-012024-06-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300001071739us-gaap:CommonStockMember2024-04-012024-06-300001071739us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300001071739us-gaap:TreasuryStockCommonMember2024-04-012024-06-300001071739us-gaap:AdditionalPaidInCapitalMember2024-06-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001071739us-gaap:RetainedEarningsMember2024-06-300001071739us-gaap:NoncontrollingInterestMember2024-06-300001071739us-gaap:CommonStockMember2023-06-300001071739us-gaap:CommonStockMember2023-03-310001071739us-gaap:CommonStockMember2022-12-310001071739us-gaap:TreasuryStockCommonMember2023-06-300001071739us-gaap:TreasuryStockCommonMember2022-12-310001071739us-gaap:TreasuryStockCommonMember2023-03-310001071739us-gaap:AdditionalPaidInCapitalMember2022-12-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001071739us-gaap:RetainedEarningsMember2022-12-310001071739us-gaap:NoncontrollingInterestMember2022-12-3100010717392022-12-310001071739us-gaap:RetainedEarningsMember2023-01-012023-03-310001071739us-gaap:NoncontrollingInterestMember2023-01-012023-03-3100010717392023-01-012023-03-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001071739us-gaap:CommonStockMember2023-01-012023-03-310001071739us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001071739us-gaap:TreasuryStockCommonMember2023-01-012023-03-310001071739us-gaap:AdditionalPaidInCapitalMember2023-03-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001071739us-gaap:RetainedEarningsMember2023-03-310001071739us-gaap:NoncontrollingInterestMember2023-03-3100010717392023-03-310001071739us-gaap:RetainedEarningsMember2023-04-012023-06-300001071739us-gaap:NoncontrollingInterestMember2023-04-012023-06-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001071739us-gaap:CommonStockMember2023-04-012023-06-300001071739us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001071739us-gaap:TreasuryStockCommonMember2023-04-012023-06-300001071739us-gaap:AdditionalPaidInCapitalMember2023-06-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001071739us-gaap:RetainedEarningsMember2023-06-300001071739us-gaap:NoncontrollingInterestMember2023-06-3000010717392023-06-300001071739cnc:MagellanRxMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2024-01-012024-06-300001071739us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMembercnc:CircleHealthMember2023-01-012023-12-310001071739us-gaap:CurrencySwapMember2023-08-310001071739us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembercnc:CircleHealthMember2024-01-122024-01-120001071739us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembercnc:CircleHealthMember2024-01-012024-06-300001071739us-gaap:USTreasuryAndGovernmentMember2024-06-300001071739us-gaap:USTreasuryAndGovernmentMember2023-12-310001071739us-gaap:CorporateDebtSecuritiesMember2024-06-300001071739us-gaap:CorporateDebtSecuritiesMember2023-12-310001071739cnc:RestrictedCertificatesOfDepositMember2024-06-300001071739cnc:RestrictedCertificatesOfDepositMember2023-12-310001071739cnc:RestrictedCashEquivalentsMember2024-06-300001071739cnc:RestrictedCashEquivalentsMember2023-12-310001071739us-gaap:BankTimeDepositsMember2024-06-300001071739us-gaap:BankTimeDepositsMember2023-12-310001071739us-gaap:MunicipalBondsMember2024-06-300001071739us-gaap:MunicipalBondsMember2023-12-310001071739us-gaap:AssetBackedSecuritiesMember2024-06-300001071739us-gaap:AssetBackedSecuritiesMember2023-12-310001071739us-gaap:ResidentialMortgageBackedSecuritiesMember2024-06-300001071739us-gaap:ResidentialMortgageBackedSecuritiesMember2023-12-310001071739us-gaap:CommercialMortgageBackedSecuritiesMember2024-06-300001071739us-gaap:CommercialMortgageBackedSecuritiesMember2023-12-310001071739cnc:RatedSecuritiesMembercnc:InvestmentSecuritiesMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2024-01-012024-06-300001071739us-gaap:CommercialMortgageBackedSecuritiesMember2024-01-012024-06-300001071739us-gaap:InvestmentsMember2024-06-300001071739us-gaap:DepositsMember2024-06-300001071739us-gaap:InvestmentsMember2023-12-310001071739us-gaap:DepositsMember2023-12-310001071739us-gaap:FairValueInputsLevel1Member2024-06-300001071739us-gaap:FairValueInputsLevel2Member2024-06-300001071739us-gaap:FairValueInputsLevel3Member2024-06-300001071739us-gaap:InvestmentsMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Member2024-06-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:USTreasuryAndGovernmentMember2024-06-300001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMember2024-06-300001071739us-gaap:InvestmentsMemberus-gaap:USTreasuryAndGovernmentMember2024-06-300001071739us-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2024-06-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2024-06-300001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2024-06-300001071739us-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2024-06-300001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MunicipalBondsMember2024-06-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:MunicipalBondsMember2024-06-300001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MunicipalBondsMember2024-06-300001071739us-gaap:InvestmentsMemberus-gaap:MunicipalBondsMember2024-06-300001071739us-gaap:InvestmentsMemberus-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel1Member2024-06-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:BankTimeDepositsMember2024-06-300001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:BankTimeDepositsMember2024-06-300001071739us-gaap:InvestmentsMemberus-gaap:BankTimeDepositsMember2024-06-300001071739us-gaap:AssetBackedSecuritiesMemberus-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel1Member2024-06-300001071739us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2024-06-300001071739us-gaap:AssetBackedSecuritiesMemberus-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-06-300001071739us-gaap:AssetBackedSecuritiesMemberus-gaap:InvestmentsMember2024-06-300001071739us-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2024-06-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2024-06-300001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ResidentialMortgageBackedSecuritiesMember2024-06-300001071739us-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2024-06-300001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel1Member2024-06-300001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2024-06-300001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-06-300001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMember2024-06-300001071739us-gaap:EquitySecuritiesMemberus-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel1Member2024-06-300001071739us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2024-06-300001071739us-gaap:EquitySecuritiesMemberus-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-06-300001071739us-gaap:EquitySecuritiesMemberus-gaap:InvestmentsMember2024-06-300001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel1Member2024-06-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2024-06-300001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Member2024-06-300001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel1Member2024-06-300001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMember2024-06-300001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Member2024-06-300001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMember2024-06-300001071739us-gaap:DepositsMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Member2024-06-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMemberus-gaap:USTreasuryAndGovernmentMember2024-06-300001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMember2024-06-300001071739us-gaap:DepositsMemberus-gaap:USTreasuryAndGovernmentMember2024-06-300001071739us-gaap:DepositsMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2024-06-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMemberus-gaap:CorporateDebtSecuritiesMember2024-06-300001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2024-06-300001071739us-gaap:DepositsMemberus-gaap:CorporateDebtSecuritiesMember2024-06-300001071739us-gaap:DepositsMemberus-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel1Member2024-06-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMemberus-gaap:CertificatesOfDepositMember2024-06-300001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CertificatesOfDepositMember2024-06-300001071739us-gaap:DepositsMemberus-gaap:CertificatesOfDepositMember2024-06-300001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MunicipalBondsMember2024-06-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMemberus-gaap:MunicipalBondsMember2024-06-300001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MunicipalBondsMember2024-06-300001071739us-gaap:DepositsMemberus-gaap:MunicipalBondsMember2024-06-300001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel1Member2024-06-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMember2024-06-300001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Member2024-06-300001071739us-gaap:FairValueInputsLevel1Member2023-12-310001071739us-gaap:FairValueInputsLevel2Member2023-12-310001071739us-gaap:FairValueInputsLevel3Member2023-12-310001071739us-gaap:InvestmentsMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Member2023-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:USTreasuryAndGovernmentMember2023-12-310001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMember2023-12-310001071739us-gaap:InvestmentsMemberus-gaap:USTreasuryAndGovernmentMember2023-12-310001071739us-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2023-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2023-12-310001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2023-12-310001071739us-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2023-12-310001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MunicipalBondsMember2023-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:MunicipalBondsMember2023-12-310001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MunicipalBondsMember2023-12-310001071739us-gaap:InvestmentsMemberus-gaap:MunicipalBondsMember2023-12-310001071739us-gaap:InvestmentsMemberus-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel1Member2023-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:BankTimeDepositsMember2023-12-310001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:BankTimeDepositsMember2023-12-310001071739us-gaap:InvestmentsMemberus-gaap:BankTimeDepositsMember2023-12-310001071739us-gaap:AssetBackedSecuritiesMemberus-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel1Member2023-12-310001071739us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2023-12-310001071739us-gaap:AssetBackedSecuritiesMemberus-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001071739us-gaap:AssetBackedSecuritiesMemberus-gaap:InvestmentsMember2023-12-310001071739us-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2023-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2023-12-310001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ResidentialMortgageBackedSecuritiesMember2023-12-310001071739us-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2023-12-310001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel1Member2023-12-310001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2023-12-310001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMember2023-12-310001071739us-gaap:EquitySecuritiesMemberus-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel1Member2023-12-310001071739us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2023-12-310001071739us-gaap:EquitySecuritiesMemberus-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001071739us-gaap:EquitySecuritiesMemberus-gaap:InvestmentsMember2023-12-310001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel1Member2023-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2023-12-310001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel1Member2023-12-310001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMember2023-12-310001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMember2023-12-310001071739us-gaap:DepositsMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Member2023-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMemberus-gaap:USTreasuryAndGovernmentMember2023-12-310001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMember2023-12-310001071739us-gaap:DepositsMemberus-gaap:USTreasuryAndGovernmentMember2023-12-310001071739us-gaap:DepositsMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2023-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMemberus-gaap:CorporateDebtSecuritiesMember2023-12-310001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2023-12-310001071739us-gaap:DepositsMemberus-gaap:CorporateDebtSecuritiesMember2023-12-310001071739us-gaap:DepositsMemberus-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel1Member2023-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMemberus-gaap:CertificatesOfDepositMember2023-12-310001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CertificatesOfDepositMember2023-12-310001071739us-gaap:DepositsMemberus-gaap:CertificatesOfDepositMember2023-12-310001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MunicipalBondsMember2023-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMemberus-gaap:MunicipalBondsMember2023-12-310001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MunicipalBondsMember2023-12-310001071739us-gaap:DepositsMemberus-gaap:MunicipalBondsMember2023-12-310001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel1Member2023-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMember2023-12-310001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001071739us-gaap:CurrencySwapMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:FairValueInputsLevel1Member2023-12-310001071739us-gaap:CurrencySwapMemberus-gaap:FairValueInputsLevel2Memberus-gaap:AccountsPayableAndAccruedLiabilitiesMember2023-12-310001071739us-gaap:CurrencySwapMemberus-gaap:FairValueInputsLevel3Memberus-gaap:AccountsPayableAndAccruedLiabilitiesMember2023-12-310001071739us-gaap:CurrencySwapMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMember2023-12-310001071739cnc:MedicaidSegmentMember2023-12-310001071739cnc:MedicareSegmentMember2023-12-310001071739cnc:CommercialSegmentMember2023-12-310001071739us-gaap:AllOtherSegmentsMember2023-12-310001071739cnc:MedicaidSegmentMember2024-01-012024-06-300001071739cnc:MedicareSegmentMember2024-01-012024-06-300001071739cnc:CommercialSegmentMember2024-01-012024-06-300001071739us-gaap:AllOtherSegmentsMember2024-01-012024-06-300001071739cnc:MedicaidSegmentMember2024-06-300001071739cnc:MedicareSegmentMember2024-06-300001071739cnc:CommercialSegmentMember2024-06-300001071739us-gaap:AllOtherSegmentsMember2024-06-300001071739cnc:MedicaidSegmentMember2022-12-310001071739cnc:MedicareSegmentMember2022-12-310001071739cnc:CommercialSegmentMember2022-12-310001071739us-gaap:AllOtherSegmentsMember2022-12-310001071739cnc:MedicaidSegmentMember2023-01-012023-06-300001071739cnc:MedicareSegmentMember2023-01-012023-06-300001071739cnc:CommercialSegmentMember2023-01-012023-06-300001071739us-gaap:AllOtherSegmentsMember2023-01-012023-06-300001071739cnc:MedicaidSegmentMember2023-06-300001071739cnc:MedicareSegmentMember2023-06-300001071739cnc:CommercialSegmentMember2023-06-300001071739us-gaap:AllOtherSegmentsMember2023-06-300001071739cnc:MedicareSegmentMember2024-03-310001071739us-gaap:SeniorNotesMembercnc:FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember2024-06-300001071739us-gaap:SeniorNotesMembercnc:FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember2023-12-310001071739us-gaap:SeniorNotesMembercnc:A2300Million245SeniorNotsDueJuly2028Member2024-06-300001071739us-gaap:SeniorNotesMembercnc:A2300Million245SeniorNotsDueJuly2028Member2023-12-310001071739us-gaap:SeniorNotesMembercnc:A3500Million4625SeniorNotesDueDecember2029Member2024-06-300001071739us-gaap:SeniorNotesMembercnc:A3500Million4625SeniorNotesDueDecember2029Member2023-12-310001071739us-gaap:SeniorNotesMembercnc:A2200Million375SeniorNotesDueFebruary2030Member2024-06-300001071739us-gaap:SeniorNotesMembercnc:A2200Million375SeniorNotesDueFebruary2030Member2023-12-310001071739us-gaap:SeniorNotesMembercnc:A2200Million300SeniorNotesDueOctober2030Member2024-06-300001071739us-gaap:SeniorNotesMembercnc:A2200Million300SeniorNotesDueOctober2030Member2023-12-310001071739cnc:A2200Million250SeniorNotesDueMarch2031Memberus-gaap:SeniorNotesMember2024-06-300001071739cnc:A2200Million250SeniorNotesDueMarch2031Memberus-gaap:SeniorNotesMember2023-12-310001071739cnc:A1300Million2625SeniorNotesDueAugust2031Memberus-gaap:SeniorNotesMember2024-06-300001071739cnc:A1300Million2625SeniorNotesDueAugust2031Memberus-gaap:SeniorNotesMember2023-12-310001071739cnc:TermLoanCreditAgreementMember2024-06-300001071739cnc:TermLoanCreditAgreementMember2023-12-310001071739us-gaap:RevolvingCreditFacilityMember2024-06-300001071739us-gaap:RevolvingCreditFacilityMember2023-12-310001071739us-gaap:CommonStockMember2024-04-012024-06-300001071739us-gaap:CommonStockMember2023-04-012023-06-300001071739us-gaap:CommonStockMember2024-01-012024-06-300001071739us-gaap:CommonStockMember2023-01-012023-06-300001071739cnc:EmployeeStockCompensationPlanMember2024-04-012024-06-300001071739cnc:EmployeeStockCompensationPlanMember2023-04-012023-06-300001071739cnc:EmployeeStockCompensationPlanMember2024-01-012024-06-300001071739cnc:EmployeeStockCompensationPlanMember2023-01-012023-06-300001071739us-gaap:HealthCarePremiumMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2024-04-012024-06-300001071739us-gaap:HealthCarePremiumMembercnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2024-04-012024-06-300001071739us-gaap:HealthCarePremiumMembercnc:CommercialSegmentMember2024-04-012024-06-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:HealthCarePremiumMemberus-gaap:OperatingSegmentsMember2024-04-012024-06-300001071739us-gaap:OperatingSegmentsMemberus-gaap:ServiceMembercnc:MedicaidSegmentMember2024-04-012024-06-300001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMemberus-gaap:ServiceMember2024-04-012024-06-300001071739us-gaap:OperatingSegmentsMemberus-gaap:ServiceMembercnc:CommercialSegmentMember2024-04-012024-06-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMemberus-gaap:ServiceMember2024-04-012024-06-300001071739cnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2024-04-012024-06-300001071739cnc:MedicareSegmentMembercnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMember2024-04-012024-06-300001071739cnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMembercnc:CommercialSegmentMember2024-04-012024-06-300001071739us-gaap:AllOtherSegmentsMembercnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMember2024-04-012024-06-300001071739cnc:TotalPremiumAndServiceMember2024-04-012024-06-300001071739us-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2024-04-012024-06-300001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2024-04-012024-06-300001071739us-gaap:OperatingSegmentsMembercnc:CommercialSegmentMember2024-04-012024-06-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2024-04-012024-06-300001071739us-gaap:OperatingSegmentsMember2024-04-012024-06-300001071739us-gaap:IntersegmentEliminationMembercnc:MedicaidSegmentMember2024-04-012024-06-300001071739us-gaap:IntersegmentEliminationMembercnc:MedicareSegmentMember2024-04-012024-06-300001071739us-gaap:IntersegmentEliminationMembercnc:CommercialSegmentMember2024-04-012024-06-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:IntersegmentEliminationMember2024-04-012024-06-300001071739us-gaap:IntersegmentEliminationMember2024-04-012024-06-300001071739cnc:MedicaidSegmentMember2024-04-012024-06-300001071739cnc:MedicareSegmentMember2024-04-012024-06-300001071739cnc:CommercialSegmentMember2024-04-012024-06-300001071739us-gaap:AllOtherSegmentsMember2024-04-012024-06-300001071739us-gaap:HealthCarePremiumMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2023-04-012023-06-300001071739us-gaap:HealthCarePremiumMembercnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2023-04-012023-06-300001071739us-gaap:HealthCarePremiumMembercnc:CommercialSegmentMember2023-04-012023-06-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:HealthCarePremiumMemberus-gaap:OperatingSegmentsMember2023-04-012023-06-300001071739us-gaap:OperatingSegmentsMemberus-gaap:ServiceMembercnc:MedicaidSegmentMember2023-04-012023-06-300001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMemberus-gaap:ServiceMember2023-04-012023-06-300001071739us-gaap:OperatingSegmentsMemberus-gaap:ServiceMembercnc:CommercialSegmentMember2023-04-012023-06-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMemberus-gaap:ServiceMember2023-04-012023-06-300001071739cnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2023-04-012023-06-300001071739cnc:MedicareSegmentMembercnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMember2023-04-012023-06-300001071739cnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMembercnc:CommercialSegmentMember2023-04-012023-06-300001071739us-gaap:AllOtherSegmentsMembercnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMember2023-04-012023-06-300001071739cnc:TotalPremiumAndServiceMember2023-04-012023-06-300001071739us-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2023-04-012023-06-300001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2023-04-012023-06-300001071739us-gaap:OperatingSegmentsMembercnc:CommercialSegmentMember2023-04-012023-06-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2023-04-012023-06-300001071739us-gaap:OperatingSegmentsMember2023-04-012023-06-300001071739us-gaap:IntersegmentEliminationMembercnc:MedicaidSegmentMember2023-04-012023-06-300001071739us-gaap:IntersegmentEliminationMembercnc:MedicareSegmentMember2023-04-012023-06-300001071739us-gaap:IntersegmentEliminationMembercnc:CommercialSegmentMember2023-04-012023-06-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:IntersegmentEliminationMember2023-04-012023-06-300001071739us-gaap:IntersegmentEliminationMember2023-04-012023-06-300001071739cnc:MedicaidSegmentMember2023-04-012023-06-300001071739cnc:MedicareSegmentMember2023-04-012023-06-300001071739cnc:CommercialSegmentMember2023-04-012023-06-300001071739us-gaap:AllOtherSegmentsMember2023-04-012023-06-300001071739us-gaap:HealthCarePremiumMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2024-01-012024-06-300001071739us-gaap:HealthCarePremiumMembercnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2024-01-012024-06-300001071739us-gaap:HealthCarePremiumMembercnc:CommercialSegmentMember2024-01-012024-06-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:HealthCarePremiumMemberus-gaap:OperatingSegmentsMember2024-01-012024-06-300001071739us-gaap:OperatingSegmentsMemberus-gaap:ServiceMembercnc:MedicaidSegmentMember2024-01-012024-06-300001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMemberus-gaap:ServiceMember2024-01-012024-06-300001071739us-gaap:OperatingSegmentsMemberus-gaap:ServiceMembercnc:CommercialSegmentMember2024-01-012024-06-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMemberus-gaap:ServiceMember2024-01-012024-06-300001071739cnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2024-01-012024-06-300001071739cnc:MedicareSegmentMembercnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMember2024-01-012024-06-300001071739cnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMembercnc:CommercialSegmentMember2024-01-012024-06-300001071739us-gaap:AllOtherSegmentsMembercnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMember2024-01-012024-06-300001071739cnc:TotalPremiumAndServiceMember2024-01-012024-06-300001071739us-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2024-01-012024-06-300001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2024-01-012024-06-300001071739us-gaap:OperatingSegmentsMembercnc:CommercialSegmentMember2024-01-012024-06-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2024-01-012024-06-300001071739us-gaap:OperatingSegmentsMember2024-01-012024-06-300001071739us-gaap:IntersegmentEliminationMembercnc:MedicaidSegmentMember2024-01-012024-06-300001071739us-gaap:IntersegmentEliminationMembercnc:MedicareSegmentMember2024-01-012024-06-300001071739us-gaap:IntersegmentEliminationMembercnc:CommercialSegmentMember2024-01-012024-06-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:IntersegmentEliminationMember2024-01-012024-06-300001071739us-gaap:IntersegmentEliminationMember2024-01-012024-06-300001071739us-gaap:HealthCarePremiumMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2023-01-012023-06-300001071739us-gaap:HealthCarePremiumMembercnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-06-300001071739us-gaap:HealthCarePremiumMembercnc:CommercialSegmentMember2023-01-012023-06-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:HealthCarePremiumMemberus-gaap:OperatingSegmentsMember2023-01-012023-06-300001071739us-gaap:OperatingSegmentsMemberus-gaap:ServiceMembercnc:MedicaidSegmentMember2023-01-012023-06-300001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMemberus-gaap:ServiceMember2023-01-012023-06-300001071739us-gaap:OperatingSegmentsMemberus-gaap:ServiceMembercnc:CommercialSegmentMember2023-01-012023-06-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMemberus-gaap:ServiceMember2023-01-012023-06-300001071739cnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2023-01-012023-06-300001071739cnc:MedicareSegmentMembercnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMember2023-01-012023-06-300001071739cnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMembercnc:CommercialSegmentMember2023-01-012023-06-300001071739us-gaap:AllOtherSegmentsMembercnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMember2023-01-012023-06-300001071739cnc:TotalPremiumAndServiceMember2023-01-012023-06-300001071739us-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2023-01-012023-06-300001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-06-300001071739us-gaap:OperatingSegmentsMembercnc:CommercialSegmentMember2023-01-012023-06-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2023-01-012023-06-300001071739us-gaap:OperatingSegmentsMember2023-01-012023-06-300001071739us-gaap:IntersegmentEliminationMembercnc:MedicaidSegmentMember2023-01-012023-06-300001071739us-gaap:IntersegmentEliminationMembercnc:MedicareSegmentMember2023-01-012023-06-300001071739us-gaap:IntersegmentEliminationMembercnc:CommercialSegmentMember2023-01-012023-06-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:IntersegmentEliminationMember2023-01-012023-06-300001071739us-gaap:IntersegmentEliminationMember2023-01-012023-06-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
___________________________________________
FORM 10-Q
____________________________________________
(Mark One)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2024

OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from  _____ to _____
____________________________________________
Commission file number: 001-31826
____________________________________________
CENTENE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware42-1406317
(State or other jurisdiction of(I.R.S. Employer
incorporation or organization)Identification Number)
7700 Forsyth Boulevard 
St. Louis,Missouri63105
(Address of principal executive offices)(Zip Code)

Registrant's telephone number, including area code: (314) 725-4477 
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered
Common Stock $0.001 Par ValueCNCNew York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days ☒ Yes ☐ No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files) ☒ Yes ☐ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act. 
Large accelerated filer☒Accelerated filer☐
Non-accelerated filer ☐Smaller reporting company☐
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No ☒
As of July 24, 2024, the registrant had 526,030 thousand shares of common stock outstanding.


CENTENE CORPORATION
QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS
 PAGE
  
Part I
Financial Information
Item 1.
 
 
 
 
 
 
Item 2.
Item 3.
Item 4.
Part II
Other Information
Item 1.
Item 1A.
Item 2.
Item 5.
Item 6.


CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS

All statements, other than statements of current or historical fact, contained in this filing are forward-looking statements. Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "intend," "seek," "target," "goal," "may," "will," "would," "could," "should," "can," "continue," and other similar words or expressions (and the negative thereof). Centene Corporation and its subsidiaries (Centene, the Company, our or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. In particular, these statements include, without limitation, statements about our future operating or financial performance, market opportunity, competition, expected contract start dates and terms, expected activities in connection with completed and future acquisitions and dispositions, our investments, and the adequacy of our available cash resources. These statements may be found in the various sections of this filing, such as Part I, Item 2. "Management's Discussion and Analysis of Financial Condition and Results of Operations," Part II, Item 1. "Legal Proceedings," and Part II, Item 1A. "Risk Factors."

These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments, and other factors we believe appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive, and other factors that may cause our or our industry's actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions.

All forward-looking statements included in this filing are based on information available to us on the date of this filing. Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this filing, whether as a result of new information, future events, or otherwise, after the date of this filing. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables, and events including, but not limited to:

•our ability to design and price products that are competitive and/or actuarially sound including but not limited to any impacts resulting from Medicaid redeterminations;
•our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth;
•our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates;
•competition, including for providers, broker distribution networks, contract reprocurements and organic growth;
•our ability to adequately anticipate demand and provide for operational resources to maintain service level requirements;
•our ability to manage our information systems effectively;
•disruption, unexpected costs, or similar risks from business transactions, including acquisitions, divestitures, and changes in our relationships with third parties;
•impairments to real estate, investments, goodwill and intangible assets;
•changes in senior management, loss of one or more key personnel or an inability to attract, hire, integrate and retain skilled personnel;
•membership and revenue declines or unexpected trends;
•rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses;
•changes in healthcare practices, new technologies, and advances in medicine;
•our ability to effectively and ethically use artificial intelligence and machine learning in compliance with applicable laws;
•increased healthcare costs;
•inflation and interest rates;
•the effect of social, economic, and political conditions and geopolitical events, including as a result of changes in U.S. presidential administrations or Congress;
•changes in market conditions;
i
•changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder;
•uncertainty concerning government shutdowns, debt ceilings or funding;
•tax matters;
•disasters, climate-related incidents, acts of war or aggression or major epidemics;
•changes in expected contract start dates and terms;
•changes in provider, broker, vendor, state, federal and other contracts and delays in the timing of regulatory approval of contracts, including due to protests;
•the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare or other customers);
•the difficulty of predicting the timing or outcome of legal or regulatory audits, investigations, proceedings or matters including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices on acceptable terms, or at all, or whether additional claims, reviews or investigations will be brought by states, the federal government or shareholder litigants, or government investigations;
•challenges to our contract awards;
•cyber-attacks or other data security incidents or our failure to comply with applicable privacy, data or security laws and regulations;
•the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the terms of our contracts and the undertakings in connection with any regulatory, governmental, or third party consents or approvals for acquisitions or dispositions;
•any changes in expected closing dates, estimated purchase price, or accretion for acquisitions or dispositions;
•losses in our investment portfolio;
•restrictions and limitations in connection with our indebtedness;
•a downgrade of our corporate family rating, issuer rating or credit rating of our indebtedness; and
•the availability of debt and equity financing on terms that are favorable to us.

This list of important factors is not intended to be exhaustive. We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition, and results of operations, in our filings with the Securities and Exchange Commission (SEC), including our annual report on Form 10-K, other quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, we cannot give assurances with respect to our future performance, including without limitation our ability to maintain adequate premium levels or our ability to control our future medical and selling, general and administrative costs.


ii

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures in this report as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance more consistently across periods. The Company uses the presented non-GAAP financial measures internally in evaluating the Company's performance and for planning purposes, by allowing management to focus on period-to-period changes in the Company's core business operations, and in determining employee incentive compensation. Therefore, the Company believes that this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The Company strongly encourages investors to review its consolidated financial statements and publicly filed reports in their entirety and cautions investors that the non-GAAP financial measures used by the Company may differ from similar measures used by other companies, even when similar terms are used to identify such measures. The presentation of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

Specifically, the Company believes the presentation of non-GAAP financial measures that excludes amortization of acquired intangible assets, acquisition and divestiture related expenses, as well as other items, allows investors to develop a more meaningful understanding of the Company's core performance over time.

The tables below provide reconciliations of non-GAAP items ($ in millions, except per share data):
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
GAAP net earnings attributable to Centene$1,146 $1,058 $2,309 $2,188 
Amortization of acquired intangible assets173 179 346 362 
Acquisition and divestiture related expenses6 13 67 36 
Other adjustments (1)
2 (74)(97)(127)
Income tax effects of adjustments (2)
(44)(21)(126)(135)
Adjusted net earnings $1,283 $1,155 $2,499 $2,324 
GAAP diluted earnings per share (EPS) attributable to Centene$2.16 $1.92 $4.32 $3.96 
Amortization of acquired intangible assets0.33 0.33 0.65 0.66 
Acquisition and divestiture related expenses0.01 0.02 0.13 0.07 
Other adjustments (1)
— (0.13)(0.18)(0.23)
Income tax effects of adjustments (2)
(0.08)(0.04)(0.24)(0.25)
Adjusted diluted EPS$2.42 $2.10 $4.68 $4.21 
(1) Other adjustments include the following pre-tax items:
2024:
(a) for the three months ended June 30, 2024: gain on the previously reported divestiture of Circle Health Group (Circle Health) of $10 million, or $0.02 per share ($0.02 after-tax), an additional loss on the divestiture of our Spanish and Central European businesses of $7 million, or $0.01 per share ($0.01 after-tax), severance costs due to a restructuring of $4 million, or $0.01 per share ($0.01 after-tax), reduction to the net gain on the sale of property due to closing costs of $3 million, or $0.00 per share ($0.00 after-tax) and net gain on the finalization of working capital adjustments for the previously reported divestiture of Magellan Specialty Health of $2 million, or $0.00 per share ($0.00 after-tax);

iii
(b) for the six months ended June 30, 2024: net gain on the previously reported divestiture of Magellan Specialty Health due to the achievement of contingent consideration and finalization of working capital adjustments of $83 million, or $0.15 per share ($0.11 after-tax), net gain on the sale of property of $21 million, or $0.04 per share ($0.03 after-tax), gain on the previously reported divestiture of Circle Health of $20 million, or $0.04 per share ($0.12 after-tax), Health Net Federal Services asset impairment due to the 2024 final ruling on the TRICARE Managed Care Support Contract of $14 million, or $0.03 per share ($0.02 after-tax), severance costs due to a restructuring of $13 million, or $0.02 per share ($0.02 after-tax), an additional loss on the divestiture of our Spanish and Central European businesses of $7 million, or $0.01 per share ($0.01 after-tax) and gain on the previously reported divestiture of HealthSmart due to the finalization of working capital adjustments of $7 million, or $0.01 per share ($0.01 after-tax).

2023:
(a) for the three months ended June 30, 2023: gain on the sale of Apixio of $91 million, or $0.16 per share ($0.11 after-tax), gain on the previously reported divestiture of Centurion of $15 million, or $0.02 per share ($0.01 after-tax), an additional loss on the divestiture of our Spanish and Central European businesses of $13 million, or $0.02 per share ($0.01 after-tax) and real estate impairments of $19 million, or $0.03 per share ($0.02 after-tax);

(b) for the six months ended June 30, 2023: gain on the sale of Apixio of $91 million, or $0.16 per share ($0.11 after-tax), gain on the sale of Magellan Specialty Health of $79 million, or $0.14 per share ($0.12 after-tax), gain on the previously reported divestiture of Centurion of $15 million, or $0.03 per share ($0.02 after-tax), an additional loss on the divestiture of our Spanish and Central European businesses of $13 million, or $0.02 per share ($0.01 after-tax) and real estate impairments of $45 million, or $0.08 per share ($0.06 after-tax).

(2) The income tax effects of adjustments are based on the effective income tax rates applicable to each adjustment. The six months ended June 30, 2023, include a one-time income tax benefit of $69 million, or $0.12 per share, resulting from the distribution of long-term stock awards to the estate of the Company's former CEO.

Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
GAAP selling, general and administrative expenses$2,894 $3,016 $6,112 $6,027 
Less:
Acquisition and divestiture related expenses6 13 67 36 
Restructuring costs4 — 13 — 
Real estate optimization— 1 — 7 
Adjusted selling, general and administrative expenses$2,884 $3,002 $6,032 $5,984 
iv
PART I
FINANCIAL INFORMATION

Item 1. Financial Statements.
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In millions, except shares in thousands and per share data in dollars)
June 30, 2024December 31, 2023
(Unaudited)
ASSETS  
Current assets:  
Cash and cash equivalents$17,605 $17,193 
Premium and trade receivables16,587 15,532 
Short-term investments2,609 2,459 
Other current assets1,605 5,572 
Total current assets38,406 40,756 
Long-term investments16,870 16,286 
Restricted deposits1,415 1,386 
Property, software and equipment, net2,041 2,019 
Goodwill17,558 17,558 
Intangible assets, net5,755 6,101 
Other long-term assets1,092 535 
Total assets$83,137 $84,641 
LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY 
Current liabilities:  
Medical claims liability$18,173 $18,000 
Accounts payable and accrued expenses12,232 16,420 
Return of premium payable1,615 1,462 
Unearned revenue597 715 
Current portion of long-term debt112 119 
Total current liabilities32,729 36,716 
Long-term debt17,516 17,710 
Deferred tax liability665 641 
Other long-term liabilities4,770 3,618 
Total liabilities55,680 58,685 
Commitments and contingencies
Redeemable noncontrolling interests16 19 
Stockholders' equity:  
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at June 30, 2024 and December 31, 2023
— — 
Common stock, $0.001 par value; authorized 800,000 shares; 619,495 issued and 526,001 outstanding at June 30, 2024, and 615,291 issued and 534,484 outstanding at December 31, 2023
1 1 
Additional paid-in capital20,461 20,304 
Accumulated other comprehensive (loss)(646)(652)
Retained earnings14,352 12,043 
Treasury stock, at cost (93,494 and 80,807 shares, respectively)
(6,817)(5,856)
Total Centene stockholders' equity27,351 25,840 
Nonredeemable noncontrolling interest90 97 
Total stockholders' equity27,441 25,937 
Total liabilities, redeemable noncontrolling interests and stockholders' equity$83,137 $84,641 
The accompanying notes to the consolidated financial statements are an integral part of these statements. 
1
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions, except shares in thousands and per share data in dollars)
(Unaudited)
 Three Months Ended June 30,Six Months Ended June 30,
 2024202320242023
Revenues:
Premium$35,140 $33,713 $70,669 $67,538 
Service833 1,125 1,641 2,252 
Premium and service revenues35,973 34,838 72,310 69,790 
Premium tax3,863 2,770 7,933 6,707 
Total revenues39,836 37,608 80,243 76,497 
Expenses:  
Medical costs30,765 29,347 61,697 58,781 
Cost of services680 877 1,349 1,747 
Selling, general and administrative expenses2,894 3,016 6,112 6,027 
Depreciation expense133 146 268 288 
Amortization of acquired intangible assets173 179 346 362 
Premium tax expense3,962 2,854 8,123 6,865 
Impairment— 18 13 38 
Total operating expenses38,607 36,437 77,908 74,108 
Earnings from operations1,229 1,171 2,335 2,389 
Other income (expense):  
Investment and other income463 425 1,008 778 
Interest expense(176)(181)(354)(361)
Earnings before income tax1,516 1,415 2,989 2,806 
Income tax expense370 360 685 621 
Net earnings1,146 1,055 2,304 2,185 
Loss attributable to noncontrolling interests— 3 5 3 
Net earnings attributable to Centene Corporation$1,146 $1,058 $2,309 $2,188 

Net earnings per common share attributable to Centene Corporation:
Basic earnings per common share$2.16 $1.93 $4.34 $3.98 
Diluted earnings per common share$2.16 $1.92 $4.32 $3.96 

Weighted average number of common shares outstanding:
Basic529,602 548,932 532,385 549,850 
Diluted530,755 550,308 534,517 551,996 

The accompanying notes to the consolidated financial statements are an integral part of these statements.
2
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)
(In millions, unaudited)
 Three Months Ended June 30,Six Months Ended June 30,
 2024202320242023
Net earnings$1,146 $1,055 $2,304 $2,185 
Change in unrealized gain (loss) on investments(26)(142)(107)111 
Change in unrealized gain (loss) on investments, tax effect6 34 21 (27)
Change in unrealized gain (loss) on investments, net of tax(20)(108)(86)84 
Reclassification adjustment, net of tax4 2 92 4 
Foreign currency translation adjustments, net of tax— 23 — 46 
Other comprehensive earnings (loss)(16)(83)6 134 
Comprehensive earnings1,130 972 2,310 2,319 
Comprehensive loss attributable to noncontrolling interests— 3 5 3 
Comprehensive earnings attributable to Centene Corporation$1,130 $975 $2,315 $2,322 

The accompanying notes to the consolidated financial statements are an integral part of these statements.
3
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(In millions, except shares in thousands and per share data in dollars)
(Unaudited)

Three and Six Months Ended June 30, 2024
 Centene Stockholders' Equity  
 Common Stock   Treasury Stock  
 
$0.001 Par Value Shares
AmtAdditional Paid-in CapitalAccumulated Other Comprehensive
Earnings (Loss)		Retained Earnings
$0.001 Par Value Shares
AmtNoncontrolling
Interest		Total
Balance, December 31, 2023615,291 $1 $20,304 $(652)$12,043 80,807 $(5,856)$97 $25,937 
Comprehensive Earnings:         
Net earnings (loss)— — — — 1,163 — — (4)1,159 
Other comprehensive earnings, net of $(12) tax
— — — 22 — — — — 22 
Common stock issued for employee benefit plans3,882 — 14 — — — — — 14 
Common stock repurchases— — — — — 1,983 (151)— (151)
Stock compensation expense— — 70 — — — — — 70 
Divestiture of non-controlling interest— — — — — — — (3)(3)
Balance, March 31, 2024619,173 $1 $20,388 $(630)$13,206 82,790 $(6,007)$90 $27,048 
Comprehensive Earnings:         
Net earnings— — — — 1,146 — — — 1,146 
Other comprehensive loss, net of $(5) tax
— — — (16)— — — — (16)
Common stock issued for employee benefit plans322 — 11 — — — — — 11 
Common stock repurchases— — — — — 10,704 (810)— (810)
Stock compensation expense— — 62 — — — — — 62 
Balance, June 30, 2024619,495 $1 $20,461 $(646)$14,352 93,494 $(6,817)$90 $27,441 

4
Three and Six Months Ended June 30, 2023
 Centene Stockholders' Equity  
 Common Stock   Treasury Stock  
 
$0.001 Par Value Shares
AmtAdditional Paid-in CapitalAccumulated Other Comprehensive
Earnings (Loss)		Retained Earnings
$0.001 Par Value Shares
AmtNoncontrolling
Interest		Total
Balance, December 31, 2022607,847 $1 $20,060 $(1,132)$9,341 57,093 $(4,213)$124 $24,181 
Comprehensive Earnings:         
Net earnings— — — — 1,130 — — — 1,130 
Other comprehensive earnings, net of $61 tax
— — — 217 — — — — 217 
Common stock issued for employee benefit plans6,508 — 12 — — — — — 12 
Common stock repurchases— — — — — 5,548 (423)— (423)
Stock compensation expense— — 61 — — — — — 61 
Purchase of redeemable noncontrolling interest— — (12)— — — — — (12)
Balance, March 31, 2023614,355 $1 $20,121 $(915)$10,471 62,641 $(4,636)$124 $25,166 
Comprehensive Earnings:         
Net earnings (loss)— — — — 1,058 — — (3)1,055 
Other comprehensive loss, net of $(34) tax
— — — (83)— — — — (83)
Common stock issued for employee benefit plans388 — 9 — — — — — 9 
Common stock repurchases— — — — — 6,099 (408)— (408)
Stock compensation expense— — 56 — — — — — 56 
Purchase of non-redeemable noncontrolling interests— — (3)— — — — (24)(27)
Balance, June 30, 2023614,743 $1 $20,183 $(998)$11,529 68,740 $(5,044)$97 $25,768 

The accompanying notes to the consolidated financial statements are an integral part of these statements.
5
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions, unaudited)

 Six Months Ended June 30,
 20242023
Cash flows from operating activities:  
Net earnings$2,304 $2,185 
Adjustments to reconcile net earnings to net cash provided by operating activities
Depreciation and amortization614 650 
Stock compensation expense132 117 
Impairment13 38 
Deferred income taxes40 (160)
(Gain) loss on divestitures, net(103)(172)
Other adjustments, net(11)68 
Changes in assets and liabilities  
Premium and trade receivables(1,059)(319)
Other assets(404)(325)
Medical claims liabilities173 139 
Unearned revenue(118)1,895 
Accounts payable and accrued expenses(1,704)618 
Other long-term liabilities1,838 2,081 
Other operating activities, net4 — 
Net cash provided by operating activities1,719 6,815 
Cash flows from investing activities:  
Capital expenditures(337)(440)
Purchases of investments(3,434)(3,199)
Sales and maturities of investments2,497 2,293 
Divestiture proceeds, net of divested cash959 669 
Net cash used in investing activities(315)(677)
Cash flows from financing activities:  
Proceeds from long-term debt350 1,281 
Payments and repurchases of long-term debt(565)(1,322)
Common stock repurchases(954)(828)
Proceeds from common stock issuances25 21 
Purchase of noncontrolling interest— (85)
Other financing activities, net(4)— 
Net cash used in financing activities(1,148)(933)
Effect of exchange rate changes on cash, cash equivalents and restricted cash7 (7)
Net increase in cash, cash equivalents and restricted cash and cash equivalents263 5,198 
Cash, cash equivalents and restricted cash and cash equivalents, beginning of period
17,452 12,330 
Cash, cash equivalents and restricted cash and cash equivalents, end of period
$17,715 $17,528 
Supplemental disclosures of cash flow information:  
Interest paid$352 $348 
Income taxes paid$610 $592 
The following table provides a reconciliation of cash, cash equivalents and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above:
June 30,
20242023
Cash and cash equivalents$17,605 $17,170 
Restricted cash and cash equivalents, included in restricted deposits110 358 
Total cash, cash equivalents and restricted cash and cash equivalents$17,715 $17,528 

The accompanying notes to the consolidated financial statements are an integral part of these statements.
6
CENTENE CORPORATION AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

1. Organization and Operations

Basis of Presentation

The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Annual Report on Form 10-K for the fiscal year ended December 31, 2023. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2023 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.

Certain 2023 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2024 presentation. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.

Accounting Guidance Not Yet Adopted

In November 2023, the Financial Accounting Standards Board (FASB) issued an Accounting Standards Update (ASU) which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant expenses. The amendments will require public entities to disclose significant segment expenses that are regularly provided to the chief operating decision-maker and included within segment profit and loss. The new standard is effective for annual periods beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. The Company is currently evaluating the effect of the new disclosure requirements.

In December 2023, the FASB issued an ASU which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The new standard is effective for annual periods beginning after December 15, 2024. The Company is currently evaluating the effect of the new disclosure requirements.

In March 2024, the SEC adopted the final rule under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors. This rule will require disclosure of material climate-related risks and material direct greenhouse gas emissions from operations owned or controlled (Scope 1) and/or material indirect greenhouse gas emissions from purchased energy consumed in owned or controlled operations (Scope 2). Additionally, the rules require disclosure in the notes to the financial statements of the effects of severe weather events and other natural conditions, subject to certain materiality thresholds. The disclosure requirements will begin phasing in for reports and registration statements including financial information with respect to annual periods beginning in 2025. In April 2024, the SEC voluntarily stayed the final rule pending the completion of judicial review by the Court of Appeals for the Eighth Circuit. The Company is monitoring the development of litigation related to the SEC's rule, and is currently evaluating the effect of the new disclosure requirements.

2. Acquisitions and Divestitures

Magellan Specialty Health Divestiture

For the six months ended June 30, 2024, the Company recorded an additional gain on the previously reported divestiture of Magellan Specialty Health of $83 million for achievement of contingent consideration related to the sale and finalization of working capital adjustments, which is included in investment and other income in the Consolidated Statements of Operations.

Circle Health Group Divestiture

On August 28, 2023, the Company signed a definitive agreement to sell Circle Health Group (Circle Health), one of the U.K.'s largest independent hospital operators, which is included in the Other segment.

7
In accordance with the signed definitive agreement in the third quarter of 2023, and subsequently updated in the fourth quarter of 2023, the Company recorded impairment charges related to goodwill associated with the pending divestiture totaling $292 million, or $258 million after-tax.

In order to manage the foreign exchange risk on the sale price associated with the pending divestiture of Circle Health, in August 2023 the Company entered into a foreign currency swap agreement for a notional amount of $931 million, to sell £740 million. The swap agreement was formally designated and qualified as a cash flow hedge. The swap expired on the earlier of the divestiture closing date or March 28, 2024. The gain or loss due to changes in the fair value of the foreign currency swap was recorded in other comprehensive income until the Circle Health divestiture closed, at which time the gain or loss was recorded in earnings to the same line in the Consolidated Statement of Operations as the gain or loss on sale.

On January 12, 2024, the Company completed the divestiture for $931 million. Upon closing the divestiture, the Company settled the foreign currency swap and recorded a corresponding gain of $20 million, which includes the cumulative translation adjustment previously recorded in accumulated other comprehensive income in the Consolidated Balance Sheet. The gain is included in investment and other income in the Consolidated Statements of Operations. During the six months ended June 30, 2024, the Company realized a net tax benefit of approximately $40 million on the loss recognized on the divestiture.

3. Short-term and Long-term Investments, Restricted Deposits

Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):
 June 30, 2024December 31, 2023
 Amortized CostGross
Unrealized Gains		Gross
Unrealized Losses		Fair ValueAmortized CostGross
Unrealized Gains		Gross
Unrealized Losses		Fair Value
Debt securities:
U.S. Treasury securities and obligations of
U.S. government corporations and agencies
$591 $— $(7)$584 $403 $— $(8)$395 
Corporate securities10,554 32 (468)10,118 9,984 78 (461)9,601 
Restricted certificates of deposit
4 — — 4 4 — — 4 
Restricted cash equivalents
110 — — 110 259 — — 259 
Short-term time deposits
586 — — 586 746 — — 746 
Municipal securities4,229 7 (184)4,052 4,135 21 (171)3,985 
Asset-backed securities1,741 8 (29)1,720 1,665 8 (35)1,638 
Residential mortgage-backed securities1,606 2 (129)1,479 1,503 7 (103)1,407 
Commercial mortgage-backed securities
1,222 2 (79)1,145 1,149 5 (82)1,072 
Equity securities17 — — 17 17 — — 17 
Private equity investments
890 — — 890 833 — — 833 
Life insurance contracts
189 — — 189 174 — — 174 
Total$21,739 $51 $(896)$20,894 $20,872 $119 $(860)$20,131 

The Company's investments are debt securities classified as available-for-sale with the exception of equity securities, certain private equity investments and life insurance contracts. Private equity investments include direct investments in private equity securities as well as private equity funds. The Company's investment policies are designed to provide liquidity, preserve capital and maximize total return on invested assets with a focus on high credit quality securities. The Company limits the size of investment in any single issuer other than U.S. treasury securities and obligations of U.S. government corporations and agencies. As of June 30, 2024, 99% of the Company's investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations. At June 30, 2024, the Company held certificates of deposit, equity securities, private equity investments and life insurance contracts, which did not carry a credit rating. Accrued interest income on available-for-sale debt securities was $168 million and $153 million at June 30, 2024 and December 31, 2023, respectively, and is included in other current assets in the Consolidated Balance Sheets.

8
The Company's residential mortgage-backed securities are primarily issued by the Federal National Mortgage Association, Government National Mortgage Association or Federal Home Loan Mortgage Corporation, which carry implicit or explicit guarantees of the U.S. government. The Company's commercial mortgage-backed securities are primarily senior tranches with a weighted average rating of AA+ and a weighted average duration of 3 years at June 30, 2024.

The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):
 June 30, 2024December 31, 2023
 Less Than 12 Months12 Months or MoreLess Than 12 Months12 Months or More
 Unrealized LossesFair ValueUnrealized LossesFair ValueUnrealized LossesFair ValueUnrealized LossesFair Value
U.S. Treasury securities and obligations of
U.S. government corporations and agencies
$— $205 $(7)$224 $— $79 $(8)$232 
Corporate securities(20)1,895 (448)6,017 (6)658 (455)6,260 
Municipal securities(11)959 (173)2,365 (4)553 (167)2,237 
Asset-backed securities(1)266 (28)519 (2)197 (33)855 
Residential mortgage-backed securities(7)397 (122)857 (2)153 (101)814 
Commercial mortgage-backed securities(1)147 (78)802 (2)114 (80)754 
Short-term time deposits— — — — — 31 — — 
Total$(40)$3,869 $(856)$10,784 $(16)$1,785 $(844)$11,152 

As of June 30, 2024, the gross unrealized losses were generated from 4,626 positions out of a total of 6,830 positions. The change in fair value of available-for-sale debt securities is primarily a result of movement in interest rates subsequent to the purchase of the security.

For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes. If the security meets this criterion, the decline in fair value is recorded in earnings. The Company does not intend to sell these securities prior to maturity and it is not likely that the Company will be required to sell these securities prior to maturity; therefore, the Company did not record an impairment for these securities.

In addition, the Company monitors available-for-sale debt securities for credit losses. Certain investments have experienced a decline in fair value due to changes in credit quality, market interest rates and/or general economic conditions. The Company recognizes an allowance when evidence demonstrates that the decline in fair value is credit related. Evidence of a credit-related loss may include rating agency actions, adverse conditions specifically related to the security or failure of the issuer of the security to make scheduled payments.

The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):
 June 30, 2024December 31, 2023
 InvestmentsRestricted DepositsInvestmentsRestricted Deposits
 Amortized CostFair ValueAmortized CostFair ValueAmortized CostFair ValueAmortized CostFair Value
One year or less$2,428 $2,403 $395 $392 $2,308 $2,284 $566 $564 
One year through five years7,877 7,546 733 709 7,738 7,431 527 504 
Five years through ten years4,166 3,947 291 278 3,905 3,735 298 283 
Greater than ten years147 143 37 36 155 154 34 35 
Asset-backed securities4,569 4,344 — — 4,317 4,117 — — 
Total$19,187 $18,383 $1,456 $1,415 $18,423 $17,721 $1,425 $1,386 
 
9
Actual maturities may differ from contractual maturities due to call or prepayment options. Equity securities, private equity investments and life insurance contracts are excluded from the table above because they do not have a contractual maturity. The Company has an option to redeem substantially all of the securities included in the greater than ten years category listed above at amortized cost.

4. Fair Value Measurements

Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:
Level Input:Input Definition:
Level IInputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
 
Level IIInputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.
 
Level IIIUnobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.

The following table summarizes fair value measurements by level at June 30, 2024, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$17,605 $— $— $17,605 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$58 $— $— $58 
Corporate securities— 10,080 — 10,080 
Municipal securities— 3,315 — 3,315 
Short-term time deposits— 586 — 586 
Asset-backed securities— 1,720 — 1,720 
Residential mortgage-backed securities— 1,479 — 1,479 
Commercial mortgage-backed securities— 1,145 — 1,145 
Equity securities14 3 — 17 
Total investments$72 $18,328 $— $18,400 
Restricted deposits:    
Cash and cash equivalents$110 $— $— $110 
U.S. Treasury securities and obligations of U.S. government corporations and agencies526 — — 526 
Corporate securities— 38 — 38 
Certificates of deposit— 4 — 4 
Municipal securities— 737 — 737 
Total restricted deposits$636 $779 $— $1,415 
Total assets at fair value$18,313 $19,107 $— $37,420 

10
The following table summarizes fair value measurements by level at December 31, 2023, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$17,193 $— $— $17,193 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$62 $— $— $62 
Corporate securities— 9,564 — 9,564 
Municipal securities— 3,232 — 3,232 
Short-term time deposits— 746 — 746 
Asset backed securities— 1,638 — 1,638 
Residential mortgage-backed securities— 1,407 — 1,407 
Commercial mortgage-backed securities— 1,072 — 1,072 
Equity securities15 2 — 17 
Total investments$77 $17,661 $— $17,738 
Restricted deposits:    
Cash and cash equivalents$259 $— $— $259 
U.S. Treasury securities and obligations of U.S. government corporations and agencies333 — — 333 
Corporate securities— 37 — 37 
Certificates of deposit— 4 — 4 
Municipal securities— 753 — 753 
Total restricted deposits$592 $794 $— $1,386 
Total assets at fair value$17,862 $18,455 $— $36,317 
Liabilities
Accounts payable and accrued expenses:
Foreign currency swap agreement$— $13 $— $13 
Total liabilities at fair value$— $13 $— $13 
 
The Company utilizes matrix-pricing services to estimate fair value for securities which are not actively traded on the measurement date. The Company designates these securities as Level II fair value measurements. In addition, the aggregate carrying amount of the Company's private equity investments and life insurance contracts, which approximates fair value, was $1,079 million and $1,007 million as of June 30, 2024 and December 31, 2023, respectively.
11
5. Medical Claims Liability

The following table summarizes the change in medical claims liability for the six months ended June 30, 2024 ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, January 1, 2024$10,814 $3,612 $3,460 $114 $18,000 
Less: Reinsurance recoverable5 — 44 — 49 
Balance, January 1, 2024, net10,809 3,612 3,416 114 17,951 
Incurred related to:
Current year39,398 10,953 12,274 758 63,383 
Prior years(1,136)(316)(326)7 (1,771)
Total incurred38,262 10,637 11,948 765 61,612 
Paid related to:
Current year30,696 8,093 9,143 633 48,565 
Prior years7,918 2,562 2,367 121 12,968 
Total paid38,614 10,655 11,510 754 61,533 
Plus: Premium deficiency reserve— 85 — — 85 
Balance, June 30, 2024, net
10,457 3,679 3,854 125 18,115 
Plus: Reinsurance recoverable15 — 43 — 58 
Balance, June 30, 2024
$10,472 $3,679 $3,897 $125 $18,173 

The following table summarizes the change in medical claims liability for the six months ended June 30, 2023 ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, January 1, 2023$11,253 $3,431 $1,921 $140 $16,745 
Less: Reinsurance recoverable7 — 19 — 26 
Balance, January 1, 2023, net11,246 3,431 1,902 140 16,719 
Incurred related to:
Current year40,622 10,083 8,857 773 60,335 
Prior years(1,153)(191)(208)(2)(1,554)
Total incurred39,469 9,892 8,649 771 58,781 
Paid related to:
Current year31,837 7,726 6,751 656 46,970 
Prior years7,890 2,357 1,282 137 11,666 
Total paid39,727 10,083 8,033 793 58,636 
Balance, June 30, 2023, net
10,988 3,240 2,518 118 16,864 
Plus: Reinsurance recoverable5 — 15 — 20 
Balance, June 30, 2023
$10,993 $3,240 $2,533 $118 $16,884 

Reinsurance recoverables related to medical claims are included in premium and trade receivables. Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. Additionally, as a result of development within "Incurred related to: Prior years," the Company recorded $88 million and $319 million as a reduction to premium revenue in the six months ended June 30, 2024 and 2023, respectively, for minimum health benefits ratio (HBR) and other return of premium programs.

Incurred but not reported (IBNR) plus expected development on reported claims as of June 30, 2024 was $12,337 million. Total IBNR plus expected development on reported claims represents estimates for claims incurred but not reported, development on reported claims and estimates for the costs necessary to process unpaid claims at the end of each period. The Company estimates its liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice. These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services and other relevant factors.

12
The Company reviews actual and anticipated experience compared to the assumptions used to establish medical costs. The Company establishes premium deficiency reserves if actual and anticipated experience indicates that existing policy liabilities together with the present value of future gross premiums will not be sufficient to cover the present value of future benefits, settlement and maintenance costs. For purposes of determining premium deficiencies, contracts are grouped in a manner consistent with the method of acquiring, servicing and measuring the profitability of such contracts and expected investment income is excluded. In December 2023, the Company recorded a premium deficiency reserve of $250 million related to the 2024 Medicare Advantage contract year, which was increased to $300 million in the first quarter of 2024 and to $335 million in the second quarter of 2024 consistent with the intra-year flow of seasonality.

6. Affordable Care Act

The Affordable Care Act established risk spreading premium stabilization programs as well as a minimum annual medical loss ratio (MLR) and cost sharing reductions.

The Company's net receivables (payables) for each of the programs are as follows ($ in millions):
June 30, 2024December 31, 2023
Risk adjustment receivable$2,047 $893 
Risk adjustment payable(3,475)(2,553)
Minimum medical loss ratio(675)(164)
Cost sharing reduction receivable12 — 
Cost sharing reduction payable(111)(114)
In July 2024, the Centers for Medicare and Medicaid Services (CMS) announced the final risk adjustment transfers for the 2023 benefit year. Based on the Company's estimate of the final settlement, the risk adjustment net payable was decreased by $1,344 million in the first half of 2024. After consideration of minimum MLR and other related impacts, the net pre-tax benefit recognized was $945 million in the six months ended June 30, 2024 ($78 million in the first quarter of 2024 and $867 million in the second quarter of 2024).

7. Debt
 
Debt consists of the following ($ in millions):
 June 30, 2024December 31, 2023
$2,500 million 4.25% Senior Notes due December 15, 2027
$2,397 $2,395 
$2,300 million 2.45% Senior Notes due July 15, 2028
2,303 2,303 
$3,500 million 4.625% Senior Notes due December 15, 2029
3,277 3,277 
$2,000 million 3.375% Senior Notes due February 15, 2030
2,000 2,000 
$2,200 million 3.00% Senior Notes due October 15, 2030
2,200 2,200 
$2,200 million 2.50% Senior Notes due March 1, 2031
2,200 2,200 
$1,300 million 2.625% Senior Notes due August 1, 2031
1,300 1,300 
Total senior notes15,677 15,675 
Term Loan Facility2,060 2,115 
Revolving Credit Agreement— 150 
Finance leases and other2 11 
Debt issuance costs(111)(122)
Total debt17,628 17,829 
Less: current portion(112)(119)
 Long-term debt$17,516 $17,710 
13
8. Stockholders' Equity

The Company's Board of Directors has authorized a stock repurchase program of the Company's common stock from time to time on the open market or through privately negotiated transactions. The Company is authorized to repurchase up to $10,000 million, inclusive of past authorizations. As of June 30, 2024, the Company had a remaining amount of $4,378 million available under the stock repurchase program.

The following represents the Company's share repurchase activity ($ in millions, shares in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
SharesCostSharesCostSharesCostSharesCost
Share buybacks10,660 $800 6,028 $400 11,341 $851 10,880 $777 
Income tax withholding44 3 71 5 1,346 103 767 51 
Total share repurchases (1)
10,704 $803 6,099 $405 12,687 $954 11,647 $828 
(1)
Excludes share repurchase excise tax of approximately $7 million and $3 million accrued as of June 30, 2024 and 2023, respectively.

Shares repurchased for income tax withholding are shares withheld in connection with employee stock plans to meet applicable tax withholding requirements. These shares are typically included in the Company's treasury stock.

9. Earnings Per Share

The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):
Three Months Ended June 30,Six Months Ended June 30,
 2024202320242023
Earnings attributable to Centene Corporation$1,146 $1,058 $2,309 $2,188 
Shares used in computing per share amounts: 
Weighted average number of common shares outstanding529,602 548,932 532,385 549,850 
Common stock equivalents (as determined by applying the treasury stock method)1,153 1,376 2,132 2,146 
Weighted average number of common shares and potential dilutive common shares outstanding530,755 550,308 534,517 551,996 
Net earnings per common share attributable to Centene Corporation:
Basic earnings per common share$2.16 $1.93 $4.34 $3.98 
Diluted earnings per common share$2.16 $1.92 $4.32 $3.96 

The calculation of diluted earnings per common share for the three months ended June 30, 2024 and 2023 excludes 271 thousand shares and 1,519 thousand shares, respectively, related to anti-dilutive stock options, restricted stock and restricted stock units.

The calculation of diluted earnings per common share for the six months ended June 30, 2024 and 2023 excludes 267 thousand shares and 1,611 thousand shares, respectively, related to anti-dilutive stock options, restricted stock and restricted stock units.
14
10. Segment Information

The Company operates in four segments: (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment and (4) an Other segment.

The Medicaid, Medicare and Commercial segments represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies, among others. The Company's international businesses, Operose Health Group (Operose Health) and Circle Health, were divested in December 2023 and January 2024, respectively.

Factors used in determining the reportable business segments include the nature of operating activities, the existence of separate senior management teams and the type of information presented to the Company's chief operating decision-maker to evaluate all results of operations. The Company does not report total assets by segment since this is not a metric used to allocate resources or evaluate segment performance.

Segment information for the three months ended June 30, 2024, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$20,229 $5,978 $8,534 $399 $35,140 
Service21 — 1 811 833 
Premium and service revenues20,250 5,978 8,535 1,210 35,973 
Premium tax3,863 — — — 3,863 
Total external revenues24,113 5,978 8,535 1,210 39,836 
Internal revenues— — — 4,081 4,081 
Eliminations— — — (4,081)(4,081)
Total revenues$24,113 $5,978 $8,535 $1,210 $39,836 
Medical costs$18,767 $5,333 $6,268 $397 $30,765 
Cost of services$22 $— $— $658 $680 
Gross margin (1)
$1,461 $645 $2,267 $155 $4,528 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.

Segment information for the three months ended June 30, 2023, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$21,895 $5,665 $5,734 $419 $33,713 
Service— — — 1,125 1,125 
Premium and service revenues21,895 5,665 5,734 1,544 34,838 
Premium tax2,770 — — — 2,770 
Total external revenues24,665 5,665 5,734 1,544 37,608 
Internal revenues— — — 3,789 3,789 
Eliminations— — — (3,789)(3,789)
Total revenues$24,665 $5,665 $5,734 $1,544 $37,608 
Medical costs$19,459 $4,884 $4,644 $360 $29,347 
Cost of services$2 $— $— $875 $877 
Gross margin (1)
$2,434 $781 $1,090 $309 $4,614 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.
15
Segment information for the six months ended June 30, 2024, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$41,667 $11,913 $16,284 $805 $70,669 
Service43 — 2 1,596 1,641 
Premium and service revenues41,710 11,913 16,286 2,401 72,310 
Premium tax7,933 — — — 7,933 
Total external revenues49,643 11,913 16,286 2,401 80,243 
Internal revenues— — — 8,161 8,161 
Eliminations— — — (8,161)(8,161)
Total revenues$49,643 $11,913 $16,286 $2,401 $80,243 
Medical costs$38,262 $10,722 $11,948 $765 $61,697 
Cost of services$43 $— $— $1,306 $1,349 
Gross margin (1)
$3,405 $1,191 $4,338 $330 $9,264 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.

Segment information for the six months ended June 30, 2023, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$44,122 $11,541 $10,986 $889 $67,538 
Service— — — 2,252 2,252 
Premium and service revenues44,122 11,541 10,986 3,141 69,790 
Premium tax6,707 — — — 6,707 
Total external revenues50,829 11,541 10,986 3,141 76,497 
Internal revenues— — — 7,656 7,656 
Eliminations— — — (7,656)(7,656)
Total revenues$50,829 $11,541 $10,986 $3,141 $76,497 
Medical costs$39,469 $9,892 $8,649 $771 $58,781 
Cost of services$2 $— $— $1,745 $1,747 
Gross margin (1)
$4,651 $1,649 $2,337 $625 $9,262 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.
16
11. Contingencies

The Company is routinely subjected to legal and regulatory proceedings in the normal course of business. These matters can include, without limitation:

•periodic compliance and other reviews and investigations by various federal and state regulatory agencies with respect to requirements applicable to the Company's business, including, without limitation, those related to payment of out-of-network claims, compliance with CMS Medicare and Marketplace regulations, including risk adjustment and broker compensation, compliance with the False Claims Act, the calculation of minimum MLR and rebates related thereto, submissions to state agencies related to payments or state false claims acts, pre-authorization penalties, timely review of grievances and appeals, timely and accurate payment of claims, cybersecurity issues, including those related to the Company's or the Company's third-party vendors' information systems, and the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and other federal and state fraud, waste and abuse laws;
•litigation arising out of general business activities, such as tax matters, disputes related to healthcare benefits coverage or reimbursement, putative securities class actions, and medical malpractice, privacy, real estate, intellectual property, vendor disputes and employment-related claims; and
•disputes regarding reinsurance arrangements, claims arising out of the acquisition or divestiture of various assets, class actions and claims relating to the performance of contractual and non-contractual obligations to providers, members, employer groups, vendors and others, including, but not limited to, the alleged failure to properly pay claims and challenges to the manner in which the Company processes claims, claims related to network adequacy and claims alleging that the Company has engaged in unfair business practices.

Among other things, these matters may result in awards of damages, fines or penalties, which could be substantial, and/or could require changes to the Company's business. The Company intends to vigorously defend itself against legal and regulatory proceedings to which it is currently a party; however, these proceedings are subject to many uncertainties. In some of the cases pending against the Company, substantial non-economic or punitive damages are being sought.

The Company records reserves and accrues costs for certain legal proceedings and regulatory matters to the extent that it determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect the Company's best estimate of the probable loss for such matters, the recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to, they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; involve a large number of parties, claimants or regulatory bodies; are in the early stages of the proceedings; involve a number of separate proceedings and/or a wide range of potential outcomes; or result in a change of business practices.

As of the date of this report, amounts accrued for legal proceedings and regulatory matters were not material, except for the reserve estimate as previously disclosed in the Company's 2023 Annual Report on Form 10-K with respect to claims or potential claims involving services provided by Envolve Pharmacy Solutions, Inc. (Envolve), as the Company's pharmacy benefits management (PBM) subsidiary. The Company has reached no-fault settlement agreements related to services previously provided by Envolve with the vast majority of states impacted. Such agreements have provided for payment amounts consistent with the initial reserve estimate established in the second quarter of 2021 related to this issue.

It is possible that in a particular quarter or annual period the Company's financial condition, results of operations, cash flow and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of or development in legal and/or regulatory proceedings. The Company believes that the ultimate outcome of any of the regulatory and legal proceedings that are currently pending against it should not have a material adverse effect on financial condition, results of operations, cash flow or liquidity.

17

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes included elsewhere in this filing. The discussion contains forward-looking statements that involve known and unknown risks and uncertainties.

EXECUTIVE OVERVIEW

General

We are a leading provider of government-sponsored healthcare. We provide access to quality healthcare for more than 1 in 15 individuals nationwide through government-sponsored programs, including Medicaid, Medicare and the Health Insurance Marketplace. Our focus is on improving health and health care for low-income, complex populations.

Our results of operations depend on our ability to manage expenses associated with health benefits (including estimated costs incurred) and selling, general and administrative (SG&A) costs. We measure operating performance based upon two key ratios. The health benefits ratio (HBR) represents medical costs as a percentage of premium revenues, excluding premium tax revenues that are separately billed, and reflects the direct relationship between the premiums received and the medical services provided. The SG&A expense ratio represents SG&A costs as a percentage of premium and service revenues, excluding premium taxes separately billed.

Regulatory Trends and Uncertainties

The United States government, policymakers and healthcare experts continue to discuss and debate various elements of the United States healthcare model. We remain focused on the promise of delivering access to high-quality, affordable healthcare to all of our members and believe we are well positioned to meet the needs of the changing healthcare landscape.

In contrast to previous executive and legislative efforts to restrict or limit certain provisions of the Affordable Care Act (ACA), legislation and regulations at the federal level over the last few years have contained provisions aimed at leveraging Medicaid and the Health Insurance Marketplace to expand health insurance coverage and affordability to consumers. The American Rescue Plan Act (ARPA), enacted in March 2021, initially enhanced eligibility for the premium tax credit for enrollees in the Health Insurance Marketplace, which was extended through 2025 by the Inflation Reduction Act, enacted in August 2022.

In addition, newly finalized Centers for Medicare & Medicaid Services (CMS) regulations will require beneficiaries dually enrolled in Medicare and Medicaid who receive integrated care through Medicare Advantage Dual Eligible Special Needs Plans (D-SNPs) to have aligned enrollment with their Medicaid Managed Care Organization beginning in 2027, which may restrict our product offerings in some geographic service areas. We believe we are positioned well given our overlapping Medicaid and Medicare Advantage footprints and are committed to navigating evolving regulations.

The COVID-19 pandemic impacted and continues to affect our business as it relates to Medicaid eligibility changes. The Families First Coronavirus Response Act, enacted in March 2020, increased federal matching rates for state Medicaid programs with a requirement that states suspend Medicaid redeterminations throughout the public health emergency (PHE). As a result, since the onset of the PHE through March 2023, our Medicaid membership increased by 3.6 million members (excluding new states North Carolina and Delaware and various state product expansions or managed care organization changes). The Consolidated Appropriations Act, 2023, signed into law on December 29, 2022, delinked the Medicaid continuous coverage requirements from the PHE and, as a result, some states began Medicaid disenrollments on April 1, 2023. Per the Act and clarifying CMS guidance, redeterminations related to the PHE were largely intended to conclude during the second quarter of 2024. However, redeterminations in certain states moved at a slower pace due to CMS compliance action to pause and/or complete corrective action prior to disenrolling beneficiaries and some states have seen redeterminations extend past the second quarter of 2024. Since redeterminations began in April 2023, our Medicaid membership decreased by 2.4 million members. We anticipate that any remaining reductions will be limited as the majority of states have substantially completed their unwinding processes as of July 2024.

We are actively engaged to help ensure individuals take the state agency requested action to confirm eligibility in their Medicaid coverage or find other appropriate coverage that is best for themselves and their families. Our Ambetter Health product covers the majority of our Medicaid states, and we believe we are among the best positioned in the healthcare market to enroll those transitioning coverage through redeterminations.

18
We also closely monitor state legislation across our markets and are advocating for and seeing adoption of coverage expansions for Medicaid adult populations (e.g., North Carolina), postpartum, foster care children, among others, as well as mitigating adverse legislation addressing pharmacy, prior authorization and other issues. The Consolidated Appropriations Act, 2023 outlined key coverage expansion provisions, which went into effect in January 2024, requiring states to provide 12 months of continuous coverage for children under Medicaid and the Children's Health Insurance Program (CHIP). The year-end spending bill also made the state option to extend coverage for postpartum women for up to 12 months permanent.

We have more than three decades of experience, spanning seven presidents from both sides of the aisle, in delivering high-quality healthcare services on behalf of states and the federal government to under-insured and uninsured families, commercial organizations and military families. This expertise has allowed us to deliver cost-effective services to our government partners and our members. With trends in the personalization of healthcare technology, we continue the use of data and analytics to optimize our business. We continue to believe we have both the capacity and capability to successfully navigate industry changes to the benefit of our members, customers, providers and shareholders.

Second Quarter 2024 Highlights

Our financial performance for the second quarter of 2024 is summarized as follows:

•Managed care membership of 28.5 million, an increase of 66 thousand members, or 0.2% year-over-year.

•Total revenues of $39.8 billion, representing 6% growth year-over-year.

•Premium and service revenues of $36.0 billion, representing 3% growth year-over-year.

•HBR of 87.6%, compared to 87.0% for the second quarter of 2023.

•SG&A expense ratio of 8.0%, compared to 8.7% for the second quarter of 2023.

•Adjusted SG&A expense ratio of 8.0%, compared to 8.6% for the second quarter of 2023.

•Operating cash flows provided cash of $2.2 billion in the second quarter of 2024.

•Diluted earnings per share (EPS) of $2.16, compared to $1.92 for the second quarter of 2023.

•Adjusted diluted EPS of $2.42, compared to $2.10 for the second quarter of 2023.

19
A reconciliation from GAAP diluted EPS to adjusted diluted EPS is highlighted below, and additional detail is provided above under the heading "Non-GAAP Financial Presentation":
Three Months Ended June 30,
20242023
GAAP diluted EPS attributable to Centene$2.16 $1.92 
Amortization of acquired intangible assets0.33 0.33 
Acquisition and divestiture related expenses0.01 0.02 
Other adjustments (1)
— (0.13)
Income tax effects of adjustments (2)
(0.08)(0.04)
Adjusted diluted EPS$2.42 $2.10 
(1) Other adjustments include the following pre-tax items:
2024:
(a) gain on the previously reported divestiture of Circle Health Group (Circle Health) of $10 million, or $0.02 per share ($0.02 after-tax), an additional loss on the divestiture of our Spanish and Central European businesses of $7 million, or $0.01 per share ($0.01 after-tax), severance costs due to a restructuring of $4 million, or $0.01 per share ($0.01 after-tax), reduction to the net gain on the sale of property due to closing costs of $3 million, or $0.00 per share ($0.00 after-tax) and net gain on the finalization of working capital adjustments for the previously reported divestiture of Magellan Specialty Health of $2 million, or $0.00 per share ($0.00 after-tax);

2023:
(a) gain on the sale of Apixio of $91 million, or $0.16 per share ($0.11 after-tax), gain on the previously reported divestiture of Centurion of $15 million, or $0.02 per share ($0.01 after-tax), an additional loss on the divestiture of our Spanish and Central European businesses of $13 million, or $0.02 per share ($0.01 after-tax) and real estate impairments of $19 million, or $0.03 per share ($0.02 after-tax).

(2) The income tax effects of adjustments are based on the effective income tax rates applicable to each adjustment. The six months ended June 30, 2023, include a one-time income tax benefit of $69 million, or $0.12 per share, resulting from the distribution of long-term stock awards to the estate of the Company's former CEO.

We reference an adjusted SG&A expense ratio, defined as adjusted SG&A expenses, which excludes acquisition and divestiture related expenses and other items, divided by premium and service revenues. A reconciliation from GAAP SG&A to adjusted SG&A and additional detail is provided above under the heading "Non-GAAP Financial Presentation." We also reference effective tax rate on adjusted earnings, defined as GAAP income tax expense (benefit) excluding the income tax effects of adjustments to net earnings divided by adjusted earnings (loss) before income tax expense.


20
Current and Future Operating Drivers

The following items contributed to our results of operations as compared to the previous year:

Medicaid

•In April 2024, our subsidiary, Oklahoma Complete Health, commenced the statewide contracts to provide managed care for the SoonerSelect and SoonerSelect Children's Specialty Plan programs. The new contracts have a one-year term with five, one-year renewal options.

•In January 2024, our subsidiary, Nebraska Total Care, commenced the statewide Medicaid managed care contract to continue serving the state's Medicaid Managed Care Program, known as Heritage Health. The initial contract term is five years and includes the option for two subsequent, one-year renewals, for a potential total of seven years.

•In January 2024, our California health plan commenced direct Medicaid contracts in 10 counties (Los Angeles, Sacramento, Amador, Calaveras, Inyo, Mono, San Joaquin, Stanislaus, Tulare and Tuolumne). In Los Angeles, a portion of the membership is subcontracted. Prior to January 2024, our California health plan previously served the state's Medicaid Managed Care population with contracts in 13 counties, including San Diego.

•In December 2023, our subsidiaries, Carolina Complete Health and WellCare of North Carolina, began providing coverage under North Carolina's new Medicaid Expansion program.

•In September 2023, our subsidiary, Superior HealthPlan (Superior), commenced a new six-year contract awarded by the Texas Health and Human Services Commission to continue providing youth in foster care with healthcare coverage through the STAR Health Medicaid program. Superior has been the sole provider of STAR Health coverage since the program launched in 2008.

•In April 2023, eligibility redeterminations related to the PHE began. We anticipate that any remaining reductions will be limited as the majority of states have substantially completed their unwinding processes as of July 2024. We continue to work with our state partners to match rates to acuity post-redeterminations.

•In April 2023, the state of New York removed pharmacy services for certain of our managed care contracts in connection with the state's transition of pharmacy services to Medicaid fee-for-service.

•In February 2023, our subsidiary, Buckeye Health Plan, commenced the Medicaid contract awarded by the Ohio Department of Medicaid to continue providing members with quality healthcare, coordinated services and benefits.

Medicare

•Given our strong bid positioning, Medicare Prescription Drug Plan (PDP) membership increased 47% year-over-year.

•Consistent with our strategic positioning and bid strategy, Medicare Advantage membership declined year-over-year.

•The decrease in our Star quality ratings in the 2023 rating year, which CMS published in October 2022, adversely impacts our 2024 Medicare revenue. The decrease in Star quality ratings is driven by the expiration of certain disaster relief provisions as well as deterioration in select metrics. As a result of this expectation, we recorded a premium deficiency reserve of $250 million in the fourth quarter of 2023, which increased to $300 million in the first quarter of 2024 and to $335 million in the second quarter of 2024 to reflect the seasonality of earnings, in connection with the 2024 Medicare Advantage business.

Commercial

•In 2024, our Health Insurance Marketplace product, Ambetter Health expanded into Delaware. In total, the Marketplace plan is available across 29 states. Additionally, Marketplace membership increased 34% year-over-year due to the expanded footprint, strong product positioning and open enrollment results, as well as overall market growth.

21
Other

•In December 2023 and January 2024, we completed the divestitures of Operose Health Group (Operose Health) and Circle Health, respectively.

•In June 2023, we completed the divestiture of Apixio. We maintain a close relationship with, and a minority interest in, the business.

•In January 2023, we completed the divestitures of Magellan Specialty Health, Centurion and HealthSmart.

The benefits of successful execution of our value creation initiatives have impacted our current results of operations and will continue to impact future results of operations, including the implementation of our new third-party pharmacy benefits management (PBM) contract, which commenced in January 2024.

We expect the following items to impact our future results of operations, subject to the resolution of various third-party protests within the Medicaid segment:

Medicaid

•In July 2024, our subsidiaries, Carolina Complete Health and WellCare of North Carolina, began coordinating physical and/or other health services with Local Management Entities/Managed Care Organizations under the state's new Tailored Plan program. The Tailored Plans are integrated health plans designed for individuals with significant behavioral health needs or intellectual/developmental disabilities.

•In June 2024, our subsidiary, Western Sky Community Care, concluded serving members upon the expiration of its New Mexico Medicaid managed care contract.

•In May 2024, our subsidiary, Sunflower Health Plan, was selected to continue providing managed health care services through KanCare, the State of Kansas' Medicaid and Children's Health Insurance Program. The new, three-year contract is expected to take effect on January 1, 2025, with the option to renew for up to two, 12-month extensions.

•In April 2024, the state of Florida announced its intent to award contracts to five health plans, including Centene's Florida subsidiary, Sunshine Health, as a result of the reprocurement of the Statewide Medicaid Managed Care program.

•In April 2024, our subsidiary, Meridian in Michigan, was selected by the Michigan Department of Health and Human Services to continue to serve as a Medicaid health plan for the Comprehensive Health Care Program. The proposed Medicaid contracts are expected to begin on October 1, 2024, and run through September 30, 2029, with three, one-year optional extensions.

•In January 2024, our subsidiary, NH Healthy Families, was selected by the New Hampshire Department of Health and Human Services to continue providing physical health, behavioral health and pharmacy services for New Hampshire's Medicaid managed care program, known as Medicaid Care Management. The contract is expected to begin in September 2024 for a five-year term.

•In December 2023, our subsidiary, Arizona Complete Health, was selected by the Arizona Health Care Cost Containment System – Arizona's single state Medicaid agency – to provide managed care for the Arizona Long Term Care System (ALTCS). The program supports Arizonans who are elderly and/or have a physical disability (E/PD) with physical and behavioral healthcare, as well as provides pharmacy benefits. The new ALTCS-E/PD contract is anticipated to begin in October 2024 and is a three-year term, with four optional one-year extensions, for a total of seven possible contract years.

•In July 2023, our subsidiary, Superior, announced it entered into a contract to continue to provide healthcare coverage to the aged, blind or disabled (ABD) population in the state's STAR+PLUS program. The contract is anticipated to begin in September 2024 for a six-year term with a maximum of three additional two-year extensions.

•In August 2022, our subsidiary, Magnolia Health Plan (Magnolia), was awarded the Mississippi Division of Medicaid contract. Under the new contract, Magnolia will continue serving the state's Coordinated Care Organization Program, which will consist of the Mississippi Coordinated Access Network and the Mississippi CHIP. The contract is anticipated to begin in July 2025.

22
Medicare

•In October 2023, CMS issued 2024 Medicare Advantage Star Ratings on the Medicare Plan Finder, which was subsequently updated in July 2024. Based on the data, approximately 74% of membership is associated with contracts showing year-over-year unrounded score improvement, and approximately 91% of membership is associated with contracts rated 3.0 stars or better - compared to 53% in the prior year.

Other

•In July 2024, we entered into a definitive agreement to sell Collaborative Health Systems, a management services organization, to Astrana Health, Inc. The transaction is expected to close by the end of 2024.

•In July 2024, our subsidiary, Magellan Health, commenced the Idaho Behavioral Health Plan contract.

•In December 2022, the Department of Defense announced that the TRICARE Managed Care Support Contract commencing in 2025 were not awarded to Health Net Federal Services.
23

MEMBERSHIP

From June 30, 2023 to June 30, 2024, our managed care membership increased by 66 thousand, or 0.2%. The following table sets forth our membership by line of business:
 June 30, 2024December 31, 2023June 30, 2023
Traditional Medicaid (1)
11,640,900 12,754,000 14,260,400 
High Acuity Medicaid (2)
1,499,000 1,718,000 1,799,200 
Total Medicaid13,139,900 14,472,000 16,059,600 
Commercial Marketplace4,401,300 3,900,100 3,295,200 
Commercial Group426,400 427,500 435,000 
Total Commercial4,827,700 4,327,600 3,730,200 
Medicare (3)
1,138,400 1,284,200 1,329,000 
Medicare PDP6,603,600 4,617,800 4,493,700 
Total at-risk membership25,709,600 24,701,600 25,612,500 
TRICARE eligibles2,768,000 2,773,200 2,799,300 
Total
28,477,600 27,474,800 28,411,800 
(1)
Membership includes Temporary Assistance for Needy Families (TANF), Medicaid Expansion, Children's Health Insurance Program (CHIP), Foster Care, and Behavioral Health.
(2)
Membership includes Aged, Blind, or Disabled (ABD), Intellectual and Developmental Disabilities (IDD), Long-Term Services and Supports (LTSS) and Medicare-Medicaid Plans (MMP) Duals.
(3)
Membership includes Medicare Advantage and Medicare Supplement.
24

RESULTS OF OPERATIONS

The following discussion and analysis is based on our Consolidated Statements of Operations, which reflect our results of operations for the three and six months ended June 30, 2024 and 2023, prepared in accordance with generally accepted accounting principles in the United States (GAAP). 

Summarized comparative financial data for the three and six months ended June 30, 2024 and 2023 is as follows ($ in millions, except per share data in dollars):
Three Months Ended June 30,
Six Months Ended June 30,
 20242023% Change20242023% Change
Premium$35,140 $33,713 4 %$70,669 $67,538 5 %
Service833 1,125 (26)%1,641 2,252 (27)%
Premium and service revenues35,973 34,838 3 %72,310 69,790 4 %
Premium tax3,863 2,770 39 %7,933 6,707 18 %
Total revenues39,836 37,608 6 %80,243 76,497 5 %
Medical costs30,765 29,347 5 %61,697 58,781 5 %
Cost of services680 877 (22)%1,349 1,747 (23)%
Selling, general and administrative expenses2,894 3,016 (4)%6,112 6,027 1 %
Depreciation expense133 146 (9)%268 288 (7)%
Amortization of acquired intangible assets173 179 (3)%346 362 (4)%
Premium tax expense3,962 2,854 39 %8,123 6,865 18 %
Impairment— 18 n.m.13 38 (66)%
Earnings from operations1,229 1,171 5 %2,335 2,389 (2)%
Investment and other income463 425 9 %1,008 778 30 %
Interest expense(176)(181)3 %(354)(361)2 %
Earnings before income tax1,516 1,415 7 %2,989 2,806 7 %
Income tax expense370 360 3 %685 621 10 %
Net earnings1,146 1,055 9 %2,304 2,185 5 %
Loss attributable to noncontrolling interests— 3 n.m.5 3 67 %
Net earnings attributable to Centene Corporation$1,146 $1,058 8 %$2,309 $2,188 6 %
Diluted earnings per common share attributable to Centene Corporation$2.16 $1.92 13 %$4.32 $3.96 9 %
n.m.: not meaningful


25
Three Months Ended June 30, 2024 Compared to Three Months Ended June 30, 2023

Total Revenues

Total revenues increased 6% in the three months ended June 30, 2024, over the corresponding period in 2023, primarily driven by membership growth in the Marketplace business due to strong product positioning as well as overall market growth and outperformance in Marketplace risk adjustment for the 2023 benefit year, along with increased premium tax revenue, partially offset by recent divestitures in the Other segment and lower Medicaid membership primarily due to redeterminations.

Operating Expenses

Medical Costs/HBR

The HBR for the three months ended June 30, 2024, was 87.6%, compared to 87.0% in the same period in 2023. The increase was driven by higher acuity in Medicaid as we progressed through the redetermination process and continue to work with states to match rates with acuity. The increase was also driven by Medicare Star rating impacts. The increase was partially offset by Marketplace membership growth and improved margin through strong 2024 product design and execution as well as outperformance in Marketplace risk adjustment for the 2023 benefit year.

Cost of Services

Cost of services decreased by $197 million in the three months ended June 30, 2024, compared to the corresponding period in 2023. The decrease was driven by recent divestitures. The cost of service ratio for the three months ended June 30, 2024, was 81.6%, compared to 78.0% in the same period in 2023. The increase was primarily driven by the divestiture of Circle Health, which operated at a lower cost of service ratio.

Selling, General & Administrative Expenses

The SG&A expense ratio was 8.0% for the second quarter of 2024, compared to 8.7% in the second quarter of 2023. The adjusted SG&A expense ratio was 8.0% for the second quarter of 2024, compared to 8.6% in the second quarter of 2023. The decreases were driven by Marketplace risk adjustment revenue, the divestiture of Circle Health, which operated at a higher SG&A expense ratio, and ongoing SG&A reduction initiatives. The decreases were partially offset by growth in the Marketplace business, which operates at a meaningfully higher SG&A expense ratio as compared to Medicaid.

Impairment

During the second quarter of 2023, we recorded total impairment charges of $18 million related to our ongoing real estate optimization initiative.

Other Income (Expense)

The following table summarizes the components of other income (expense) for the three months ended June 30, ($ in millions): 
 20242023
Investment and other income$463 $425 
Interest expense(176)(181)
Other income (expense), net$287 $244 

Investment and other income. Investment and other income increased by $38 million in the three months ended June 30, 2024, compared to the corresponding period in 2023. The three months ended June 30, 2024 included increased interest income on investments driven by higher interest rates and cash balances. The three months ended June 30, 2024 also included a $10 million gain on the previously reported divestiture of Circle Health partially offset by a $7 million additional loss on the divestiture of our Spanish and Central European businesses, a $3 million reduction to the net gain on the sale of property due to closing costs and a net gain on the finalization of working capital adjustments for the previously reported divestiture of Magellan Specialty Health of $2 million.
26

The three months ended June 30, 2023 included a $91 million gain on the sale of Apixio and a $15 million gain on the previously reported divestiture of Centurion, partially offset by an additional loss on the divestiture of our Spanish and Central European businesses of $13 million.

Interest expense. Interest expense decreased by $5 million in the three months ended June 30, 2024, compared to the corresponding period in 2023.

Income Tax Expense

For the three months ended June 30, 2024, we recorded income tax expense of $370 million on pre-tax earnings of $1.5 billion, or an effective tax rate of 24.4%. The effective tax rate for the second quarter of 2024 reflects tax effects of settlements with taxing authorities. For the second quarter of 2024, our effective tax rate on adjusted earnings was 24.4%.

For the three months ended June 30, 2023, we recorded an income tax expense of $360 million on pre-tax earnings of $1.4 billion, or an effective tax rate of 25.4%. For the second quarter of 2023, our effective tax rate on adjusted earnings was 24.9%.

Segment Results

The following table summarizes our consolidated operating results by segment for the three months ended June 30, ($ in millions):
 20242023% Change
Total Revenues   
Medicaid$24,113 $24,665 (2)%
Medicare5,978 5,665 6 %
Commercial8,535 5,734 49 %
Other1,210 1,544 (22)%
Consolidated total$39,836 $37,608 6 %
Gross Margin (1)
  
Medicaid$1,461 $2,434 (40)%
Medicare645 781 (17)%
Commercial2,267 1,090 108 %
Other155 309 (50)%
Consolidated total$4,528 $4,614 (2)%
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.

Medicaid

Total revenues decreased 2% in the three months ended June 30, 2024, compared to the corresponding period in 2023. Gross margin decreased $973 million in the three months ended June 30, 2024, compared to the corresponding period in 2023. The decrease in total revenues was driven by lower membership largely due to redeterminations. Gross margin decreased due to lower overall membership as a result of the redetermination process, coupled with higher acuity post-redeterminations as we continue to work with our state partners to match rates to the changes in acuity.

Medicare

Total revenues increased 6% in the three months ended June 30, 2024, compared to the corresponding period in 2023 primarily driven by increased PDP membership of 47%, partially offset by lower Medicare Advantage revenue resulting from the Star quality ratings impact discussed above. Gross margin decreased $136 million in the three months ended June 30, 2024, compared to the corresponding period in 2023, primarily driven by lower Medicare Advantage revenue.
27
Commercial

Total revenues increased 49% in the three months ended June 30, 2024, compared to the corresponding period in 2023. Gross margin increased $1.2 billion in the three months ended June 30, 2024, compared to the corresponding period in 2023. Increases were primarily driven by 34% membership growth in the Marketplace business along with improved margin through strong 2024 product design and execution as well as outperformance in Marketplace risk adjustment for the 2023 benefit year.

Other

Total revenues decreased 22% in the three months ended June 30, 2024, compared to the corresponding period in 2023. Gross margin decreased $154 million in the three months ended June 30, 2024, compared to the corresponding period in 2023. Decreases were primarily due to recent divestitures.

Six Months Ended June 30, 2024 Compared to Six Months Ended June 30, 2023

Total Revenues

Total revenues increased 5% in the six months ended June 30, 2024, over the corresponding period in 2023 primarily driven by membership growth in the Marketplace business due to strong product positioning as well as overall market growth and outperformance in Marketplace risk adjustment for the 2023 benefit year, along with increased premium tax revenue, partially offset by recent divestitures in the Other segment and lower Medicaid membership primarily due to redeterminations.

Operating Expenses

Medical Costs/HBR

The HBR for the six months ended June 30, 2024 was 87.3%, compared to 87.0% in the same period in 2023. The increase was driven by higher acuity in Medicaid as we progressed through the redetermination process and continue to work with states to match rates with acuity. The increase was also driven by Medicare Star rating impacts. The increase was partially offset by Marketplace membership growth and improved margin through strong 2024 product design and execution as well as outperformance in Marketplace risk adjustment for the 2023 benefit year.

Cost of Services

Cost of services decreased by $398 million in the six months ended June 30, 2024, compared to the corresponding period in 2023. The decrease was driven by recent divestitures. The cost of service ratio for the six months ended June 30, 2024 was 82.2%, compared to 77.6% in the same period in 2023. The increase was primarily driven by the divestiture of Circle Health, which operated at a lower cost of service ratio.

Selling, General & Administrative Expenses

The SG&A expense ratio for the six months ended June 30, 2024 was 8.5%, compared to 8.6% for the corresponding period in 2023. The adjusted SG&A expense ratio for the six months ended June 30, 2024 was 8.3%, compared to 8.6% for the six months ended June 30, 2023. The decrease in the adjusted SG&A expense ratio was driven by Marketplace risk adjustment revenue, the divestiture of Circle Health, which operated at a higher SG&A expense ratio, and ongoing SG&A reduction initiatives. The decrease was partially offset by growth in the Marketplace business, which operates at a meaningfully higher SG&A expense ratio as compared to Medicaid, and Medicare distribution costs.

Impairment

During the six months ended June 30, 2024 we recorded total impairment charges of $13 million, driven by Health Net Federal Services property, software and equipment related to the TRICARE Managed Care Support Contract that was no longer recoverable following the 2024 final ruling.

During the six months ended June 30, 2023, we recorded total impairment charges of $38 million related to our ongoing real estate optimization initiative.


28
Other Income (Expense)

The following table summarizes the components of other income (expense) for the six months ended June 30, ($ in millions): 
 20242023
Investment and other income$1,008 $778 
Interest expense(354)(361)
Other income (expense), net$654 $417 

Investment and other income. Investment and other income increased by $230 million in the six months ended June 30, 2024, compared to the corresponding period in 2023, driven by higher interest rates on larger investment balances. The six months ended June 30, 2024 also included an $83 million Magellan Specialty Health divestiture gain, $21 million net gain on the sale of property, $20 million Circle Health divestiture gain and $7 million HealthSmart divestiture gain partially offset by an additional loss on the divestiture of our Spanish and Central European businesses of $7 million.

The six months ended June 30, 2023 included a $91 million gain on the sale of Apixio, the $79 million gain on the sale of Magellan Specialty Health, and the $15 million gain on the previously reported divestiture of Centurion, partially offset by an additional loss on the divestiture of our Spanish and Central European businesses of $13 million.

Interest expense. Interest expense decreased by $7 million in the six months ended June 30, 2024, compared to the corresponding period in 2023.

Income Tax Expense

For the six months ended June 30, 2024, we recorded income tax expense of $685 million on pre-tax earnings of $3.0 billion, or an effective tax rate of 22.9%. The effective tax rate for 2024 reflects tax effects of the Circle Health divestiture. For the six months ended June 30, 2024, our effective tax rate on adjusted earnings was 24.5%.

For the six months ended June 30, 2023, we recorded income tax expense of $621 million on pre-tax earnings of $2.8 billion, or an effective tax rate of 22.1%. The effective tax rate for 2023 reflects the tax effects of the distribution of long-term stock awards to the estate of the Company's former CEO as well as divestiture gains. For the six months ended June 30, 2023, our effective tax rate on adjusted earnings was 24.6%.

29
Segment Results

The following table summarizes our consolidated operating results by segment for the six months ended June 30, ($ in millions):
 20242023% Change
Total Revenues   
Medicaid$49,643 $50,829 (2)%
Medicare11,913 11,541 3 %
Commercial16,286 10,986 48 %
Other2,401 3,141 (24)%
Consolidated total$80,243 $76,497 5 %
Gross Margin (1)
  
Medicaid$3,405 $4,651 (27)%
Medicare1,191 1,649 (28)%
Commercial4,338 2,337 86 %
Other330 625 (47)%
Consolidated total$9,264 $9,262 n.m.
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.
n.m.: not meaningful

Medicaid

Total revenues decreased 2% in the six months ended June 30, 2024, compared to the corresponding period in 2023. Gross margin decreased $1.2 billion in the six months ended June 30, 2024, compared to the corresponding period in 2023. The decrease in total revenues was driven by lower membership largely due to redeterminations. Gross margin decreased due to lower overall membership as a result of the redetermination process, coupled with higher acuity post-redeterminations as we continue to work with our state partners to match rates to the changes in acuity.

Medicare

Total revenues increased 3% in the six months ended June 30, 2024, compared to the corresponding period in 2023, primarily driven by increased PDP membership of 47%, partially offset by lower Medicare Advantage revenue resulting from the Star quality ratings impact discussed above. Gross margin decreased $458 million in the six months ended June 30, 2024, compared to the corresponding period in 2023 driven primarily by lower Medicare Advantage revenue.

Commercial

Total revenues increased 48% in the six months ended June 30, 2024, compared to the corresponding period in 2023. Gross margin increased $2.0 billion in the six months ended June 30, 2024, compared to the corresponding period in 2023. Increases were primarily driven by 34% membership growth in the Marketplace business along with improved margin through strong 2024 product design and execution as well as outperformance in Marketplace risk adjustment for the 2023 benefit year.

Other

Total revenues decreased 24% in the six months ended June 30, 2024, compared to the corresponding period in 2023. Gross margin decreased $295 million in the six months ended June 30, 2024, compared to the corresponding period in 2023. Decreases were primarily due to recent divestitures.
30
LIQUIDITY AND CAPITAL RESOURCES

Shown below is a condensed schedule of cash flows used in the discussion of liquidity and capital resources ($ in millions).
 Six Months Ended June 30,
 20242023
Net cash provided by operating activities$1,719 $6,815 
Net cash used in investing activities(315)(677)
Net cash used in financing activities(1,148)(933)
Effect of exchange rate changes on cash and cash equivalents7 (7)
Net increase in cash, cash equivalents and restricted cash and cash equivalents$263 $5,198 

Cash Flows Provided by Operating Activities

Normal operations are funded primarily through operating cash flows and borrowings under our Revolving Credit Facility. Operating activities provided cash of $1.7 billion in the six months ended June 30, 2024, compared to providing cash of $6.8 billion in the comparable period in 2023.

Cash flows provided by operations in 2024 were primarily driven by net earnings partially offset by pharmacy rebate remittance timing as we transitioned to the new third-party PBM, which commenced in January 2024.

Cash flows provided by operations in 2023 were driven by net earnings and increases in unearned revenue and accounts payable driven by the early receipt of payments from CMS.

Cash Flows Used in Investing Activities

Investing activities used cash of $315 million in the six months ended June 30, 2024, and used cash of $677 million in the comparable period in 2023. Cash flows used in investing activities in 2024 and 2023 were driven primarily by net additions to the investment portfolio of our regulated subsidiaries (including transfers from cash and cash equivalents to long-term investments) and capital expenditures, partially offset by divestiture proceeds.

We spent $337 million and $440 million in the six months ended June 30, 2024 and 2023, respectively, on capital expenditures the majority of which was driven by system enhancements and computer hardware.

As of June 30, 2024, our investment portfolio consisted primarily of fixed-income securities with an average duration of 3.4 years. At June 30, 2024, we had unregulated cash and investments of $1.1 billion, including $217 million of cash and cash equivalents and $860 million of investments. Unregulated cash and investments at December 31, 2023 was $1.0 billion, including $200 million of cash and cash equivalents and $810 million of investments.

Cash Flows Used in Financing Activities

Financing activities used cash of $1.1 billion in the six months ended June 30, 2024, compared to using cash of $933 million in the comparable period in 2023. Financing activities in 2024 were driven by stock repurchases of $954 million, which included $851 million under the stock repurchase program and $103 million of repurchases related to income tax withholding upon the vesting of previously awarded stock grants, and net decreases in debt of $215 million.

Financing activities in 2023 were driven by stock repurchases of $828 million.

Liquidity Metrics

We have a stock repurchase program authorizing us to repurchase common stock from time to time on the open market or through privately negotiated transactions. In 2023, the Company's Board of Directors authorized up to a cumulative total of $10.0 billion of repurchases under the program.

31
During the second quarter of 2024, we repurchased 10.7 million shares of common stock for $800 million under the stock repurchase program. We have approximately $4.4 billion remaining under the program for repurchases as of June 30, 2024. No duration has been placed on the repurchase program. We reserve the right to discontinue the repurchase program at any time. Refer to Note 8. Stockholders' Equity for further information on stock repurchases.

As of June 30, 2024, we had an aggregate principal amount of $15.7 billion of senior notes issued and outstanding. The indentures governing our various maturities of senior notes contain restrictive covenants. As of June 30, 2024, we were in compliance with all covenants.

As part of our capital allocation strategy, we may decide to repurchase debt or raise capital through the issuance of debt in the form of senior notes. In 2022, the Company's Board of Directors also authorized a $1.0 billion senior note debt repurchase program. No repurchases were made during the quarter ended June 30, 2024. As of June 30, 2024, there was $700 million available under the senior note debt repurchase program.

The credit agreement underlying our Revolving Credit Facility and Term Loan Facility contains customary covenants as well as financial covenants including a minimum fixed charge coverage ratio and a maximum debt-to-EBITDA ratio. Our maximum debt-to-EBITDA ratio under the credit agreement may not exceed 4.0 to 1.0. As of June 30, 2024, we had no borrowings outstanding under our Revolving Credit Facility, $2.1 billion of borrowings under our Term Loan Facility, and we were in compliance with all covenants. As of June 30, 2024, there were no limitations on the availability of our Revolving Credit Facility as a result of the debt-to-EBITDA ratio.

We had outstanding letters of credit of $146 million as of June 30, 2024, which were not part of our Revolving Credit Facility. The letters of credit bore weighted interest of 0.7% as of June 30, 2024. In addition, we had outstanding surety bonds of $914 million as of June 30, 2024.

At June 30, 2024, our debt to capital ratio, defined as total debt divided by the sum of total debt and total equity, was 39.1%, compared to 40.7% at December 31, 2023. The debt to capital ratio decrease was primarily driven by net earnings, partially offset by year-to-date stock repurchases. We utilize the debt to capital ratio as a measure, among others, of our leverage and financial flexibility.

At June 30, 2024, we had working capital, defined as current assets less current liabilities, of $5.7 billion, compared to $4.0 billion at December 31, 2023. We manage our short-term and long-term investments aiming to ensure a sufficient portion of the portfolio is highly liquid and can be sold to fund short-term requirements as needed.

2024 Expectations

During the remainder of 2024, we expect to receive net dividends from our insurance subsidiaries of approximately $1.2 billion and spend approximately $300 million in additional capital expenditures.

Based on our operating plan, we expect that our available cash, cash equivalents and investments, cash from our operations and cash available under our Revolving Credit Facility will be sufficient to finance our general operations and capital expenditures for at least 12 months from the date of this filing. While we are currently in a strong liquidity position and believe we have adequate access to capital, we may elect to increase borrowings on our Revolving Credit Facility, which matures in August 2026. Additionally, our senior notes mature between December 2027 and August 2031. From time to time, we may elect to raise additional funds for working capital and other purposes, either through issuance of debt or equity, the sale of investment securities or otherwise, as appropriate. In addition, we may strategically pursue refinancing or redemption opportunities to extend maturities and/or improve terms of our indebtedness if we believe such opportunities are favorable to us.

We intend to continue to target initiatives to improve productivity, efficiencies and reduced organizational costs, as well as capital deployment activities, including stock repurchases, portfolio optimization and the evaluation of refinancing opportunities. In addition to creating shareholder value, these actions encompass a larger organizational mission to enhance our member and provider experience, improve outcomes for our members and innovate to ensure that Centene is a great partner in all aspects of our operations.
32
REGULATORY CAPITAL AND DIVIDEND RESTRICTIONS
 
Our operations are conducted through our subsidiaries. As managed care organizations, most of our subsidiaries are subject to state regulations and other requirements that, among other things, require the maintenance of minimum levels of statutory capital, as defined by each state, and restrict the timing, payment and amount of dividends and other distributions that may be paid to us. Generally, the amount of dividend distributions that may be paid by a regulated subsidiary without prior approval by state regulatory authorities is limited based on the entity's level of statutory net income and statutory capital and surplus.

Our regulated subsidiaries are required to maintain minimum capital requirements prescribed by various regulatory authorities in each of the states in which we operate. During the six months ended June 30, 2024, we received dividends of $1.6 billion from and made $282 million of capital contributions to our regulated subsidiaries. For our subsidiaries that file with the National Association of Insurance Commissioners (NAIC), the aggregate risk-based capital (RBC) level as of December 31, 2023, which was the most recent date for which reporting was required, was in excess of 350% of the Authorized Control Level. We intend to continue to maintain an aggregate RBC level in excess of 350% of the Authorized Control Level during 2024.

Under the California Knox-Keene Health Care Service Plan Act of 1975, as amended (Knox-Keene), certain of our California subsidiaries must comply with tangible net equity (TNE) requirements. Under these Knox-Keene TNE requirements, actual net worth less certain unsecured receivables and intangible assets must be more than the greater of (i) a fixed minimum amount, (ii) a minimum amount based on premiums or (iii) a minimum amount based on healthcare expenditures, excluding capitated amounts.

Under the New York State Department of Health Codes, Rules and Regulations Title 10, Part 98, our New York subsidiary must comply with contingent reserve requirements. Under these requirements, net worth based upon admitted assets must equal or exceed a minimum amount based on annual net premium income.

The NAIC has adopted rules which set minimum RBC requirements for insurance companies, managed care organizations and other entities bearing risk for healthcare coverage. As of June 30, 2024, each of our health plans was in compliance with the RBC requirements enacted in those states.

As a result of the above requirements and other regulatory requirements, certain of our subsidiaries are subject to restrictions on their ability to make dividend payments, loans or other transfers of cash to their parent companies. Such restrictions, unless amended or waived or unless regulatory approval is granted, limit the use of any cash generated by these subsidiaries to pay our obligations. The maximum amount of dividends that can be paid by our insurance company subsidiaries without prior approval of the applicable state insurance departments is subject to restrictions relating to statutory surplus, statutory income and unassigned surplus.

CRITICAL ACCOUNTING ESTIMATES

Please see "Critical Accounting Estimates in Item 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations" included in our 2023 Annual Report on Form 10-K for a description of our Critical Accounting Estimates.
33

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

INVESTMENTS AND DEBT

As of June 30, 2024, we had short-term investments of $2.6 billion and long-term investments of $18.3 billion, including restricted deposits of $1.4 billion. The short-term investments generally consist of highly liquid securities with maturities between three and 12 months. The long-term investments consist of municipal, corporate and U.S. Treasury securities, government-sponsored obligations, life insurance contracts, asset-backed securities, and equity securities, and have maturities greater than one year. Restricted deposits consist of investments required by various state statutes to be deposited or pledged to state agencies. Due to the nature of the states' requirements, these investments are classified as long-term regardless of the contractual maturity date. Substantially all of our investments are subject to interest rate risk and will decrease in value if market rates increase. Assuming a hypothetical and immediate 1% increase in market interest rates at June 30, 2024, the fair value of our fixed income investments would decrease by approximately $645 million.

For a discussion of the interest rate risk that our investments are subject to, refer to our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, Part 1, Item 1A, "Risk Factors – Our investment portfolio may suffer losses which could materially and adversely affect our results of operations or liquidity."

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures - We maintain disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the Exchange Act) that are designed to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms; and (ii) accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

In connection with the filing of this Form 10-Q, management evaluated, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2024. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of June 30, 2024.

Changes in Internal Control Over Financial Reporting - No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the quarter ended June 30, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

34
PART II
OTHER INFORMATION


Item 1. Legal Proceedings.

A description of the legal proceedings to which the Company and its subsidiaries are a party is contained in Note 11. Contingencies to the consolidated financial statements included in Part I of this Quarterly Report on Form 10-Q, and is incorporated herein by reference.

Item 1A. Risk Factors.

There have been no material changes to the risk factors disclosed in our 2023 Annual Report on Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

In November 2005, the Company's Board of Directors announced a stock repurchase program, which was most recently increased in December 2023. The Company is authorized to repurchase up to $10.0 billion, inclusive of past authorizations, of which $4.4 billion remains as of June 30, 2024.

The stock repurchase program is effected primarily through regular open-market purchases (which may include repurchase plans designed to comply with Rule 10b5-1 and accelerated share repurchases), the amounts and timing of which are subject to the Company's discretion as part of its capital allocation strategy, and may be based upon general market conditions and the prevailing price and trading volumes of its common stock. No duration has been placed on the repurchase program. The Company reserves the right to discontinue the repurchase program at any time.

Issuer Purchases of Equity Securities
Second Quarter 2024
(Shares in thousands)
Period
 
Total Number of Shares Purchased (1)
Average Price
Paid per Share (2)
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
($ in millions) (3)
April 1, 2024 - April 30, 2024
2,758 $73.01 2,741 $4,978 
May 1, 2024 - May 31, 2024
7,928 75.78 7,919 4,378 
June 1, 2024 - June 30, 2024
18 68.61 — 4,378 
Total10,704 $75.05 10,660 $4,378 
(1)
Includes 44 thousand shares relinquished to the Company by certain employees for payment of taxes.
(2)
Average price paid per share excludes accrued share repurchase excise tax of approximately $7 million.
(3)
A remaining amount of approximately $4.4 billion is available under the stock repurchase program as of June 30, 2024.
35
Item 5. Other Information

(a) Centene Corporation (the Company) announced today that, as of December 2, 2024, Dave Thomas, the Company's CEO of Markets & Medicaid, will no longer be employed by the Company. Until his departure, Mr. Thomas will assist with the transition of his role and will advise on other matters. During his more than 25 years with Fidelis Care in New York and Centene Corporation, Mr. Thomas was influential in the Company’s success and dedication to its mission, building a team of exceptional market leaders and advancing our uniquely local approach. Subject to Mr. Thomas' compliance with the release of claims and other conditions set forth in the Executive Severance and Change in Control Plan filed with the Company's Form 10-K for the fiscal year ended December 31, 2023, Mr. Thomas is expected to receive severance and other benefits applicable to his separation and pursuant to the benefits for Tier I eligible employees set forth in Section V of the plan, including vesting of his outstanding performance-based restricted stock units prorated through his departure date based on actual performance during the performance period, consistent with his outstanding award agreements.

(b) None.

(c) During the three months ended June 30, 2024, no director or officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

36

Item 6. Exhibits.
EXHIBIT NUMBER 
DESCRIPTION
10.1
10.2
31.1
31.2
32.1*
32.2*
101The following materials from the Centene Corporation Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) the Consolidated Balance Sheets; (ii) the Consolidated Statements of Operations; (iii) the Consolidated Statements of Comprehensive Earnings (Loss); (iv) the Consolidated Statements of Stockholders' Equity; (v) the Consolidated Statements of Cash Flows and (vi) related notes.
104Cover Page Interactive Data File, formatted in iXBRL and contained in Exhibit 101.
* This certification is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.
37
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized as of July 26, 2024.

 CENTENE CORPORATION
 
 By: /s/ SARAH M. LONDON
 Chief Executive Officer
(principal executive officer)
 By: /s/ ANDREW L. ASHER
 Executive Vice President, Chief Financial Officer
(principal financial officer)
 By: /s/ KATIE N. CASSO
 Senior Vice President, Corporate Controller and Chief Accounting Officer
(principal accounting officer)

38
 EX-10.1 2 a2024063010-qexhibit101.htm EX-10.1 Document
EXHIBIT 10.1
CENTENE CORPORATION
NON-EMPLOYEE DIRECTORS
DEFERRED STOCK COMPENSATION PLAN
As amended and restated
ARTICLE I
INTRODUCTION
I.1    Establishment. Centene Corporation (the “Company”) hereby establishes the Centene Corporation Non-Employee Directors Deferred Stock Compensation Plan, as amended and restated (the “Plan”) for those directors of the Company who are not employees of the Company or any of its subsidiaries or affiliates. The Plan allows Non-Employee Directors to defer the receipt of cash compensation and to receive such deferred compensation in the form of Shares.
I.2    Purpose. The Plan is intended to advance the interests of the Company and its stockholders by providing a means to attract and retain qualified persons to serve as Non-Employee Directors and to promote ownership by Non-Employee Directors of a greater proprietary interest in the Company, thereby aligning such Directors' interests more closely with the interests of stockholders of the Company.
I.3    Effective Date. The Plan was effective as of September 15, 2004 (the “Effective Date”). This restatement shall be effective as of May 14, 2024.
ARTICLE II
DEFINITIONS
II.1 “Board” means the Board of Directors of the Company.
II.2 “Change in Control” means the occurrence of any of the following:
(a)Any “Person” (having the meaning ascribed to such term in Section 3(a)(9) of the Securities Exchange Act of 1934, as amended (“1934 Act”) and used in Sections 13(d) and 14(d) thereof, other than (A) Persons, who, on the Effective Date of the Plan, are beneficial owners (within the meaning of Rule 13d-3 under the 1934 Act) directly or indirectly of twenty-five percent (25%) or more of the Company's then outstanding voting securities entitled to vote generally in the election of directors (“Voting Securities”) or (B) a group which includes one or more Plan participants, is or become beneficial owners directly or indirectly of fifty percent (50%) or more of the combined voting power of the Company's Voting Securities.
(b)If individuals who, as the Effective Date hereof, constitute the Board of Directors of the Company (the “Incumbent Board) cease for any reason to constitute at least a majority of the Board of Directors of the Company; provided, however, that an individual becoming a director subsequent to the date hereof whose election, or nomination for election by the Company's shareholders, was approved by at least a majority of the directors then comprising the Incumbent Board shall be included within the definition of Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of either an actual election contest (or such terms are used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board.
1


(c)The shareholders of the Company approve a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the Voting Securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into Voting Securities of the surviving entity) at least fifty percent (50%) of the combined voting power of the Voting Securities of the Company or such surviving entity outstanding immediately after such merger or consolidation, and such merger or consolidation occurs.
(d)The shareholders of the Company approve a plan of complete liquidation or dissolution of the Company and such event commences, or there is consummated an agreement for the sale or disposition of all or substantially all of the assets of the Company, other than a sale or disposition by the Company of all or substantially all of the assets of the Company to an entity at least fifty percent (50%) of the combined voting securities of which are owned by shareholders of the Company in substantially the same proportions as their ownership of the Company immediately prior to such transaction.
An event shall be considered a Change in Control only if such event satisfies the above definition and such event is a change in the ownership or effective control of a corporation or a change in the ownership of a substantial portion of the assets of a corporation under Code Section 409A.
II.3  “Code” means the Internal Revenue Code of 1986, as amended, and the regulations and other guidance promulgated thereunder.
II.4  “Committee” means the Board or a committee appointed to administer the Plan under Article IV.
II.5  “Common Stock” means the Company's class of capital stock designated as Common Stock, par value one tenth of one cent ($0.001) per share, or, in the event that the outstanding shares of Common Stock are after the Effective Date recapitalized, converted into or exchanged for different stock or securities of the Company, such other stock or securities.
II.6  “Company” means Centene Corporation, a Delaware corporation, or any successor thereto.
II.7  “Deferral Date” means the date Fees would otherwise have been paid to the Participant.
II.8  “Deferral Election” means a written election to defer Fees under the Plan.
II.9  “Director” means any individual who is a member of the Board.
II.10  “Fair Market Value” of a share of Common Stock on a given valuation date means (i) the closing sales price for such Common Stock reported on the New York Stock Exchange on the day prior to such valuation date, (ii) if the Common Stock is not listed on the New York Stock Exchange, the closing sales price for such Common Stock as reported on the day prior to such valuation date on the principal stock exchange or quotation system in the U.S. on which Common Stock is listed or quoted (as determined by the Committee), or (iii) if neither of the preceding clauses is applicable, the fair market value of a share of Common Stock as determined in good faith by the Board on such valuation date and stated in writing in a notice delivered to the holders of Common Stock involved.
II.11  “Fees” means all or part of any retainer or meeting fees payable in cash to a Non-Employee Director in his or her capacity as a Director Fees shall not include any expenses paid directly or through reimbursement.
II.12  “Non-Employee Director” means a Director who is not an employee of the Company or any of its subsidiaries or affiliates. For purposes of the Plan, an employee is an individual whose wages are subject to withholding of federal income tax under Section 3401 of the Internal Revenue Code of 1986, as amended.
II.13  “Participant” means a Non-Employee Director who defers Fees under Article VI of the Plan.
II.14  “Secretary” means the Secretary or any Assistant Secretary of the Company.
II.15  “Shares” means shares of the Common Stock.
2


II.16  “Stock Units” means the credits to a Participant's Stock Unit Account under Article VI of the Plan, each of which represents the right to receive one Share upon settlement of the Stock Unit Account.
II.17  “Stock Unit Account” means the bookkeeping account established by the Company pursuant to Section VI.5.
II.18  “Termination of Service” means termination of service as a Director for any reason.
ARTICLE III
SHARES AVAILABLE UNDER THE PLAN
Subject to adjustment as provided in Article X, the maximum number of Shares that may be distributed in settlement of Stock Unit Accounts under the Plan shall be five hundred thousand (500,0001). Such Shares may include authorized but unissued Shares, treasury Shares or Shares that have been reacquired by the Company.
ARTICLE IV
ADMINISTRATION
The Plan shall be administered by the Board or such other committee as may be designated by the Board. The Committee shall have the authority to make all determinations it deems necessary or advisable for administering the Plan, subject to the express provisions of the Plan. Notwithstanding the foregoing, no Director who is a Participant under the Plan shall participate in any determination relating solely or primarily to his or her own Shares, Stock Units or Stock Unit Account.
ARTICLE V
ELIGIBILITY
Each person who is a Non-Employee Director on a Deferral Date shall be eligible to defer Fees payable on such date in accordance with Article VI of the Plan. If any Non-Employee Director subsequently becomes an employee of the Company or any of its subsidiaries, but does not incur a Termination of Service, such Director shall continue as a Participant with respect to Fees previously deferred and Fees subject to a current deferral election, but shall cease eligibility with respect to all future Fees, if any, earned while an employee.
ARTICLE VI
DEFERRAL ELECTIONS IN LIEU OF CASH PAYMENTS
VI.1    General Rule. Each Non-Employee Director may, in lieu of receipt of Fees, defer such Fees in accordance with this Article VI, provided that such Non-Employee director is eligible under Article V of the Plan to defer such Fees at the date any such Fees are otherwise payable. A Director may only elect to defer one hundred percent (100%) of his or her Fees.
VI.2    Timing of Election. A Non-Employee Director may make a Deferral Election within thirty (30) days after commencing to serve as a Non-Employee Director, effective for Fees for services rendered and payable after the date such election is made. A Non-Employee Director who does not make a Deferral Election when first eligible to do so may make a Deferral Election at such time before the first day of any subsequent calendar year for which such Deferral Election shall be effective, in accordance with administrative procedures established with respect to the Plan.
1 2,000,000 shares on a split-adjusted basis
3


VI.3    Effect and Duration of Election. A Deferral Election shall apply to Fees for services rendered and payable after the date such election is made and shall be deemed to be continuing and applicable to all Fees payable in subsequent calendar years, unless the participant revokes or modifies such election by filing a new election form at such time before the first day of any subsequent calendar year in accordance with administrative procedures established with respect to the Plan, effective for all Fees for services rendered and payable on and after the first day of such subsequent calendar year.
VI.4    Form of Election. A Deferral Election shall be made in a manner satisfactory to the Committee. Generally, a Deferral Election shall be made by completing and filing the specified election form with the Secretary or his or her designee within the period described in Section VI.2 or Section VI.3.
VI.5    Establishment of Stock Unit Account. The Company shall establish a Stock Unit Account for each Participant. All Fees deferred pursuant to this Article VI shall be credited to the Participant's Stock Unit Account as of the Deferral Date and converted to Stock Units. The number of Stock Units credited to a Participant's Stock Unit Account as of a Deferral Date shall equal the amount of the deferred Fees divided by the Fair Market Value of a Share on such Deferral Date, rounded to the nearest whole share. If there are fractional Stock Units in a Participant's Stock Unit Account at the time of a distribution under Article VII, the amount shall be rounded down to the nearest whole share on the date of distribution.
VI.6    Crediting of Dividend Equivalents. As of each dividend payment date with respect to Shares, each Participant shall have credited to his or her Stock Unit Account a dollar amount equal to the amount of cash dividends that would have been paid on the number of Shares equal to the number of Stock Units credited to the Participant's Stock Unit Account as of the close of business on the record date for such dividend. Such dollar amount shall then be converted into a number of Stock Units equal to the number of whole and fractional Shares that could have been purchased with such dollar amount at Fair Market Value on the dividend payment date.
ARTICLE VII
SETTLEMENT OF STOCK UNITS
VII.1    Timing of Payment. A Participant shall receive or begin receiving a distribution of his or her Stock Unit Account in the manner described in Section VII.2 either (i) on or as soon as administratively feasible after the first day of the second full calendar month immediately following the month in which the Participant incurs a Termination of Service (but not less than six months after the Participant has made a Deferral Election), (ii) if the Participant has made an election to defer payment in accordance with this Section, on or as soon as administratively feasible after the date specified by the Participant in such election, or (iii) if elected by the Participant, upon a Change of Control. A Participant must deliver an election to defer the distribution or commencement of distribution beyond the date applicable in clause (i) to the Secretary or his or her designee at the time that the Participant makes the deferral election pursuant to Article VI. A Participant may make an election to make a subsequent deferral election at least one (1) year before the earlier of the date on which the Participant incurs a Termination of Service or the previously designated distribution date; provided that, the first payment with respect to which the election is made shall be deferred for at least five (5) years from the date the payment would otherwise have been made.
VII.2    Payment Options. A Deferral Election filed under Article VI shall specify whether the Participant's Stock Unit Account is to be settled by delivering to the Participant the number of Shares equal to the number of whole Stock Units then credited to the Participant's Stock Unit Account, in either (i) a lump sum, or (ii) substantially equal annual installments over a period not to exceed five (5) years. A Participant may change the manner in which his or her Stock Unit Account is distributed by delivering a new election form to the Secretary or to his or her designee at least one (1) year before the earlier of the date on which the Participant incurs a Termination of Service or the previously designated distribution date; provided that, the first payment with respect to which the election is made shall be deferred for at least five (5) years from the date the payment would otherwise have been made.
4


VII.3    Payment Upon Death of a Participant. If a Participant dies before the entire balance of his or her Stock Unit Account has been distributed, the balance of the Participant's Stock Unit Account shall be paid in Shares as soon as administratively feasible after the Participant's death, to the beneficiary designated by the Participant under Article IX.
VII.4    Continuation of Dividend Equivalents. If the distribution of Shares is deferred pursuant to Section VII.2, the Participant's Stock Unit Account shall continue to be credited with dividend equivalents as provided in Section VI.6 on the undistributed Stock Units until the entire balance of the Participant's Stock Unit Account has been distributed.
ARTICLE VIII
UNFUNDED STATUS
VIII.1     General. The interest of each Participant in any Fees deferred under the Plan (and any Stock Units or Stock Unit Account relating thereto) shall be that of an unsecured general creditor of the Company. Stock Unit Accounts, and Stock Units credited thereto, shall at all times be maintained by the Company as bookkeeping entries evidencing unfunded and unsecured general obligations of the Company. Except as provided in Section VIII.2, any money or other assets set aside or earmarked for the purpose of satisfying the obligations of the Company hereunder shall at all times be the property of the Company and the Participant shall have no interest in such assets other than as an unsecured general creditor of the Company.
VIII.2     Trust. To the extent determined by the Board, the Company may transfer funds necessary to fund all or part of the payments under the Plan to a trust; provided, the assets held in such trust shall remain at all times subject to the claims of the general creditors of the Company. No participant or beneficiary shall have any interest in the assets held in such trust or in the general assets of the Company other than as an unsecured general creditor.
ARTICLE IX
DESIGNATION OF BENEFICIARY
Each Participant may designate, on a form provided by the Committee, one or more beneficiaries to receive payment of the Participant's Stock Unit Account in the event of such Participant's death. The Company may rely upon the beneficiary designation list filed with the Committee, provided that such form was executed by the Participant or his or her legal representative and filed with the Committee prior to the Participant's death. If a Participant has not designated a beneficiary, or if the designated beneficiary is not surviving when a payment is to be made to such person under the Plan, the beneficiary with respect to such payment shall be the Participant's surviving spouse, or if there is no surviving spouse, the Participant's estate.
ARTICLE X
ADJUSTMENT PROVISIONS
In the event of a reorganization, recapitalization, stock split, stock dividend, spin-off, combination, corporate exchange, merger, consolidation or other change in the Common Stock or any distribution to stockholders of Common Stock other than cash dividends or any transaction determined in good faith by the Board or Committee to be similar to the foregoing, the Board or Committee shall make appropriate equitable changes in the number and type of Shares authorized by this Plan, and the number and type of Shares to be delivered upon settlement of Stock Unit Accounts under Article VII.
ARTICLE XI
GENERAL PROVISIONS
XI.1    No Stockholder Rights Conferred. Nothing contained in the Plan will confer upon any Participant or beneficiary any rights of a Stockholder of the Company, unless and until Shares are in fact issued or transferred to such Participant or beneficiary in accordance with Article VII.
5


XI.2    Changes to The Plan. The Board may amend, alter, suspend, discontinue, extend, or terminate the Plan without the consent of Participants; provided, no action taken without the consent of an affected Participant may materially impair the rights of such Participant with respect to any Stock Units credited to his or her Stock Unit Account at the time of such change or termination except that the Board may without the consent of any Participant terminate the Plan and distribute Shares with respect to Stock Units then credited to Participant's Stock Unit Account upon a Change in Control. A termination of the Plan must comply with the restrictions or requirements applicable under Code Section 409A and the regulations promulgated thereunder.
XI.3    Compliance With Laws and Obligations. The Company will not be obligated to issue or deliver Shares in connection with the Plan in a transaction subject to the registration requirements of the Securities Act of 1933, as amended, or any other federal or state securities law, any requirement under any listing agreement between the Company and any national securities exchange or automated quotation system or any other laws, regulations, or contractual obligations of the Company, until the Company is satisfied that such laws, regulations and other obligations of the Company have been complied with in full. Certificates representing Shares delivered under the Plan will be subject to such restrictions as may be applicable under such laws, regulations and other obligations of the Company.
XI.4    Limitations on Transferability. Stock Units and other rights under the Plan may not be assigned, pledged, mortgaged, hypothecated or otherwise encumbered, and shall not be subject to the claims of creditors of any Participant.
XI.5    Governing Law. The validity, construction and effect of the Plan and any agreement hereunder will be determined in accordance with the Delaware General Corporation Law. Payments and benefits under the Plan are intended to comply with Section 409A of the Code to the extent subject thereto, and, accordingly, to the maximum extent permitted, this Plan shall be interpreted and administered to be in compliance therewith.
XI.6    Plan Termination. Unless earlier terminated by action of the Board pursuant to Section XI.2, the Plan will remain in effect until such time as no Shares remain available for delivery under the Plan and the Company has no further rights or obligations under the Plan. A termination of the Plan must comply with the restrictions or requirements applicable under Code Section 409A and the regulations promulgated thereunder.




6

 EX-10.2 3 a2024063010-qexhibit102.htm EX-10.2 Document
EXHIBIT 10.2
CENTENE CORPORATION

Restricted Stock Unit Agreement Granted Under
2012 Stock Incentive Plan, As Amended

THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and [Participant Name] (hereinafter the “Participant”).

WHEREAS, the Company desires to align the long-term interests of its directors with those of the Company by providing the ownership interest granted herein;

NOW, THEREFORE, in consideration of the foregoing and the mutual agreements herein contained, the parties hereto hereby agree as follows:

1.Grant of RSUs.

This Agreement evidences the grant by the Company on [Grant Date] (or the “Grant Date”) to [Participant Name] of [Number] restricted stock units (each an “RSU,” and collectively the “RSUs”) pursuant to the Company’s 2012 Stock Incentive Plan, as Amended (the “Plan”), that will settle in shares of common stock, $.001 par value per share, of the Company (“Common Stock”), as provided in this RSU Agreement (the “Agreement”). The shares of Common Stock that are issuable upon vesting of the RSUs are referred to in this Agreement as “Shares.” Capitalized terms not otherwise defined in this Agreement have the meanings ascribed to such terms in the Plan.
2.Vesting.

Subject to Section 3 and 4 of this Agreement, 100% of the RSUs shall become vested on the earlier of the one year anniversary of the grant date and date of the first annual meeting of stockholders of the Company (or any special meeting held in lieu of such annual meeting) to occur after the date of this Agreement (such date, the “Vesting Date”), provided that the continuous service of the Participant continues through the Vesting Date.
3.Reorganization Event.

The foregoing vesting schedule notwithstanding, if a Change in Control (as defined below) occurs, all unvested RSUs shall automatically become 100% vested (“CIC Payment”). A “Change in Control” shall be deemed to have occurred if any of the events set forth in any one of the following clauses shall occur: (i) any Person (as defined in section 3(a)(9) of the Exchange Act, and as such term is modified in sections 13(d) and 14(d) of the Exchange Act), excluding a group of persons including the Participant, is or becomes the “beneficial owner” (as defined in Rule 13(d)(3) under the Exchange Act), directly or indirectly, of securities of the Company representing forty percent or more of the combined voting power of the Company’s then-outstanding securities; (ii) individuals who, as of the Grant Date, constitute the Board of Directors of the Company (the “Incumbent Board”), cease for any reason to constitute a majority thereof (provided, however, that an individual becoming a director subsequent to the Grant Date whose election, or nomination for election by the Company’s stockholders, was approved by at least a majority of the directors then comprising the Incumbent Board shall be included within the definition of Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of either an actual election contest (or such terms used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board of Directors of the Company); or (iii) the stockholders of the Company consummate a merger or consolidation of the Company with any other corporation, other than a merger or consolidation that would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation. To the extent required to avoid the adverse tax consequences under
1


    
Section 409A of the Code (“Section 409A”), a Change in Control shall be deemed to have occurred only if it meets the foregoing requirements and meets the requirements for a change in control event under Section 409A.
4.Distribution of Shares.

(a)Timing of Distribution. The Company will distribute to the Participant (or to the Participant’s beneficiary in the event of the death of the Participant occurring after the Vesting Date but before distribution of the corresponding Shares), as soon as administratively practicable after the Vesting Date, the Shares represented by RSUs that vested on such Vesting Date, except that, payment shall occur earlier and extinguish any further payment on any future Vesting Date in the event that a CIC Payment occurs or payment on death or disability occurs in accordance with Section 4(c) or, if applicable, in accordance with the terms of a valid deferral election made by the Participant with respect to the RSUs under the Company’s deferral election form.

(b)No Fractional Shares. No fractional Shares shall be issuable pursuant to any RSU. In lieu of any fractional shares to which the Participant would otherwise be entitled, the Company may, in its discretion, determine whether to pay, in lieu of such fractional Share, cash in an amount equal to such fractional Share multiplied by the Fair Market Value (as defined in the Plan) of a share of Common Stock, or whether any such fractional Share should be rounded down to the nearest whole Share, forfeited without consideration therefor, or otherwise eliminated.

(c)Termination of Service. In the event that the Participant’s service with the Company is terminated for any reason by the Company or by the Participant other than by reason of death or disability (within the meaning of Section 409A(a)(2)(c) of the Internal Revenue Code of 1986, as amended (the “Code”)), the unvested RSUs shall cease vesting and be forfeited as of the date of termination. In the event the Participant’s service with the Company is terminated by reason of death or disability (as defined previously in this Section 4(c)), 100% of the RSUs shall immediately vest and be distributed on the date of such death or disability (or within 30 days thereafter).

(d)Compliance Restrictions. The Company shall not be obligated to issue to the Participant the Shares upon the vesting of any RSU (or otherwise) unless the issuance and delivery of such Shares shall comply with all relevant provisions of law and other legal requirements including any applicable federal or state securities laws and the requirements of any stock exchange or quotation system upon which Common Stock may then be listed or quoted.
5.Restrictions on Transfer.

The RSUs may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of law, except to the Participant's beneficiary as provided in Section 4(a) in the event of the Participant's death. The Participant's beneficiary can be designated and recorded with the Company’s stock plan administrator. In the absence of any such beneficiary designation, benefits remaining unpaid at the Participant’s death shall be paid to the Participant’s executor, administrator, or legal representative.
6.No Rights as a Stockholder.

Except as set forth in the Plan, neither the Participant nor any person claiming under or through the Participant shall be, or shall have any rights or privileges of, a stockholder of the Company in respect of any Share issuable pursuant to the RSUs granted hereunder until such Share has been delivered to the Participant.
7.Withholding Taxes.

The Participant acknowledges and agrees that the Company has the right to deduct from payments of any kind otherwise due to the Participant any federal, state or local taxes of any kind required by law to be withheld with respect to the RSUs. The Participant acknowledges that, regardless of any action taken by the Company, the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other
2

    
tax-related items related to the Participant’s participation in the Plan and legally applicable to the Participant is and remains the Participant’s responsibility.
8.Provisions of the Plan.

The RSUs are subject to the provisions of the Plan, a copy of which is being furnished to the Participant with this Agreement.
9.Miscellaneous.

(a)Severability. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law. If a court of competent jurisdiction should determine that any of the provisions of this Agreement are overbroad or otherwise unenforceable because of the scope of such provisions, to the extent allowed by law, such court shall modify such provisions in a manner to render them enforceable, and such provisions, as may be modified, shall be fully enforceable as though set forth herein. Any such modification shall not affect the other provisions or clauses of this Agreement in any respect.

(b)Waiver. Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any particular instance, by the Board of Directors of the Company.

(c)Binding Effect. This Agreement shall be binding upon and inure to the benefit of the Company and the Participant and their respective heirs, executors, administrators, legal representatives, successors and assigns, subject to the restrictions on transfer set forth in Section 5 of this Agreement.

(d)Notice. All notices required or permitted hereunder shall be in writing and deemed effectively given upon personal delivery or five days after delivery to a United States Post Office, by registered or certified mail, postage prepaid, addressed to the other party hereto at the address shown beneath his or its respective signature to this Agreement, or at such other address or addresses as either party shall designate to the other in accordance with this subparagraph (d).

(e)Entire Agreement. This Agreement and the Plan constitute the entire agreement between the parties, and supersede all prior agreements and understandings, relating to the RSUs.

(f)Participant’s Acknowledgments. The Participant acknowledges that he or she: (i) has read this Agreement; (ii) has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of the Participant’s own choice or has voluntarily declined to seek such counsel; (iii) understands the terms and consequences of this Agreement; and (iv) is fully aware of the legal and binding effect of this Agreement.

(g)Unfunded Rights. The right of the Participant to receive Common Stock pursuant to this Agreement is an unfunded and unsecured obligation of the Company. The Participant shall have no rights under this Agreement other than those of an unsecured general creditor of the Company.

(h)Deferral. The Participant may elect to defer delivery of Shares issuable under unvested RSUs in accordance with the terms of a valid deferral election made by the Participant with respect to the RSUs under the Company’s deferral election form. Neither the Company nor the Participant may defer delivery of any Shares issuable under unvested RSUs except to the extent that such deferral complies with the provisions of Section 409A.

3

    
(i)Section 409A.

(i)This Agreement is intended to comply with the requirements of Section 409A, including the exceptions thereto, and shall be construed and administered in accordance with such intent. Notwithstanding any other provision of this Agreement, payments provided under this Agreement may only be made upon an event and in a manner that complies with Section 409A or an applicable exemption. For purposes of Section 409A, each installment payment provided under this Agreement shall be treated as a separate payment. Any payments to be made under this Agreement in connection with a termination of service shall only be made if such termination of service constitutes a "separation from service" under Section 409A. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement comply with Section 409A and in no event shall the Company be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Participant on account of non-compliance with Section 409A.

(ii)If any provision of this Agreement or the Plan shall be invalid or unenforceable, in whole or in part, or as applied to any circumstance, under the laws of any jurisdiction that may govern for such purpose, or if any provision of this Agreement or the Plan needs to be interpreted to comply with the requirements of Section 409A, then such provision shall be deemed to be modified or restricted, or so interpreted, to the extent and in the manner necessary to render the same valid and enforceable, or to the extent and in the manner necessary to be interpreted in compliance with such requirements of the Code, either generally or as applied to such circumstance, or shall be deemed excised from this Agreement or the Plan, as the case may require, and this Agreement or the Plan shall be construed and enforced to the maximum extent permitted by law as if such provision had been originally incorporated herein as so modified or restricted, or as if such provision had not been originally incorporated herein, as the case may be.

(iii)Notwithstanding any other provision of this Agreement, if at the time of the Participant’s termination of service, the Participant is a "specified employee," determined in accordance with Section 409A, any payments and benefits provided under this Agreement that constitute "nonqualified deferred compensation" subject to Section 409A that are provided to the Participant on account of separation from service shall not be paid until the first payroll date to occur following the six-month anniversary of the Participant’s termination date ("Specified Employee Payment Date"). The aggregate amount of any payments that would otherwise have been made during such six-month period shall be paid in a lump sum on the Specified Employee Payment Date without interest. If the Participant dies before the Specified Employee Payment Date, any delayed payments shall be paid to the Participant’s beneficiary in a lump sum within upon the Participant’s death.

(j)Provisions Related to Golden Parachute Excise Tax.

(i)Change in Control When the Shares are Not Publicly Traded. Notwithstanding anything to the contrary contained in this Agreement, to the extent that, upon a Change in Control prior to the time at which the Shares have become publicly traded, any of the payments and benefits provided for under the Plan, any award agreement or any other agreement or arrangement between the Company or any of its affiliates and the Participant (collectively, the “Payments”) would constitute a “parachute payment” within the meaning of Section 280G of the Code (a “Parachute Payment”), the amount of such Payments shall be reduced to the amount (the “Safe Harbor Amount”) that would result in no portion of the Payments being treated as an excess parachute payment pursuant to Section 280G of the Code (the “Excise Tax”). If, upon a Change in Control prior to the time at which the Shares have become publicly traded, the Parachute Payments that would otherwise be reduced or eliminated, as the case may be, pursuant to this Section 9(j)(i) could be paid without the loss of a deduction under Section 280G of the Code if the shareholder approval exception to treatment as a Parachute Payment can be and is satisfied, then the Company shall use its reasonable best efforts to cause such Parachute Payments to be submitted for such approval in accordance with Section 280G(b)(5)(B) prior to the Change in Control giving rise to such Parachute Payments. If such approval is received, any reduction or forfeiture pursuant to this Section 9(j)(i) shall be reversed, and the subject amount shall be payable to the Participant without regard to this Section 9(j).

4

    
(ii)Change in Control When the Shares are Publicly Traded. If upon a Change in Control occurring at any time that the Shares are publicly traded, any Payments would constitute Parachute Payments, then, if and solely to the extent that reducing the benefits payable hereunder would result in the Participant’s receiving a greater amount, on an after-tax basis, taking into account any Excise Tax and all applicable income and other taxes payable on such amounts, the amounts payable hereunder shall be reduced or eliminated, as the case may be, so that the total amount of Parachute Payments received by the Participant do not exceed the Safe Harbor Amount.

(iii)Order of Reduction in Payments. Any reduction in the amount of compensation or benefits effected pursuant to this Section 9(j) shall first come, in order and, in each case, solely to the extent necessary, from any cash severance benefits payable to the Participant, then from any other payments which are treated in their entirety as Parachute Payments and then from any other Parachute Payments payable to the Participant with the later possible payment or vesting date being reduced or eliminated before a payment or benefit with an earlier payment or vesting date; provided that if the foregoing order of reduction or elimination would violate Section 409A, then the reduction shall be made pro rata among the payments or benefits otherwise due or payable to the Participant.

(k)Consent to Electronic Delivery; Electronic Signature.

    In lieu of receiving documents in paper format, the Participant accepts the electronic delivery of any documents by the Company, or any third party involved in administering the Plan that the Company may designate, may deliver in connection with this Award (including the Plan, this Agreement, account statements, or other communications or information) whether via the Company’s intranet or the internet site of such third party or via email or such other means of electronic delivery specified by the Company. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or any third party involved in administering the Plan that the Company may designate and agrees that the Participant’s electronic signature is the same as, and shall have the same force and effect as, the Participant’s manual signature.


Participant SignatureDate
5

    
ELECTRONIC ACCEPTANCE

By the Participant’s electronic acceptance hereof, the Participant and the Company agree that this Award is granted and governed by the terms and conditions of the Plan and this Agreement.
By the Participant’s electronic acceptance hereof, the Participant agrees that in lieu of receiving documents in paper format, the Participant accepts the electronic delivery of any documents by the Company, or any third party involved in administering the Plan that the Company may designate, may deliver in connection with this Award (including the Plan, this Agreement, account statements, or other communications or information) whether via the Company’s intranet or the internet site of such third party or via email or such other means of electronic delivery specified by the Company. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or any third party involved in administering the Plan that the Company may designate.

6

 EX-31.1 4 a2024063010-qexhibit311.htm EX-31.1 Document

EXHIBIT 31.1

 
CERTIFICATION
 
I, Sarah M. London, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Centene Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Dated:July 26, 2024 /s/ SARAH M. LONDON
 Chief Executive Officer
(principal executive officer)

 EX-31.2 5 a2024063010-qexhibit312.htm EX-31.2 Document

EXHIBIT 31.2

 
CERTIFICATION
 
I, Andrew L. Asher, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Centene Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:July 26, 2024  /s/ ANDREW L. ASHER
 Executive Vice President, Chief Financial Officer
(principal financial officer)

 EX-32.1 6 a2024063010-qexhibit321.htm EX-32.1 Document

EXHIBIT 32.1

 
CERTIFICATION PURSUANT TO 18 U.S.C.  SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report on Form 10-Q of Centene Corporation (the Company) for the period ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Sarah M. London, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
 
(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated:July 26, 2024 /s/ SARAH M. LONDON
 Chief Executive Officer
(principal executive officer)

 EX-32.2 7 a2024063010-qexhibit322.htm EX-32.2 Document

EXHIBIT 32.2

 
CERTIFICATION PURSUANT TO 18 U.S.C.  SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report on Form 10-Q of Centene Corporation (the Company) for the period ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Andrew L. Asher, Executive Vice President and Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
 
(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated:July 26, 2024  /s/ ANDREW L. ASHER
 Executive Vice President, Chief Financial Officer
(principal financial officer)

 EX-101.SCH 8 cnc-20240630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 9952151 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 9952154 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) link:presentationLink link:calculationLink link:definitionLink 9952155 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 9952156 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 9952157 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 9952158 - Disclosure - Organization and Operations link:presentationLink link:calculationLink link:definitionLink 9952159 - Disclosure - Acquisitions and Divestitures link:presentationLink link:calculationLink link:definitionLink 9952160 - Disclosure - Short-term and Long-term Investments, Restricted Deposits link:presentationLink link:calculationLink link:definitionLink 9952161 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 9952162 - Disclosure - Medical Claims Liability link:presentationLink link:calculationLink link:definitionLink 9952163 - Disclosure - Affordable Care Act link:presentationLink link:calculationLink link:definitionLink 9952164 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 9952165 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 9952166 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 9952167 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 9952168 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Organization and Operations (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Short-term and Long-term Investments, Restricted Deposits (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Medical Claims Liability (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Affordable Care Act (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Acquisitions and Divestitures - Divestiture (Details) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Fair Value Measurements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Medical Claims Liability - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Affordable Care Act - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Stockholders' Equity - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Stockholders' Equity - Share Repurchase Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 cnc-20240630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 cnc-20240630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 cnc-20240630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Premium tax expense Premium Tax Expense Premium tax expense, similar assessments and provider pass through payments. Term Loan Facility Term Loan Credit Agreement [Member] Term Loan Credit Agreement [Member] Adjustments to reconcile net earnings to net cash provided by operating activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Payments and repurchases of long-term debt Repayments of Long-Term Debt Stock repurchase program, remaining available Share Repurchase Program, Remaining Authorized, Amount Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Cover [Abstract] Cover [Abstract] Net increase in cash, cash equivalents and restricted cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Share buybacks (in shares) Treasury Stock, Shares, Acquired, Excluding Shares Withheld For Tax Withholding Obligation Treasury Stock, Shares, Acquired, Excluding Shares Withheld For Tax Withholding Obligation Trading Symbol Trading Symbol Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Comprehensive earnings Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest All Trading Arrangements All Trading Arrangements [Member] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Non-NEOs Non-NEOs [Member] Calculation of Basic and Diluted Net Earnings Per Common Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Income taxes paid Income Taxes Paid, Net Private equity investments Equity Method Investments Disposal Group Name [Domain] Disposal Group Name [Domain] Pay vs Performance Disclosure [Line Items] Redeemable noncontrolling interests Redeemable Noncontrolling Interest, Equity, Carrying Amount Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Residential mortgage-backed securities Residential Mortgage-Backed Securities [Member] Currency Swap Currency Swap [Member] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Fair Value Measurements Fair Value Disclosures [Text Block] Risk adjustment, decrease to net payable Affordable Care Act, Risk Adjustment, Net Payable Increase (Decrease) Affordable Care Act, Risk Adjustment, Net Payable Increase (Decrease) Change in unrealized gain (loss) on investments, net of tax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Award Timing Disclosures [Line Items] Other Performance Measure, Amount Other Performance Measure, Amount Common stock, shares outstanding (in shares) Balance (in shares) Balance (in shares) Common Stock, Shares, Outstanding Total debt Debt and Lease Obligation Risk adjustment payable Affordable Care Act Reinsurance Payable Affordable Care Act Reinsurance, Payable Purchase of redeemable noncontrolling interest Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests Unearned revenue Contract with Customer, Liability, Current Plan Name [Domain] Plan Name [Domain] Other long-term assets Other Assets, Noncurrent Entity Tax Identification Number Entity Tax Identification Number Common stock repurchases (in shares) Common stock repurchases (in shares) Treasury Stock, Shares, Acquired Operating Segments Operating Segments [Member] Premium tax Premium Tax Revenue Premium tax revenue, similar assessments and provider pass through payments. Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cost sharing reduction receivable Affordable Care Act, Cost Sharing Reduction Receivable Affordable Care Act, Cost Sharing Reduction Receivable Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Treasury Stock Treasury Stock, Common [Member] Risk adjustment and reinsurance pre-tax benefit Affordable Care Act, Risk Adjustment And Reinsurance, Pre-Tax Expense (Benefit) Affordable Care Act, Risk Adjustment And Reinsurance, Pre-Tax Expense (Benefit) Eliminations Intersegment Eliminations [Member] Plan Name [Axis] Plan Name [Axis] Equity Components [Axis] Equity Components [Axis] Other current assets Other Assets, Current Award Timing Method Award Timing Method [Text Block] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Risk adjustment receivable Affordable Care Act, Risk Adjustment Receivable Affordable Care Act, Risk Adjustment Receivable Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Share buybacks Treasury Stock, Value, Acquired, Cost Method, Excluding Shares Withheld For Tax Purposes Treasury Stock, Value, Acquired, Cost Method, Excluding Shares Withheld For Tax Purposes Notional amount Derivative Asset, Notional Amount Insider Trading Policies and Procedures [Line Items] Proceeds from sale of business Proceeds from Divestiture of Businesses Divestiture proceeds, net of divested cash Proceeds from Divestiture of Businesses, Net of Cash Divested Total operating expenses Costs and Expenses Adjustment to Compensation, Amount Adjustment to Compensation Amount Additional paid-in capital Additional Paid in Capital, Common Stock Compensation Amount Outstanding Recovery Compensation Amount Disposal Group Classification [Axis] Disposal Group Classification [Axis] Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Entity Small Business Entity Small Business Company Selected Measure Amount Company Selected Measure Amount Tabular List, Table Tabular List [Table Text Block] Level III Fair Value, Inputs, Level 3 [Member] (Gain) loss on divestitures, net Gain (loss) on divestitures Gain (Loss) on Disposition of Business Debt Securities Debt Securities, Available-for-Sale, Amortized Cost [Abstract] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Schedule Of Investments And Restricted Deposits By Type [Line Items] Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Anti-dilutive restricted stock and restricted stock units excluded from the calculation of diluted earnings (loss) per common share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Prior years Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years Credit Facility [Domain] Credit Facility [Domain] Life insurance contracts Life Insurance, Corporate or Bank Owned, Amount Cash, cash equivalents and restricted cash and cash equivalents, beginning of period Cash, cash equivalents and restricted cash and cash equivalents, end of period Total cash, cash equivalents and restricted cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Premium deficiency reserve liability Premium Deficiency Reserve Liability Premium Deficiency Reserve Liability Equity securities Equity Securities, FV-NI, Current Medical claims liability Balance, January 1 Balance, June 30 Liability for Claims and Claims Adjustment Expense Current assets: Assets, Current [Abstract] Goodwill Goodwill Consolidation Items [Axis] Consolidation Items [Axis] Stock repurchase program, authorized amount Share Repurchase Program, Authorized, Amount $3,500 million 4.625% Senior Notes due December 15, 2029 $3,500 Million 4.625% Senior Notes due December 2029 [Member] $3,500 Million 4.625% Senior Notes due December 2029 Earnings attributable to Centene Corporation Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Treasury stock (in shares) Treasury stock (in shares) Treasury stock (in shares) Treasury Stock, Common, Shares Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Product and Service [Domain] Product and Service [Domain] Employee Stock Option Share-Based Payment Arrangement, Option [Member] Schedule Of Investments And Restricted Deposits By Type [Table] Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] $2,200 million 3.00% Senior Notes due October 15, 2030 $2,200 Million 3.00% Senior Notes Due October 2030 [Member] $2,200 Million 3.00% Senior Notes Due October 2030 Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Depreciation expense Depreciation Prior years Prior Year Claims and Claims Adjustment Expense Other financing activities, net Proceeds from (Payments for) Other Financing Activities Comprehensive earnings attributable to Centene Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Municipal securities Municipal securities Municipal Bonds [Member] Security Exchange Name Security Exchange Name Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss Contractual maturities of short-term and long-term investments and restricted deposits Investments Classified by Contractual Maturity Date [Table Text Block] Change in unrealized gain (loss) on investments OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax Award Type Award Type [Axis] Corporate securities Corporate securities Corporate Debt Securities [Member] Net earnings per common share attributable to Centene Corporation: Earnings Per Share, Basic [Abstract] Property, software and equipment, net Property, Plant and Equipment, Net Total liabilities Liabilities Nonredeemable noncontrolling interest Equity, Attributable to Noncontrolling Interest Unrealized Losses Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract] Common stock, par value (in dollars per share) Par value (in dollars per share) Common Stock, Par or Stated Value Per Share Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Revolving Credit Agreement Revolving Credit Facility [Member] Expiration Date Trading Arrangement Expiration Date Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Total Shareholder Return Amount Total Shareholder Return Amount Common stock, shares issued (in shares) Common Stock, Shares, Issued Greater than ten years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 Magellan Rx Magellan Rx [Member] Magellan Rx Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Percentage of investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations Concentration Risk, Percentage Affordable Care Act [Abstract] Affordable Care Act [Abstract] Affordable Care Act [Abstract] Derivative liability Derivative Liability Share Repurchase Activity Class of Treasury Stock [Table Text Block] Premium Health Care, Premium [Member] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Premium and service revenues Total Premium and Service [Member] Total Premium and Service Debt Instrument [Line Items] Debt Instrument [Line Items] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Employee Stock Compensation Plan Employee Stock Compensation Plan [Member] Employee Stock Compensation Plan Insurance [Abstract] Insurance [Abstract] Diluted (in shares) Weighted average number of common shares and potential dilutive common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Total Centene stockholders' equity Equity, Attributable to Parent One year or less Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Input Definitions [Table Text Block] Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions Total, Amortized Cost Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost Interest expense Interest Expense, Nonoperating Deferred income taxes Deferred Income Tax Expense (Benefit) Concentration Risk Type [Domain] Concentration Risk Type [Domain] Asset-backed securities Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost Finance leases and other Finance Lease Liability And Other Finance Lease Liability And Other Selling, general and administrative expenses Selling, General and Administrative Expense Fair Value, 12 Months or More Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Impairment Asset Impairment Charges Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Document Fiscal Period Focus Document Fiscal Period Focus All Executive Categories All Executive Categories [Member] Common stock equivalents (as determined by applying the treasury stock method) (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Equity Securities Equity Securities [Member] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Acquisitions and Divestitures Mergers, Acquisitions and Dispositions Disclosures [Text Block] ASSETS Assets [Abstract] Other comprehensive earnings (loss) Other comprehensive earnings (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Document Type Document Type Derivative Contract [Domain] Derivative Contract [Domain] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Segment Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Aggregate carrying amount of life insurance contracts and equity investments, fair value Life Insurance Contracts And Equity Investments, Fair Value Life Insurance Contracts And Equity Investments, Fair Value Balance, January 1, net Balance, June 30, net Liability for Unpaid Claims and Claims Adjustment Expense, Net Investments: Debt Securities, Available-for-Sale [Abstract] Amortization of acquired intangible assets Amortization of Intangible Assets Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Schedule of change in medical claims liability Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block] Revenues: Revenues [Abstract] Current Fiscal Year End Date Current Fiscal Year End Date Short-term investments Short-Term Investments PEO Name PEO Name Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Purchase of noncontrolling interest Payments to Noncontrolling Interests Earnings before income tax Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest All Award Types Award Type [Domain] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Name Outstanding Recovery, Individual Name Common stock issued for employee benefit plans (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Goodwill impairment Goodwill, Impairment Loss Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Non-PEO NEO Non-PEO NEO [Member] Paid related to: Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract] Total investments Investments, Fair Value Disclosure Additional Paid-in Capital Additional Paid-in Capital [Member] Award Timing Predetermined Award Timing Predetermined [Flag] Accounting Guidance Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Class of Stock [Axis] Class of Stock [Axis] Diluted earnings per common share (in dollars per share) Earnings Per Share, Diluted Fair Value Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract] Name Measure Name Entity Interactive Data Current Entity Interactive Data Current Unearned revenue Increase (Decrease) in Contract with Customer, Liability Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Goodwill, impairment, net of tax Goodwill, Impairment Loss, Net of Tax Number of operating segments Number of Operating Segments Medical costs Policyholder Benefits and Claims Incurred, Net Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Asset-backed securities Asset-Backed Securities [Member] Stock compensation expense Share-Based Payment Arrangement, Noncash Expense Medical Claims Liability Insurance Disclosure [Text Block] Net earnings Net earnings Net earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Income tax expense Income tax benefit Income Tax Expense (Benefit) Other income (expense): Nonoperating Income (Expense) [Abstract] Interest rate Debt Instrument, Interest Rate, Stated Percentage Changes in assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract] Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Premium and service revenues Revenue from Contract with Customer, Excluding Assessed Tax Service Service [Member] Other long-term liabilities Increase (Decrease) in Other Noncurrent Liabilities Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Restricted certificates of deposit Restricted Certificates Of Deposit [Member] Restricted certificates of deposit [member] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Earnings from operations Operating Income (Loss) Total liabilities, redeemable noncontrolling interests and stockholders' equity Liabilities and Equity Other operating activities, net Other Operating Activities, Cash Flow Statement Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] All Adjustments to Compensation All Adjustments to Compensation [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Disposal Group, Disposed of by Sale, Not Discontinued Operations Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Individual: Individual [Axis] Income tax withholding Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Accumulated Other Comprehensive Earnings (Loss) AOCI Attributable to Parent [Member] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Product and Service [Axis] Product and Service [Axis] Entity Address, State or Province Entity Address, State or Province Statement [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Statement [Line Items] $2,000 million 3.375% Senior Notes due February 15, 2030 $2,200 Million 3.75% Senior Notes Due February 2030 [Member] $2,200 Million 3.75% Senior Notes Due February 2030 Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Expenses: Operating Expenses [Abstract] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Financial Instruments [Domain] Financial Instruments [Domain] LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Affordable Care Act Affordable Care Act Disclosure [Text Block] Affordable Care Act Disclosure [Text Block] Medicare Medicare Segment [Member] Medicare Segment Restatement Determination Date Restatement Determination Date Debt issuance costs Unamortized Debt Issuance Expense Total senior notes Senior Notes, Total Senior Notes, Total Adoption Date Trading Arrangement Adoption Date Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] External Credit Rating, Investment Grade External Credit Rating, Investment Grade [Member] Five years through ten years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 Rated Securities Rated Securities [Member] Rated Securities [Member] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Segments [Axis] Segments [Axis] Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Minimum medical loss ratio Affordable Care Act Minimum Medical Loss Ratio Affordable Care Act, Minimum Medical Loss Ratio Exercise Price Award Exercise Price Earnings Per Share Earnings Per Share [Text Block] Arrangement Duration Trading Arrangement Duration Restricted Deposits Deposits [Member] Fair Value, Less Than 12 Months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Current year Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year Long-term investments Long-Term Investments Weighted average number of common shares outstanding: Shares used in computing per share amounts: Earnings Per Share, Basic, Other Disclosure [Abstract] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Segments [Domain] Segments [Domain] Total, Fair Value Investments, Debt Securities, Equity Securities And Other, Fair Value Investments, Debt Securities, Equity Securities And Other, Fair Value Other comprehensive earning (loss), tax Other Comprehensive Income (Loss), Tax Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] All Individuals All Individuals [Member] Organization and Operations Basis of Presentation and Significant Accounting Policies [Text Block] PEO PEO [Member] Premium and trade receivables Increase (Decrease) in Premiums Receivable Name Trading Arrangement, Individual Name Commercial Commercial Segment [Member] Commercial Segment Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Premium and trade receivables Premiums and Other Receivables, Net Disposal Group Name [Axis] Disposal Group Name [Axis] Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Treasury stock, at cost (93,494 and 80,807 shares, respectively) Treasury Stock, Common, Value Short-duration insurance contracts, Incurred but not reported and expected development on reported claims Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net $1,300 million 2.625% Senior Notes due August 1, 2031 $1,300 Million 2.625% Senior Notes due August 2031 [Member] $1,300 Million 2.625% Senior Notes due August 2031 Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Incurred related to: Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract] Other Other/Eliminations Other Operating Segment [Member] Assets Assets, Fair Value Disclosure [Abstract] Investment and other income Investment Income, Nonoperating Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities, Current Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Plus: Premium deficiency reserve Premium Deficiency Reserve Liability Increase (Decrease) Premium Deficiency Reserve Liability Increase (Decrease) Local Phone Number Local Phone Number Liability Class [Axis] Liability Class [Axis] Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Deferred tax liability Deferred Income Tax Liabilities, Net Positions from which gross unrealized losses were generated Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions Other assets Increase (Decrease) in Other Operating Assets PEO Total Compensation Amount PEO Total Compensation Amount Senior notes Senior Notes Fair Value Fair Value Fair value Debt Securities, Available-for-Sale, Excluding Accrued Interest Contingencies Commitments and Contingencies Disclosure [Text Block] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Common Stock Common Stock [Member] Measure: Measure [Axis] Common stock issued for employee benefit plans Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Asset Class [Domain] Asset Class [Domain] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Entity Emerging Growth Company Entity Emerging Growth Company Total liabilities at fair value Liabilities, Fair Value Disclosure Segment Reporting [Abstract] Segment Reporting [Abstract] Income tax withholding (in shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Entity Central Index Key Entity Central Index Key Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Total incurred Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Stockholders' Equity Equity [Text Block] Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Equity Component [Domain] Equity Component [Domain] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Schedule Of Investments And Restricted Deposits By Type [Axis] Financial Instrument [Axis] Financial Instrument [Axis] Segment Information Segment Reporting Disclosure [Text Block] Current portion of long-term debt Less: current portion Long-Term Debt, Current Maturities The following table provides a reconciliation of cash, cash equivalents and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above: Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Medical claims liabilities Increase (Decrease) in Health Care Insurance Liabilities Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Stock compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Entity Shell Company Entity Shell Company Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Title Trading Arrangement, Individual Title Statement [Table] Statement [Table] Schedule of net receivables (payables) related to the Affordable Care Act Programs Schedule Of Receivables (Payables) Related To The Affordable Care Act Programs [Table Text Block] Schedule of Receivables (Payables) Related to the Affordable Care Act Programs Short-term and long-term investments and restricted deposits by investment type Short Term And Long Term Investments And Restricted Deposits By Investment Type [Table Text Block] Short-term and long-term investments and restricted deposits by investment type Comprehensive loss attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Consolidation Items [Domain] Consolidation Items [Domain] City Area Code City Area Code Current liabilities: Liabilities, Current [Abstract] Investments Investments [Member] Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activities Disposal Group Classification [Domain] Disposal Group Classification [Domain] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Level I Fair Value, Inputs, Level 1 [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Foreign currency translation adjustments, net of tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax $2,500 million 4.25% Senior Notes due December 15, 2027 Four Point Two Five Percent Senior Notes, Due In Twenty Twenty Seven [Member] Four Point Two Five Percent Senior Notes, Due In Twenty Twenty Seven [Member] Total current assets Assets, Current Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Senior Notes Senior Notes [Member] Common stock repurchases Payments for Repurchase of Common Stock $2,200 million 2.50% Senior Notes due March 1, 2031 $2,200 Million 2.50% Senior Notes due March 2031 [Member] $2,200 Million 2.50% Senior Notes due March 2031 Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Long-term debt  Long-term debt Long-Term Debt, Excluding Current Maturities Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Circle Health Circle Health [Member] Circle Health Five years through ten years Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 Total paid Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid Short-term time deposits Bank Time Deposits [Member] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Equity [Abstract] Equity [Abstract] Net earnings per common share attributable to Centene Corporation: Net Income (Loss) Attributable to Parent [Abstract] Net Income (Loss) Attributable to Parent [Abstract] Retained earnings Retained Earnings (Accumulated Deficit) Class of Stock [Domain] Class of Stock [Domain] Restricted cash equivalents Restricted Cash Equivalents [Member] Restricted Cash Equivalents [Member] Net earnings (loss) Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Schedule of Debt Schedule of Debt [Table Text Block] External Credit Rating by Grouping [Axis] External Credit Rating by Grouping [Axis] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Equity Awards Adjustments Equity Awards Adjustments [Member] Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Underlying Securities Award Underlying Securities Amount Short-term and Long-term Investments, Restricted Deposits Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Credit Facility [Axis] Credit Facility [Axis] Amendment Flag Amendment Flag Entity Registrant Name Entity Registrant Name Commercial mortgage-backed securities Commercial mortgage-backed securities Commercial mortgage-backed securities Commercial Mortgage-Backed Securities [Member] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Gross margin Gross Profit Less: Reinsurance recoverable Plus: Reinsurance recoverable Reinsurance Recoverable for Unpaid Claims and Claims Adjustments Fair Value as of Grant Date Award Grant Date Fair Value Level II Fair Value, Inputs, Level 2 [Member] One year or less Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One Debt Debt Disclosure [Text Block] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Stockholders' equity: Stockholders' equity Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Debt, face amount Debt Instrument, Face Amount Fair Value Debt Securities, Held-to-Maturity, Unrealized Loss Position, Fair Value [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date: Restatement Determination Date [Axis] External Credit Rating by Grouping [Domain] External Credit Rating by Grouping [Domain] Title of 12(b) Security Title of 12(b) Security Concentration Risk Type [Axis] Concentration Risk Type [Axis] Common stock, $0.001 par value; authorized 800,000 shares; 619,495 issued and 526,001 outstanding at June 30, 2024, and 615,291 issued and 534,484 outstanding at December 31, 2023 Common Stock, Value, Issued Accrued interest income Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] Share repurchase program, excise tax, payable Share Repurchase Program, Excise Tax, Payable Certificates of deposit Certificates of Deposit [Member] Return of premium payable Return of Premium Payable Return of Premium Payable Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at June 30, 2024 and December 31, 2023 Preferred Stock, Value, Issued Sales and maturities of investments Proceeds from Sale, Maturity and Collection of Investments Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Basic earnings per common share (in dollars per share) Earnings Per Share, Basic Proceeds from common stock issuances Proceeds from Issuance of Common Stock Cash and cash equivalents Cash and Cash Equivalents [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Disposal Group, Held-for-sale, Not Discontinued Operations Disposal Group, Held-for-Sale, Not Discontinued Operations [Member] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Fair value of available-for-sale investments with gross unrealized losses by investment type and length of time Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block] Total current liabilities Liabilities, Current Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Total assets Assets Cost of services Cost of Goods and Services Sold Credit facility Long-Term Line of Credit U.S. Treasury securities and obligations of U.S. government corporations and agencies US Treasury and Government [Member] Capital expenditures Payments to Acquire Property, Plant, and Equipment Other long-term liabilities Other Liabilities, Noncurrent Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Commitments and contingencies Commitments and Contingencies Reclassification adjustment, net of tax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax Termination Date Trading Arrangement Termination Date Accounts payable and accrued expenses: Accounts Payable and Accrued Liabilities [Member] Total revenues Revenues Revenues Divestiture of noncontrolling interest Noncontrolling Interest, Decrease from Deconsolidation Entity Address, City or Town Entity Address, City or Town Proceeds from long-term debt Proceeds from Issuance of Long-Term Debt One year through five years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five Debt Instrument [Axis] Debt Instrument [Axis] Net earnings attributable to Centene Corporation Net earnings (loss) Net Income (Loss) Attributable to Parent Trading Arrangement: Trading Arrangement [Axis] Total external revenues Revenue from Contract with Customer, Including Assessed Tax Investments recorded at fair value that carry rating of AAA Plus, weighted average (in years) Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs Amounts Recorded As An Adjustment to Premium Revenues Related to Minimum HBR and Return of Premium Programs Amounts Recorded As An Adjustment To Premium Revenues Related To Minimum HBR and Return Of Premium Programs Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Investment Securities Investment Securities [Member] Investment Securities Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Greater than ten years Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10 Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Entity File Number Entity File Number Document Fiscal Year Focus Document Fiscal Year Focus Noncontrolling Interest Noncontrolling Interest [Member] Income Statement [Abstract] Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One Common stock repurchases Common stock repurchases Treasury Stock, Value, Acquired, Cost Method Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Effect of exchange rate changes on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Total assets at fair value Assets, Fair Value Disclosure Name Forgone Recovery, Individual Name Document Period End Date Document Period End Date Other adjustments, net Other Noncash Income (Expense) Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Asset-backed securities Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value Restricted deposits Other Restricted Assets, Noncurrent Asset Class [Axis] Asset Class [Axis] Insider Trading Arrangements [Line Items] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract] Cost sharing reduction payable Affordable Care Act Cost Sharing Reductions, Payable Affordable Care Act Cost Sharing Reductions, Payable Adjustment to Compensation: Adjustment to Compensation [Axis] Loss attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Document Transition Report Document Transition Report Document Quarterly Report Document Quarterly Report Current year Current Year Claims and Claims Adjustment Expense One year through five years Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five $2,300 million 2.45% Senior Notes due July 15, 2028 $2,300 Million 2.45% Senior Nots due July 2028 [Member] $2,300 Million 2.45% Senior Nots due July 2028 Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Accumulated other comprehensive (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Current Reporting Status Entity Current Reporting Status Retained Earnings Retained Earnings [Member] Restricted cash and cash equivalents, included in restricted deposits Restricted Cash and Cash Equivalents Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Total investment positions Debt Securities, Available -for-Sale, Number of Positions Debt Securities, Available -for-Sale, Number of Positions Basic (in shares) Weighted average number of common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Change in unrealized gain (loss) on investments, tax effect OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 12 Months or More Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Total stockholders' equity Balance Balance Equity, Including Portion Attributable to Noncontrolling Interest Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Executive Category: Executive Category [Axis] Purchases of investments Payments to Acquire Investments Name Awards Close in Time to MNPI Disclosures, Individual Name Medicaid Medicaid Segment [Member] Medicaid Segment Less Than 12 Months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Entity Filer Category Entity Filer Category Company Selected Measure Name Company Selected Measure Name EX-101.PRE 12 cnc-20240630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 14 R1.htm IDEA: XBRL DOCUMENT v3.24.2
Cover - shares
shares in Thousands
 6 Months Ended
Jun. 30, 2024
Jul. 24, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2024  
Document Transition Report false  
Entity File Number 001-31826  
Entity Registrant Name CENTENE CORPORATION  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 42-1406317  
Entity Address, Address Line One 7700 Forsyth Boulevard  
Entity Address, City or Town St. Louis,  
Entity Address, State or Province MO  
Entity Address, Postal Zip Code 63105  
City Area Code 314  
Local Phone Number 725-4477  
Title of 12(b) Security Common Stock $0.001 Par Value  
Trading Symbol CNC  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   526,030
Entity Central Index Key 0001071739  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q2  
Amendment Flag false  
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 17,605 $ 17,193
Premium and trade receivables 16,587 15,532
Short-term investments 2,609 2,459
Other current assets 1,605 5,572
Total current assets 38,406 40,756
Long-term investments 16,870 16,286
Restricted deposits 1,415 1,386
Property, software and equipment, net 2,041 2,019
Goodwill 17,558 17,558
Intangible assets, net 5,755 6,101
Other long-term assets 1,092 535
Total assets 83,137 84,641
Current liabilities:    
Medical claims liability 18,173 18,000
Accounts payable and accrued expenses 12,232 16,420
Return of premium payable 1,615 1,462
Unearned revenue 597 715
Current portion of long-term debt 112 119
Total current liabilities 32,729 36,716
Long-term debt 17,516 17,710
Deferred tax liability 665 641
Other long-term liabilities 4,770 3,618
Total liabilities 55,680 58,685
Commitments and contingencies
Redeemable noncontrolling interests 16 19
Stockholders' equity:    
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at June 30, 2024 and December 31, 2023 0 0
Common stock, $0.001 par value; authorized 800,000 shares; 619,495 issued and 526,001 outstanding at June 30, 2024, and 615,291 issued and 534,484 outstanding at December 31, 2023 1 1
Additional paid-in capital 20,461 20,304
Accumulated other comprehensive (loss) (646) (652)
Retained earnings 14,352 12,043
Treasury stock, at cost (93,494 and 80,807 shares, respectively) (6,817) (5,856)
Total Centene stockholders' equity 27,351 25,840
Nonredeemable noncontrolling interest 90 97
Total stockholders' equity 27,441 25,937
Total liabilities, redeemable noncontrolling interests and stockholders' equity $ 83,137 $ 84,641
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.24.2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Jun. 30, 2024
Dec. 31, 2023
Stockholders' equity    
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 10,000,000 10,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 800,000,000 800,000,000
Common stock, shares issued (in shares) 619,495,000 615,291,000
Common stock, shares outstanding (in shares) 526,001,000 534,484,000
Treasury stock (in shares) 93,494,000 80,807,000
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenues:        
Premium and service revenues $ 35,973 $ 34,838 $ 72,310 $ 69,790
Premium tax 3,863 2,770 7,933 6,707
Total revenues 39,836 37,608 80,243 76,497
Expenses:        
Medical costs 30,765 29,347 61,697 58,781
Cost of services 680 877 1,349 1,747
Selling, general and administrative expenses 2,894 3,016 6,112 6,027
Depreciation expense 133 146 268 288
Amortization of acquired intangible assets 173 179 346 362
Premium tax expense 3,962 2,854 8,123 6,865
Impairment 0 18 13 38
Total operating expenses 38,607 36,437 77,908 74,108
Earnings from operations 1,229 1,171 2,335 2,389
Other income (expense):        
Investment and other income 463 425 1,008 778
Interest expense (176) (181) (354) (361)
Earnings before income tax 1,516 1,415 2,989 2,806
Income tax expense 370 360 685 621
Net earnings 1,146 1,055 2,304 2,185
Loss attributable to noncontrolling interests 0 3 5 3
Net earnings attributable to Centene Corporation $ 1,146 $ 1,058 $ 2,309 $ 2,188
Net earnings per common share attributable to Centene Corporation:        
Basic earnings per common share (in dollars per share) $ 2.16 $ 1.93 $ 4.34 $ 3.98
Diluted earnings per common share (in dollars per share) $ 2.16 $ 1.92 $ 4.32 $ 3.96
Weighted average number of common shares outstanding:        
Basic (in shares) 529,602 548,932 532,385 549,850
Diluted (in shares) 530,755 550,308 534,517 551,996
Premium        
Revenues:        
Premium and service revenues $ 35,140 $ 33,713 $ 70,669 $ 67,538
Service        
Revenues:        
Premium and service revenues $ 833 $ 1,125 $ 1,641 $ 2,252
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Statement of Comprehensive Income [Abstract]        
Net earnings $ 1,146 $ 1,055 $ 2,304 $ 2,185
Change in unrealized gain (loss) on investments (26) (142) (107) 111
Change in unrealized gain (loss) on investments, tax effect 6 34 21 (27)
Change in unrealized gain (loss) on investments, net of tax (20) (108) (86) 84
Reclassification adjustment, net of tax 4 2 92 4
Foreign currency translation adjustments, net of tax 0 23 0 46
Other comprehensive earnings (loss) (16) (83) 6 134
Comprehensive earnings 1,130 972 2,310 2,319
Comprehensive loss attributable to noncontrolling interests 0 3 5 3
Comprehensive earnings attributable to Centene Corporation $ 1,130 $ 975 $ 2,315 $ 2,322
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.24.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Earnings (Loss)
Retained Earnings
Treasury Stock
Noncontrolling Interest
Balance (in shares) at Dec. 31, 2022   607,847          
Treasury stock (in shares) at Dec. 31, 2022           57,093  
Balance at Dec. 31, 2022 $ 24,181 $ 1 $ 20,060 $ (1,132) $ 9,341 $ (4,213) $ 124
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 1,130       1,130   0
Other comprehensive earnings (loss), net of tax 217     217      
Common stock issued for employee benefit plans (in shares)   6,508          
Common stock issued for employee benefit plans 12   12        
Common stock repurchases (in shares)           5,548  
Common stock repurchases (423)         $ (423)  
Stock compensation expense 61   61        
Purchase of redeemable noncontrolling interest (12)   (12)        
Balance (in shares) at Mar. 31, 2023   614,355          
Treasury stock (in shares) at Mar. 31, 2023           62,641  
Balance at Mar. 31, 2023 25,166 $ 1 20,121 (915) 10,471 $ (4,636) 124
Balance (in shares) at Dec. 31, 2022   607,847          
Treasury stock (in shares) at Dec. 31, 2022           57,093  
Balance at Dec. 31, 2022 24,181 $ 1 20,060 (1,132) 9,341 $ (4,213) 124
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Other comprehensive earnings (loss), net of tax 134            
Balance (in shares) at Jun. 30, 2023   614,743          
Treasury stock (in shares) at Jun. 30, 2023           68,740  
Balance at Jun. 30, 2023 25,768 $ 1 20,183 (998) 11,529 $ (5,044) 97
Balance (in shares) at Mar. 31, 2023   614,355          
Treasury stock (in shares) at Mar. 31, 2023           62,641  
Balance at Mar. 31, 2023 25,166 $ 1 20,121 (915) 10,471 $ (4,636) 124
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 1,055       1,058   (3)
Other comprehensive earnings (loss), net of tax (83)     (83)      
Common stock issued for employee benefit plans (in shares)   388          
Common stock issued for employee benefit plans 9   9        
Common stock repurchases (in shares)           6,099  
Common stock repurchases (408)         $ (408)  
Stock compensation expense 56   56        
Purchase of redeemable noncontrolling interest (27)   (3)       (24)
Balance (in shares) at Jun. 30, 2023   614,743          
Treasury stock (in shares) at Jun. 30, 2023           68,740  
Balance at Jun. 30, 2023 $ 25,768 $ 1 20,183 (998) 11,529 $ (5,044) 97
Balance (in shares) at Dec. 31, 2023 534,484 615,291          
Treasury stock (in shares) at Dec. 31, 2023 80,807         80,807  
Balance at Dec. 31, 2023 $ 25,937 $ 1 20,304 (652) 12,043 $ (5,856) 97
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 1,159       1,163   (4)
Other comprehensive earnings (loss), net of tax 22     22      
Common stock issued for employee benefit plans (in shares)   3,882          
Common stock issued for employee benefit plans 14   14        
Common stock repurchases (in shares)           1,983  
Common stock repurchases (151)         $ (151)  
Stock compensation expense 70   70        
Divestiture of noncontrolling interest (3)           (3)
Balance (in shares) at Mar. 31, 2024   619,173          
Treasury stock (in shares) at Mar. 31, 2024           82,790  
Balance at Mar. 31, 2024 $ 27,048 $ 1 20,388 (630) 13,206 $ (6,007) 90
Balance (in shares) at Dec. 31, 2023 534,484 615,291          
Treasury stock (in shares) at Dec. 31, 2023 80,807         80,807  
Balance at Dec. 31, 2023 $ 25,937 $ 1 20,304 (652) 12,043 $ (5,856) 97
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Other comprehensive earnings (loss), net of tax $ 6            
Balance (in shares) at Jun. 30, 2024 526,001 619,495          
Treasury stock (in shares) at Jun. 30, 2024 93,494         93,494  
Balance at Jun. 30, 2024 $ 27,441 $ 1 20,461 (646) 14,352 $ (6,817) 90
Balance (in shares) at Mar. 31, 2024   619,173          
Treasury stock (in shares) at Mar. 31, 2024           82,790  
Balance at Mar. 31, 2024 27,048 $ 1 20,388 (630) 13,206 $ (6,007) 90
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 1,146       1,146   0
Other comprehensive earnings (loss), net of tax (16)     (16)      
Common stock issued for employee benefit plans (in shares)   322          
Common stock issued for employee benefit plans 11   11        
Common stock repurchases (in shares)           10,704  
Common stock repurchases (810)         $ (810)  
Stock compensation expense $ 62   62        
Balance (in shares) at Jun. 30, 2024 526,001 619,495          
Treasury stock (in shares) at Jun. 30, 2024 93,494         93,494  
Balance at Jun. 30, 2024 $ 27,441 $ 1 $ 20,461 $ (646) $ 14,352 $ (6,817) $ 90
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.24.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - USD ($)
$ in Millions
 3 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Par value (in dollars per share) $ 0.001       $ 0.001  
Other comprehensive earning (loss), tax $ (5) $ (12) $ (34) $ 61    
Common Stock            
Par value (in dollars per share) $ 0.001 $ 0.001 $ 0.001 $ 0.001 0.001 $ 0.001
Treasury Stock            
Par value (in dollars per share) $ 0.001 $ 0.001 $ 0.001 $ 0.001 $ 0.001 $ 0.001
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.24.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net earnings $ 2,304 $ 2,185
Adjustments to reconcile net earnings to net cash provided by operating activities    
Depreciation and amortization 614 650
Stock compensation expense 132 117
Impairment 13 38
Deferred income taxes 40 (160)
(Gain) loss on divestitures, net (103) (172)
Other adjustments, net (11) 68
Changes in assets and liabilities    
Premium and trade receivables (1,059) (319)
Other assets (404) (325)
Medical claims liabilities 173 139
Unearned revenue (118) 1,895
Accounts payable and accrued expenses (1,704) 618
Other long-term liabilities 1,838 2,081
Other operating activities, net 4 0
Net cash provided by operating activities 1,719 6,815
Cash flows from investing activities:    
Capital expenditures (337) (440)
Purchases of investments (3,434) (3,199)
Sales and maturities of investments 2,497 2,293
Divestiture proceeds, net of divested cash 959 669
Net cash used in investing activities (315) (677)
Cash flows from financing activities:    
Proceeds from long-term debt 350 1,281
Payments and repurchases of long-term debt (565) (1,322)
Common stock repurchases (954) (828)
Proceeds from common stock issuances 25 21
Purchase of noncontrolling interest 0 (85)
Other financing activities, net (4) 0
Net cash used in financing activities (1,148) (933)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 7 (7)
Net increase in cash, cash equivalents and restricted cash and cash equivalents 263 5,198
Cash, cash equivalents and restricted cash and cash equivalents, beginning of period 17,452 12,330
Cash, cash equivalents and restricted cash and cash equivalents, end of period 17,715 17,528
Supplemental disclosures of cash flow information:    
Interest paid 352 348
Income taxes paid 610 592
The following table provides a reconciliation of cash, cash equivalents and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above:    
Cash and cash equivalents 17,605 17,170
Restricted cash and cash equivalents, included in restricted deposits 110 358
Total cash, cash equivalents and restricted cash and cash equivalents $ 17,715 $ 17,528
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.24.2
Organization and Operations
 6 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Operations Organization and Operations
Basis of Presentation

The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Annual Report on Form 10-K for the fiscal year ended December 31, 2023. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2023 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.

Certain 2023 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2024 presentation. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.

Accounting Guidance Not Yet Adopted

In November 2023, the Financial Accounting Standards Board (FASB) issued an Accounting Standards Update (ASU) which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant expenses. The amendments will require public entities to disclose significant segment expenses that are regularly provided to the chief operating decision-maker and included within segment profit and loss. The new standard is effective for annual periods beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. The Company is currently evaluating the effect of the new disclosure requirements.

In December 2023, the FASB issued an ASU which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The new standard is effective for annual periods beginning after December 15, 2024. The Company is currently evaluating the effect of the new disclosure requirements.

In March 2024, the SEC adopted the final rule under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors. This rule will require disclosure of material climate-related risks and material direct greenhouse gas emissions from operations owned or controlled (Scope 1) and/or material indirect greenhouse gas emissions from purchased energy consumed in owned or controlled operations (Scope 2). Additionally, the rules require disclosure in the notes to the financial statements of the effects of severe weather events and other natural conditions, subject to certain materiality thresholds. The disclosure requirements will begin phasing in for reports and registration statements including financial information with respect to annual periods beginning in 2025. In April 2024, the SEC voluntarily stayed the final rule pending the completion of judicial review by the Court of Appeals for the Eighth Circuit. The Company is monitoring the development of litigation related to the SEC's rule, and is currently evaluating the effect of the new disclosure requirements.
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.24.2
Acquisitions and Divestitures
 6 Months Ended
Jun. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Acquisitions and Divestitures Acquisitions and Divestitures
Magellan Specialty Health Divestiture

For the six months ended June 30, 2024, the Company recorded an additional gain on the previously reported divestiture of Magellan Specialty Health of $83 million for achievement of contingent consideration related to the sale and finalization of working capital adjustments, which is included in investment and other income in the Consolidated Statements of Operations.

Circle Health Group Divestiture

On August 28, 2023, the Company signed a definitive agreement to sell Circle Health Group (Circle Health), one of the U.K.'s largest independent hospital operators, which is included in the Other segment.
In accordance with the signed definitive agreement in the third quarter of 2023, and subsequently updated in the fourth quarter of 2023, the Company recorded impairment charges related to goodwill associated with the pending divestiture totaling $292 million, or $258 million after-tax.

In order to manage the foreign exchange risk on the sale price associated with the pending divestiture of Circle Health, in August 2023 the Company entered into a foreign currency swap agreement for a notional amount of $931 million, to sell £740 million. The swap agreement was formally designated and qualified as a cash flow hedge. The swap expired on the earlier of the divestiture closing date or March 28, 2024. The gain or loss due to changes in the fair value of the foreign currency swap was recorded in other comprehensive income until the Circle Health divestiture closed, at which time the gain or loss was recorded in earnings to the same line in the Consolidated Statement of Operations as the gain or loss on sale.

On January 12, 2024, the Company completed the divestiture for $931 million. Upon closing the divestiture, the Company settled the foreign currency swap and recorded a corresponding gain of $20 million, which includes the cumulative translation adjustment previously recorded in accumulated other comprehensive income in the Consolidated Balance Sheet. The gain is included in investment and other income in the Consolidated Statements of Operations. During the six months ended June 30, 2024, the Company realized a net tax benefit of approximately $40 million on the loss recognized on the divestiture.
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.24.2
Short-term and Long-term Investments, Restricted Deposits
 6 Months Ended
Jun. 30, 2024
Investments, Debt and Equity Securities [Abstract]  
Short-term and Long-term Investments, Restricted Deposits Short-term and Long-term Investments, Restricted Deposits
Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):
 June 30, 2024December 31, 2023
 Amortized CostGross
Unrealized Gains		Gross
Unrealized Losses		Fair ValueAmortized CostGross
Unrealized Gains		Gross
Unrealized Losses		Fair Value
Debt securities:
U.S. Treasury securities and obligations of
U.S. government corporations and agencies
$591 $— $(7)$584 $403 $— $(8)$395 
Corporate securities10,554 32 (468)10,118 9,984 78 (461)9,601 
Restricted certificates of deposit
4 — — 4 4 — — 4 
Restricted cash equivalents
110 — — 110 259 — — 259 
Short-term time deposits
586 — — 586 746 — — 746 
Municipal securities4,229 7 (184)4,052 4,135 21 (171)3,985 
Asset-backed securities1,741 8 (29)1,720 1,665 8 (35)1,638 
Residential mortgage-backed securities1,606 2 (129)1,479 1,503 7 (103)1,407 
Commercial mortgage-backed securities
1,222 2 (79)1,145 1,149 5 (82)1,072 
Equity securities17 — — 17 17 — — 17 
Private equity investments
890 — — 890 833 — — 833 
Life insurance contracts
189 — — 189 174 — — 174 
Total$21,739 $51 $(896)$20,894 $20,872 $119 $(860)$20,131 

The Company's investments are debt securities classified as available-for-sale with the exception of equity securities, certain private equity investments and life insurance contracts. Private equity investments include direct investments in private equity securities as well as private equity funds. The Company's investment policies are designed to provide liquidity, preserve capital and maximize total return on invested assets with a focus on high credit quality securities. The Company limits the size of investment in any single issuer other than U.S. treasury securities and obligations of U.S. government corporations and agencies. As of June 30, 2024, 99% of the Company's investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations. At June 30, 2024, the Company held certificates of deposit, equity securities, private equity investments and life insurance contracts, which did not carry a credit rating. Accrued interest income on available-for-sale debt securities was $168 million and $153 million at June 30, 2024 and December 31, 2023, respectively, and is included in other current assets in the Consolidated Balance Sheets.
The Company's residential mortgage-backed securities are primarily issued by the Federal National Mortgage Association, Government National Mortgage Association or Federal Home Loan Mortgage Corporation, which carry implicit or explicit guarantees of the U.S. government. The Company's commercial mortgage-backed securities are primarily senior tranches with a weighted average rating of AA+ and a weighted average duration of 3 years at June 30, 2024.

The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):
 June 30, 2024December 31, 2023
 Less Than 12 Months12 Months or MoreLess Than 12 Months12 Months or More
 Unrealized LossesFair ValueUnrealized LossesFair ValueUnrealized LossesFair ValueUnrealized LossesFair Value
U.S. Treasury securities and obligations of
U.S. government corporations and agencies
$— $205 $(7)$224 $— $79 $(8)$232 
Corporate securities(20)1,895 (448)6,017 (6)658 (455)6,260 
Municipal securities(11)959 (173)2,365 (4)553 (167)2,237 
Asset-backed securities(1)266 (28)519 (2)197 (33)855 
Residential mortgage-backed securities(7)397 (122)857 (2)153 (101)814 
Commercial mortgage-backed securities(1)147 (78)802 (2)114 (80)754 
Short-term time deposits— — — — — 31 — — 
Total$(40)$3,869 $(856)$10,784 $(16)$1,785 $(844)$11,152 

As of June 30, 2024, the gross unrealized losses were generated from 4,626 positions out of a total of 6,830 positions. The change in fair value of available-for-sale debt securities is primarily a result of movement in interest rates subsequent to the purchase of the security.

For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes. If the security meets this criterion, the decline in fair value is recorded in earnings. The Company does not intend to sell these securities prior to maturity and it is not likely that the Company will be required to sell these securities prior to maturity; therefore, the Company did not record an impairment for these securities.

In addition, the Company monitors available-for-sale debt securities for credit losses. Certain investments have experienced a decline in fair value due to changes in credit quality, market interest rates and/or general economic conditions. The Company recognizes an allowance when evidence demonstrates that the decline in fair value is credit related. Evidence of a credit-related loss may include rating agency actions, adverse conditions specifically related to the security or failure of the issuer of the security to make scheduled payments.

The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):
 June 30, 2024December 31, 2023
 InvestmentsRestricted DepositsInvestmentsRestricted Deposits
 Amortized CostFair ValueAmortized CostFair ValueAmortized CostFair ValueAmortized CostFair Value
One year or less$2,428 $2,403 $395 $392 $2,308 $2,284 $566 $564 
One year through five years7,877 7,546 733 709 7,738 7,431 527 504 
Five years through ten years4,166 3,947 291 278 3,905 3,735 298 283 
Greater than ten years147 143 37 36 155 154 34 35 
Asset-backed securities4,569 4,344 — — 4,317 4,117 — — 
Total$19,187 $18,383 $1,456 $1,415 $18,423 $17,721 $1,425 $1,386 
 
Actual maturities may differ from contractual maturities due to call or prepayment options. Equity securities, private equity investments and life insurance contracts are excluded from the table above because they do not have a contractual maturity. The Company has an option to redeem substantially all of the securities included in the greater than ten years category listed above at amortized cost.
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.24.2
Fair Value Measurements
 6 Months Ended
Jun. 30, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:
Level Input:Input Definition:
Level IInputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
 
Level IIInputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.
 
Level IIIUnobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.

The following table summarizes fair value measurements by level at June 30, 2024, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$17,605 $— $— $17,605 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$58 $— $— $58 
Corporate securities— 10,080 — 10,080 
Municipal securities— 3,315 — 3,315 
Short-term time deposits— 586 — 586 
Asset-backed securities— 1,720 — 1,720 
Residential mortgage-backed securities— 1,479 — 1,479 
Commercial mortgage-backed securities— 1,145 — 1,145 
Equity securities14 3 — 17 
Total investments$72 $18,328 $— $18,400 
Restricted deposits:    
Cash and cash equivalents$110 $— $— $110 
U.S. Treasury securities and obligations of U.S. government corporations and agencies526 — — 526 
Corporate securities— 38 — 38 
Certificates of deposit— 4 — 4 
Municipal securities— 737 — 737 
Total restricted deposits$636 $779 $— $1,415 
Total assets at fair value$18,313 $19,107 $— $37,420 
The following table summarizes fair value measurements by level at December 31, 2023, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$17,193 $— $— $17,193 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$62 $— $— $62 
Corporate securities— 9,564 — 9,564 
Municipal securities— 3,232 — 3,232 
Short-term time deposits— 746 — 746 
Asset backed securities— 1,638 — 1,638 
Residential mortgage-backed securities— 1,407 — 1,407 
Commercial mortgage-backed securities— 1,072 — 1,072 
Equity securities15 2 — 17 
Total investments$77 $17,661 $— $17,738 
Restricted deposits:    
Cash and cash equivalents$259 $— $— $259 
U.S. Treasury securities and obligations of U.S. government corporations and agencies333 — — 333 
Corporate securities— 37 — 37 
Certificates of deposit— 4 — 4 
Municipal securities— 753 — 753 
Total restricted deposits$592 $794 $— $1,386 
Total assets at fair value$17,862 $18,455 $— $36,317 
Liabilities
Accounts payable and accrued expenses:
Foreign currency swap agreement$— $13 $— $13 
Total liabilities at fair value$— $13 $— $13 
 
The Company utilizes matrix-pricing services to estimate fair value for securities which are not actively traded on the measurement date. The Company designates these securities as Level II fair value measurements. In addition, the aggregate carrying amount of the Company's private equity investments and life insurance contracts, which approximates fair value, was $1,079 million and $1,007 million as of June 30, 2024 and December 31, 2023, respectively.
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.24.2
Medical Claims Liability
 6 Months Ended
Jun. 30, 2024
Insurance [Abstract]  
Medical Claims Liability Medical Claims Liability
The following table summarizes the change in medical claims liability for the six months ended June 30, 2024 ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, January 1, 2024$10,814 $3,612 $3,460 $114 $18,000 
Less: Reinsurance recoverable5 — 44 — 49 
Balance, January 1, 2024, net10,809 3,612 3,416 114 17,951 
Incurred related to:
Current year39,398 10,953 12,274 758 63,383 
Prior years(1,136)(316)(326)7 (1,771)
Total incurred38,262 10,637 11,948 765 61,612 
Paid related to:
Current year30,696 8,093 9,143 633 48,565 
Prior years7,918 2,562 2,367 121 12,968 
Total paid38,614 10,655 11,510 754 61,533 
Plus: Premium deficiency reserve— 85 — — 85 
Balance, June 30, 2024, net
10,457 3,679 3,854 125 18,115 
Plus: Reinsurance recoverable15 — 43 — 58 
Balance, June 30, 2024
$10,472 $3,679 $3,897 $125 $18,173 

The following table summarizes the change in medical claims liability for the six months ended June 30, 2023 ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, January 1, 2023$11,253 $3,431 $1,921 $140 $16,745 
Less: Reinsurance recoverable7 — 19 — 26 
Balance, January 1, 2023, net11,246 3,431 1,902 140 16,719 
Incurred related to:
Current year40,622 10,083 8,857 773 60,335 
Prior years(1,153)(191)(208)(2)(1,554)
Total incurred39,469 9,892 8,649 771 58,781 
Paid related to:
Current year31,837 7,726 6,751 656 46,970 
Prior years7,890 2,357 1,282 137 11,666 
Total paid39,727 10,083 8,033 793 58,636 
Balance, June 30, 2023, net
10,988 3,240 2,518 118 16,864 
Plus: Reinsurance recoverable5 — 15 — 20 
Balance, June 30, 2023
$10,993 $3,240 $2,533 $118 $16,884 

Reinsurance recoverables related to medical claims are included in premium and trade receivables. Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. Additionally, as a result of development within "Incurred related to: Prior years," the Company recorded $88 million and $319 million as a reduction to premium revenue in the six months ended June 30, 2024 and 2023, respectively, for minimum health benefits ratio (HBR) and other return of premium programs.

Incurred but not reported (IBNR) plus expected development on reported claims as of June 30, 2024 was $12,337 million. Total IBNR plus expected development on reported claims represents estimates for claims incurred but not reported, development on reported claims and estimates for the costs necessary to process unpaid claims at the end of each period. The Company estimates its liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice. These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services and other relevant factors.
The Company reviews actual and anticipated experience compared to the assumptions used to establish medical costs. The Company establishes premium deficiency reserves if actual and anticipated experience indicates that existing policy liabilities together with the present value of future gross premiums will not be sufficient to cover the present value of future benefits, settlement and maintenance costs. For purposes of determining premium deficiencies, contracts are grouped in a manner consistent with the method of acquiring, servicing and measuring the profitability of such contracts and expected investment income is excluded. In December 2023, the Company recorded a premium deficiency reserve of $250 million related to the 2024 Medicare Advantage contract year, which was increased to $300 million in the first quarter of 2024 and to $335 million in the second quarter of 2024 consistent with the intra-year flow of seasonality.
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.24.2
Affordable Care Act
 6 Months Ended
Jun. 30, 2024
Affordable Care Act [Abstract]  
Affordable Care Act Affordable Care Act
The Affordable Care Act established risk spreading premium stabilization programs as well as a minimum annual medical loss ratio (MLR) and cost sharing reductions.

The Company's net receivables (payables) for each of the programs are as follows ($ in millions):
June 30, 2024December 31, 2023
Risk adjustment receivable$2,047 $893 
Risk adjustment payable(3,475)(2,553)
Minimum medical loss ratio(675)(164)
Cost sharing reduction receivable12 — 
Cost sharing reduction payable(111)(114)
In July 2024, the Centers for Medicare and Medicaid Services (CMS) announced the final risk adjustment transfers for the 2023 benefit year. Based on the Company's estimate of the final settlement, the risk adjustment net payable was decreased by $1,344 million in the first half of 2024. After consideration of minimum MLR and other related impacts, the net pre-tax benefit recognized was $945 million in the six months ended June 30, 2024 ($78 million in the first quarter of 2024 and $867 million in the second quarter of 2024).
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.24.2
Debt
 6 Months Ended
Jun. 30, 2024
Debt Disclosure [Abstract]  
Debt Debt
 
Debt consists of the following ($ in millions):
 June 30, 2024December 31, 2023
$2,500 million 4.25% Senior Notes due December 15, 2027
$2,397 $2,395 
$2,300 million 2.45% Senior Notes due July 15, 2028
2,303 2,303 
$3,500 million 4.625% Senior Notes due December 15, 2029
3,277 3,277 
$2,000 million 3.375% Senior Notes due February 15, 2030
2,000 2,000 
$2,200 million 3.00% Senior Notes due October 15, 2030
2,200 2,200 
$2,200 million 2.50% Senior Notes due March 1, 2031
2,200 2,200 
$1,300 million 2.625% Senior Notes due August 1, 2031
1,300 1,300 
Total senior notes15,677 15,675 
Term Loan Facility2,060 2,115 
Revolving Credit Agreement— 150 
Finance leases and other2 11 
Debt issuance costs(111)(122)
Total debt17,628 17,829 
Less: current portion(112)(119)
 Long-term debt$17,516 $17,710 
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.24.2
Stockholders' Equity
 6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Stockholders' Equity Stockholders' Equity
The Company's Board of Directors has authorized a stock repurchase program of the Company's common stock from time to time on the open market or through privately negotiated transactions. The Company is authorized to repurchase up to $10,000 million, inclusive of past authorizations. As of June 30, 2024, the Company had a remaining amount of $4,378 million available under the stock repurchase program.

The following represents the Company's share repurchase activity ($ in millions, shares in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
SharesCostSharesCostSharesCostSharesCost
Share buybacks10,660 $800 6,028 $400 11,341 $851 10,880 $777 
Income tax withholding44 3 71 5 1,346 103 767 51 
Total share repurchases (1)
10,704 $803 6,099 $405 12,687 $954 11,647 $828 
(1)
Excludes share repurchase excise tax of approximately $7 million and $3 million accrued as of June 30, 2024 and 2023, respectively.

Shares repurchased for income tax withholding are shares withheld in connection with employee stock plans to meet applicable tax withholding requirements. These shares are typically included in the Company's treasury stock.
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.24.2
Earnings Per Share
 6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):
Three Months Ended June 30,Six Months Ended June 30,
 2024202320242023
Earnings attributable to Centene Corporation$1,146 $1,058 $2,309 $2,188 
Shares used in computing per share amounts: 
Weighted average number of common shares outstanding529,602 548,932 532,385 549,850 
Common stock equivalents (as determined by applying the treasury stock method)1,153 1,376 2,132 2,146 
Weighted average number of common shares and potential dilutive common shares outstanding530,755 550,308 534,517 551,996 
Net earnings per common share attributable to Centene Corporation:
Basic earnings per common share$2.16 $1.93 $4.34 $3.98 
Diluted earnings per common share$2.16 $1.92 $4.32 $3.96 

The calculation of diluted earnings per common share for the three months ended June 30, 2024 and 2023 excludes 271 thousand shares and 1,519 thousand shares, respectively, related to anti-dilutive stock options, restricted stock and restricted stock units.

The calculation of diluted earnings per common share for the six months ended June 30, 2024 and 2023 excludes 267 thousand shares and 1,611 thousand shares, respectively, related to anti-dilutive stock options, restricted stock and restricted stock units.
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.24.2
Segment Information
 6 Months Ended
Jun. 30, 2024
Segment Reporting [Abstract]  
Segment Information Segment Information
The Company operates in four segments: (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment and (4) an Other segment.

The Medicaid, Medicare and Commercial segments represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies, among others. The Company's international businesses, Operose Health Group (Operose Health) and Circle Health, were divested in December 2023 and January 2024, respectively.

Factors used in determining the reportable business segments include the nature of operating activities, the existence of separate senior management teams and the type of information presented to the Company's chief operating decision-maker to evaluate all results of operations. The Company does not report total assets by segment since this is not a metric used to allocate resources or evaluate segment performance.

Segment information for the three months ended June 30, 2024, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$20,229 $5,978 $8,534 $399 $35,140 
Service21 — 1 811 833 
Premium and service revenues20,250 5,978 8,535 1,210 35,973 
Premium tax3,863 — — — 3,863 
Total external revenues24,113 5,978 8,535 1,210 39,836 
Internal revenues— — — 4,081 4,081 
Eliminations— — — (4,081)(4,081)
Total revenues$24,113 $5,978 $8,535 $1,210 $39,836 
Medical costs$18,767 $5,333 $6,268 $397 $30,765 
Cost of services$22 $— $— $658 $680 
Gross margin (1)
$1,461 $645 $2,267 $155 $4,528 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.

Segment information for the three months ended June 30, 2023, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$21,895 $5,665 $5,734 $419 $33,713 
Service— — — 1,125 1,125 
Premium and service revenues21,895 5,665 5,734 1,544 34,838 
Premium tax2,770 — — — 2,770 
Total external revenues24,665 5,665 5,734 1,544 37,608 
Internal revenues— — — 3,789 3,789 
Eliminations— — — (3,789)(3,789)
Total revenues$24,665 $5,665 $5,734 $1,544 $37,608 
Medical costs$19,459 $4,884 $4,644 $360 $29,347 
Cost of services$2 $— $— $875 $877 
Gross margin (1)
$2,434 $781 $1,090 $309 $4,614 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.
Segment information for the six months ended June 30, 2024, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$41,667 $11,913 $16,284 $805 $70,669 
Service43 — 2 1,596 1,641 
Premium and service revenues41,710 11,913 16,286 2,401 72,310 
Premium tax7,933 — — — 7,933 
Total external revenues49,643 11,913 16,286 2,401 80,243 
Internal revenues— — — 8,161 8,161 
Eliminations— — — (8,161)(8,161)
Total revenues$49,643 $11,913 $16,286 $2,401 $80,243 
Medical costs$38,262 $10,722 $11,948 $765 $61,697 
Cost of services$43 $— $— $1,306 $1,349 
Gross margin (1)
$3,405 $1,191 $4,338 $330 $9,264 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.

Segment information for the six months ended June 30, 2023, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$44,122 $11,541 $10,986 $889 $67,538 
Service— — — 2,252 2,252 
Premium and service revenues44,122 11,541 10,986 3,141 69,790 
Premium tax6,707 — — — 6,707 
Total external revenues50,829 11,541 10,986 3,141 76,497 
Internal revenues— — — 7,656 7,656 
Eliminations— — — (7,656)(7,656)
Total revenues$50,829 $11,541 $10,986 $3,141 $76,497 
Medical costs$39,469 $9,892 $8,649 $771 $58,781 
Cost of services$2 $— $— $1,745 $1,747 
Gross margin (1)
$4,651 $1,649 $2,337 $625 $9,262 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.24.2
Contingencies
 6 Months Ended
Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Contingencies Contingencies
The Company is routinely subjected to legal and regulatory proceedings in the normal course of business. These matters can include, without limitation:

•periodic compliance and other reviews and investigations by various federal and state regulatory agencies with respect to requirements applicable to the Company's business, including, without limitation, those related to payment of out-of-network claims, compliance with CMS Medicare and Marketplace regulations, including risk adjustment and broker compensation, compliance with the False Claims Act, the calculation of minimum MLR and rebates related thereto, submissions to state agencies related to payments or state false claims acts, pre-authorization penalties, timely review of grievances and appeals, timely and accurate payment of claims, cybersecurity issues, including those related to the Company's or the Company's third-party vendors' information systems, and the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and other federal and state fraud, waste and abuse laws;
•litigation arising out of general business activities, such as tax matters, disputes related to healthcare benefits coverage or reimbursement, putative securities class actions, and medical malpractice, privacy, real estate, intellectual property, vendor disputes and employment-related claims; and
•disputes regarding reinsurance arrangements, claims arising out of the acquisition or divestiture of various assets, class actions and claims relating to the performance of contractual and non-contractual obligations to providers, members, employer groups, vendors and others, including, but not limited to, the alleged failure to properly pay claims and challenges to the manner in which the Company processes claims, claims related to network adequacy and claims alleging that the Company has engaged in unfair business practices.

Among other things, these matters may result in awards of damages, fines or penalties, which could be substantial, and/or could require changes to the Company's business. The Company intends to vigorously defend itself against legal and regulatory proceedings to which it is currently a party; however, these proceedings are subject to many uncertainties. In some of the cases pending against the Company, substantial non-economic or punitive damages are being sought.

The Company records reserves and accrues costs for certain legal proceedings and regulatory matters to the extent that it determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect the Company's best estimate of the probable loss for such matters, the recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to, they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; involve a large number of parties, claimants or regulatory bodies; are in the early stages of the proceedings; involve a number of separate proceedings and/or a wide range of potential outcomes; or result in a change of business practices.

As of the date of this report, amounts accrued for legal proceedings and regulatory matters were not material, except for the reserve estimate as previously disclosed in the Company's 2023 Annual Report on Form 10-K with respect to claims or potential claims involving services provided by Envolve Pharmacy Solutions, Inc. (Envolve), as the Company's pharmacy benefits management (PBM) subsidiary. The Company has reached no-fault settlement agreements related to services previously provided by Envolve with the vast majority of states impacted. Such agreements have provided for payment amounts consistent with the initial reserve estimate established in the second quarter of 2021 related to this issue.

It is possible that in a particular quarter or annual period the Company's financial condition, results of operations, cash flow and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of or development in legal and/or regulatory proceedings. The Company believes that the ultimate outcome of any of the regulatory and legal proceedings that are currently pending against it should not have a material adverse effect on financial condition, results of operations, cash flow or liquidity.
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.24.2
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Pay vs Performance Disclosure        
Net earnings (loss) $ 1,146 $ 1,058 $ 2,309 $ 2,188
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.24.2
Insider Trading Arrangements
 3 Months Ended
Jun. 30, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.24.2
Organization and Operations (Policies)
 6 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation

The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Annual Report on Form 10-K for the fiscal year ended December 31, 2023. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2023 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.

Certain 2023 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2024 presentation. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.
Accounting Guidance Not Yet Adopted
Accounting Guidance Not Yet Adopted

In November 2023, the Financial Accounting Standards Board (FASB) issued an Accounting Standards Update (ASU) which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant expenses. The amendments will require public entities to disclose significant segment expenses that are regularly provided to the chief operating decision-maker and included within segment profit and loss. The new standard is effective for annual periods beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. The Company is currently evaluating the effect of the new disclosure requirements.

In December 2023, the FASB issued an ASU which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The new standard is effective for annual periods beginning after December 15, 2024. The Company is currently evaluating the effect of the new disclosure requirements.

In March 2024, the SEC adopted the final rule under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors. This rule will require disclosure of material climate-related risks and material direct greenhouse gas emissions from operations owned or controlled (Scope 1) and/or material indirect greenhouse gas emissions from purchased energy consumed in owned or controlled operations (Scope 2). Additionally, the rules require disclosure in the notes to the financial statements of the effects of severe weather events and other natural conditions, subject to certain materiality thresholds. The disclosure requirements will begin phasing in for reports and registration statements including financial information with respect to annual periods beginning in 2025. In April 2024, the SEC voluntarily stayed the final rule pending the completion of judicial review by the Court of Appeals for the Eighth Circuit. The Company is monitoring the development of litigation related to the SEC's rule, and is currently evaluating the effect of the new disclosure requirements.
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.24.2
Short-term and Long-term Investments, Restricted Deposits (Tables)
 6 Months Ended
Jun. 30, 2024
Investments, Debt and Equity Securities [Abstract]  
Short-term and long-term investments and restricted deposits by investment type
Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):
 June 30, 2024December 31, 2023
 Amortized CostGross
Unrealized Gains		Gross
Unrealized Losses		Fair ValueAmortized CostGross
Unrealized Gains		Gross
Unrealized Losses		Fair Value
Debt securities:
U.S. Treasury securities and obligations of
U.S. government corporations and agencies
$591 $— $(7)$584 $403 $— $(8)$395 
Corporate securities10,554 32 (468)10,118 9,984 78 (461)9,601 
Restricted certificates of deposit
4 — — 4 4 — — 4 
Restricted cash equivalents
110 — — 110 259 — — 259 
Short-term time deposits
586 — — 586 746 — — 746 
Municipal securities4,229 7 (184)4,052 4,135 21 (171)3,985 
Asset-backed securities1,741 8 (29)1,720 1,665 8 (35)1,638 
Residential mortgage-backed securities1,606 2 (129)1,479 1,503 7 (103)1,407 
Commercial mortgage-backed securities
1,222 2 (79)1,145 1,149 5 (82)1,072 
Equity securities17 — — 17 17 — — 17 
Private equity investments
890 — — 890 833 — — 833 
Life insurance contracts
189 — — 189 174 — — 174 
Total$21,739 $51 $(896)$20,894 $20,872 $119 $(860)$20,131 
Fair value of available-for-sale investments with gross unrealized losses by investment type and length of time
The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):
 June 30, 2024December 31, 2023
 Less Than 12 Months12 Months or MoreLess Than 12 Months12 Months or More
 Unrealized LossesFair ValueUnrealized LossesFair ValueUnrealized LossesFair ValueUnrealized LossesFair Value
U.S. Treasury securities and obligations of
U.S. government corporations and agencies
$— $205 $(7)$224 $— $79 $(8)$232 
Corporate securities(20)1,895 (448)6,017 (6)658 (455)6,260 
Municipal securities(11)959 (173)2,365 (4)553 (167)2,237 
Asset-backed securities(1)266 (28)519 (2)197 (33)855 
Residential mortgage-backed securities(7)397 (122)857 (2)153 (101)814 
Commercial mortgage-backed securities(1)147 (78)802 (2)114 (80)754 
Short-term time deposits— — — — — 31 — — 
Total$(40)$3,869 $(856)$10,784 $(16)$1,785 $(844)$11,152 
Contractual maturities of short-term and long-term investments and restricted deposits
The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):
 June 30, 2024December 31, 2023
 InvestmentsRestricted DepositsInvestmentsRestricted Deposits
 Amortized CostFair ValueAmortized CostFair ValueAmortized CostFair ValueAmortized CostFair Value
One year or less$2,428 $2,403 $395 $392 $2,308 $2,284 $566 $564 
One year through five years7,877 7,546 733 709 7,738 7,431 527 504 
Five years through ten years4,166 3,947 291 278 3,905 3,735 298 283 
Greater than ten years147 143 37 36 155 154 34 35 
Asset-backed securities4,569 4,344 — — 4,317 4,117 — — 
Total$19,187 $18,383 $1,456 $1,415 $18,423 $17,721 $1,425 $1,386 
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.24.2
Fair Value Measurements (Tables)
 6 Months Ended
Jun. 30, 2024
Fair Value Disclosures [Abstract]  
Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions
Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:
Level Input:Input Definition:
Level IInputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
 
Level IIInputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.
 
Level IIIUnobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.
Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table summarizes fair value measurements by level at June 30, 2024, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$17,605 $— $— $17,605 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$58 $— $— $58 
Corporate securities— 10,080 — 10,080 
Municipal securities— 3,315 — 3,315 
Short-term time deposits— 586 — 586 
Asset-backed securities— 1,720 — 1,720 
Residential mortgage-backed securities— 1,479 — 1,479 
Commercial mortgage-backed securities— 1,145 — 1,145 
Equity securities14 3 — 17 
Total investments$72 $18,328 $— $18,400 
Restricted deposits:    
Cash and cash equivalents$110 $— $— $110 
U.S. Treasury securities and obligations of U.S. government corporations and agencies526 — — 526 
Corporate securities— 38 — 38 
Certificates of deposit— 4 — 4 
Municipal securities— 737 — 737 
Total restricted deposits$636 $779 $— $1,415 
Total assets at fair value$18,313 $19,107 $— $37,420 
The following table summarizes fair value measurements by level at December 31, 2023, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$17,193 $— $— $17,193 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$62 $— $— $62 
Corporate securities— 9,564 — 9,564 
Municipal securities— 3,232 — 3,232 
Short-term time deposits— 746 — 746 
Asset backed securities— 1,638 — 1,638 
Residential mortgage-backed securities— 1,407 — 1,407 
Commercial mortgage-backed securities— 1,072 — 1,072 
Equity securities15 2 — 17 
Total investments$77 $17,661 $— $17,738 
Restricted deposits:    
Cash and cash equivalents$259 $— $— $259 
U.S. Treasury securities and obligations of U.S. government corporations and agencies333 — — 333 
Corporate securities— 37 — 37 
Certificates of deposit— 4 — 4 
Municipal securities— 753 — 753 
Total restricted deposits$592 $794 $— $1,386 
Total assets at fair value$17,862 $18,455 $— $36,317 
Liabilities
Accounts payable and accrued expenses:
Foreign currency swap agreement$— $13 $— $13 
Total liabilities at fair value$— $13 $— $13 
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.24.2
Medical Claims Liability (Tables)
 6 Months Ended
Jun. 30, 2024
Insurance [Abstract]  
Schedule of change in medical claims liability
The following table summarizes the change in medical claims liability for the six months ended June 30, 2024 ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, January 1, 2024$10,814 $3,612 $3,460 $114 $18,000 
Less: Reinsurance recoverable5 — 44 — 49 
Balance, January 1, 2024, net10,809 3,612 3,416 114 17,951 
Incurred related to:
Current year39,398 10,953 12,274 758 63,383 
Prior years(1,136)(316)(326)7 (1,771)
Total incurred38,262 10,637 11,948 765 61,612 
Paid related to:
Current year30,696 8,093 9,143 633 48,565 
Prior years7,918 2,562 2,367 121 12,968 
Total paid38,614 10,655 11,510 754 61,533 
Plus: Premium deficiency reserve— 85 — — 85 
Balance, June 30, 2024, net
10,457 3,679 3,854 125 18,115 
Plus: Reinsurance recoverable15 — 43 — 58 
Balance, June 30, 2024
$10,472 $3,679 $3,897 $125 $18,173 

The following table summarizes the change in medical claims liability for the six months ended June 30, 2023 ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, January 1, 2023$11,253 $3,431 $1,921 $140 $16,745 
Less: Reinsurance recoverable7 — 19 — 26 
Balance, January 1, 2023, net11,246 3,431 1,902 140 16,719 
Incurred related to:
Current year40,622 10,083 8,857 773 60,335 
Prior years(1,153)(191)(208)(2)(1,554)
Total incurred39,469 9,892 8,649 771 58,781 
Paid related to:
Current year31,837 7,726 6,751 656 46,970 
Prior years7,890 2,357 1,282 137 11,666 
Total paid39,727 10,083 8,033 793 58,636 
Balance, June 30, 2023, net
10,988 3,240 2,518 118 16,864 
Plus: Reinsurance recoverable5 — 15 — 20 
Balance, June 30, 2023
$10,993 $3,240 $2,533 $118 $16,884 
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.24.2
Affordable Care Act (Tables)
 6 Months Ended
Jun. 30, 2024
Affordable Care Act [Abstract]  
Schedule of net receivables (payables) related to the Affordable Care Act Programs
The Company's net receivables (payables) for each of the programs are as follows ($ in millions):
June 30, 2024December 31, 2023
Risk adjustment receivable$2,047 $893 
Risk adjustment payable(3,475)(2,553)
Minimum medical loss ratio(675)(164)
Cost sharing reduction receivable12 — 
Cost sharing reduction payable(111)(114)
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.24.2
Debt (Tables)
 6 Months Ended
Jun. 30, 2024
Debt Disclosure [Abstract]  
Schedule of Debt
Debt consists of the following ($ in millions):
 June 30, 2024December 31, 2023
$2,500 million 4.25% Senior Notes due December 15, 2027
$2,397 $2,395 
$2,300 million 2.45% Senior Notes due July 15, 2028
2,303 2,303 
$3,500 million 4.625% Senior Notes due December 15, 2029
3,277 3,277 
$2,000 million 3.375% Senior Notes due February 15, 2030
2,000 2,000 
$2,200 million 3.00% Senior Notes due October 15, 2030
2,200 2,200 
$2,200 million 2.50% Senior Notes due March 1, 2031
2,200 2,200 
$1,300 million 2.625% Senior Notes due August 1, 2031
1,300 1,300 
Total senior notes15,677 15,675 
Term Loan Facility2,060 2,115 
Revolving Credit Agreement— 150 
Finance leases and other2 11 
Debt issuance costs(111)(122)
Total debt17,628 17,829 
Less: current portion(112)(119)
 Long-term debt$17,516 $17,710 
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.24.2
Stockholders' Equity (Tables)
 6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Share Repurchase Activity
The following represents the Company's share repurchase activity ($ in millions, shares in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
SharesCostSharesCostSharesCostSharesCost
Share buybacks10,660 $800 6,028 $400 11,341 $851 10,880 $777 
Income tax withholding44 3 71 5 1,346 103 767 51 
Total share repurchases (1)
10,704 $803 6,099 $405 12,687 $954 11,647 $828 
(1)
Excludes share repurchase excise tax of approximately $7 million and $3 million accrued as of June 30, 2024 and 2023, respectively.
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.24.2
Earnings Per Share (Tables)
 6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Calculation of Basic and Diluted Net Earnings Per Common Share
The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):
Three Months Ended June 30,Six Months Ended June 30,
 2024202320242023
Earnings attributable to Centene Corporation$1,146 $1,058 $2,309 $2,188 
Shares used in computing per share amounts: 
Weighted average number of common shares outstanding529,602 548,932 532,385 549,850 
Common stock equivalents (as determined by applying the treasury stock method)1,153 1,376 2,132 2,146 
Weighted average number of common shares and potential dilutive common shares outstanding530,755 550,308 534,517 551,996 
Net earnings per common share attributable to Centene Corporation:
Basic earnings per common share$2.16 $1.93 $4.34 $3.98 
Diluted earnings per common share$2.16 $1.92 $4.32 $3.96 
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.24.2
Segment Information (Tables)
 6 Months Ended
Jun. 30, 2024
Segment Reporting [Abstract]  
Segment Information
Segment information for the three months ended June 30, 2024, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$20,229 $5,978 $8,534 $399 $35,140 
Service21 — 1 811 833 
Premium and service revenues20,250 5,978 8,535 1,210 35,973 
Premium tax3,863 — — — 3,863 
Total external revenues24,113 5,978 8,535 1,210 39,836 
Internal revenues— — — 4,081 4,081 
Eliminations— — — (4,081)(4,081)
Total revenues$24,113 $5,978 $8,535 $1,210 $39,836 
Medical costs$18,767 $5,333 $6,268 $397 $30,765 
Cost of services$22 $— $— $658 $680 
Gross margin (1)
$1,461 $645 $2,267 $155 $4,528 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.

Segment information for the three months ended June 30, 2023, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$21,895 $5,665 $5,734 $419 $33,713 
Service— — — 1,125 1,125 
Premium and service revenues21,895 5,665 5,734 1,544 34,838 
Premium tax2,770 — — — 2,770 
Total external revenues24,665 5,665 5,734 1,544 37,608 
Internal revenues— — — 3,789 3,789 
Eliminations— — — (3,789)(3,789)
Total revenues$24,665 $5,665 $5,734 $1,544 $37,608 
Medical costs$19,459 $4,884 $4,644 $360 $29,347 
Cost of services$2 $— $— $875 $877 
Gross margin (1)
$2,434 $781 $1,090 $309 $4,614 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.
Segment information for the six months ended June 30, 2024, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$41,667 $11,913 $16,284 $805 $70,669 
Service43 — 2 1,596 1,641 
Premium and service revenues41,710 11,913 16,286 2,401 72,310 
Premium tax7,933 — — — 7,933 
Total external revenues49,643 11,913 16,286 2,401 80,243 
Internal revenues— — — 8,161 8,161 
Eliminations— — — (8,161)(8,161)
Total revenues$49,643 $11,913 $16,286 $2,401 $80,243 
Medical costs$38,262 $10,722 $11,948 $765 $61,697 
Cost of services$43 $— $— $1,306 $1,349 
Gross margin (1)
$3,405 $1,191 $4,338 $330 $9,264 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.

Segment information for the six months ended June 30, 2023, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$44,122 $11,541 $10,986 $889 $67,538 
Service— — — 2,252 2,252 
Premium and service revenues44,122 11,541 10,986 3,141 69,790 
Premium tax6,707 — — — 6,707 
Total external revenues50,829 11,541 10,986 3,141 76,497 
Internal revenues— — — 7,656 7,656 
Eliminations— — — (7,656)(7,656)
Total revenues$50,829 $11,541 $10,986 $3,141 $76,497 
Medical costs$39,469 $9,892 $8,649 $771 $58,781 
Cost of services$2 $— $— $1,745 $1,747 
Gross margin (1)
$4,651 $1,649 $2,337 $625 $9,262 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.24.2
Acquisitions and Divestitures - Divestiture (Details)
£ in Millions, $ in Millions
 3 Months Ended 6 Months Ended 12 Months Ended
Jan. 12, 2024
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Aug. 31, 2023
USD ($)
Aug. 31, 2023
GBP (£)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Gain (loss) on divestitures       $ (103) $ (172)      
Income tax benefit   $ (370) $ (360) (685) $ (621)      
Currency Swap                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Notional amount             $ 931 £ 740
Magellan Rx | Disposal Group, Disposed of by Sale, Not Discontinued Operations                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Gain (loss) on divestitures       (83)        
Circle Health | Disposal Group, Disposed of by Sale, Not Discontinued Operations                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Gain (loss) on divestitures       (20)        
Proceeds from sale of business $ 931              
Income tax benefit       $ 40        
Circle Health | Disposal Group, Held-for-sale, Not Discontinued Operations                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Goodwill impairment           $ 292    
Goodwill, impairment, net of tax           $ 258    
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.24.2
Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Debt Securities    
Gross Unrealized Gains $ 51 $ 119
Gross Unrealized Losses (896) (860)
Equity securities 17 17
Private equity investments 890 833
Life insurance contracts 189 174
Total, Amortized Cost 21,739 20,872
Total, Fair Value 20,894 20,131
U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Debt Securities    
Amortized Cost 591 403
Gross Unrealized Gains 0 0
Gross Unrealized Losses (7) (8)
Fair Value 584 395
Corporate securities    
Debt Securities    
Amortized Cost 10,554 9,984
Gross Unrealized Gains 32 78
Gross Unrealized Losses (468) (461)
Fair Value 10,118 9,601
Restricted certificates of deposit    
Debt Securities    
Amortized Cost 4 4
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 0
Fair Value 4 4
Restricted cash equivalents    
Debt Securities    
Amortized Cost 110 259
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 0
Fair Value 110 259
Short-term time deposits    
Debt Securities    
Amortized Cost 586 746
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 0
Fair Value 586 746
Municipal securities    
Debt Securities    
Amortized Cost 4,229 4,135
Gross Unrealized Gains 7 21
Gross Unrealized Losses (184) (171)
Fair Value 4,052 3,985
Asset-backed securities    
Debt Securities    
Amortized Cost 1,741 1,665
Gross Unrealized Gains 8 8
Gross Unrealized Losses (29) (35)
Fair Value 1,720 1,638
Residential mortgage-backed securities    
Debt Securities    
Amortized Cost 1,606 1,503
Gross Unrealized Gains 2 7
Gross Unrealized Losses (129) (103)
Fair Value 1,479 1,407
Commercial mortgage-backed securities    
Debt Securities    
Amortized Cost 1,222 1,149
Gross Unrealized Gains 2 5
Gross Unrealized Losses (79) (82)
Fair Value $ 1,145 $ 1,072
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.24.2
Short-term and Long-term Investments, Restricted Deposits - Narrative (Details)
$ in Millions
 6 Months Ended
Jun. 30, 2024
USD ($)
position
Dec. 31, 2023
USD ($)
Schedule Of Investments And Restricted Deposits By Type [Line Items]    
Accrued interest income | $ $ 168 $ 153
Positions from which gross unrealized losses were generated 4,626  
Total investment positions 6,830  
Commercial mortgage-backed securities    
Schedule Of Investments And Restricted Deposits By Type [Line Items]    
Investments recorded at fair value that carry rating of AAA Plus, weighted average (in years) 3 years  
Rated Securities | External Credit Rating, Investment Grade | Investment Securities    
Schedule Of Investments And Restricted Deposits By Type [Line Items]    
Percentage of investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations 99.00%  
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.24.2
Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Unrealized Losses    
Less Than 12 Months $ (40) $ (16)
12 Months or More (856) (844)
Fair Value    
Fair Value, Less Than 12 Months 3,869 1,785
Fair Value, 12 Months or More 10,784 11,152
U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Unrealized Losses    
Less Than 12 Months 0 0
12 Months or More (7) (8)
Fair Value    
Fair Value, Less Than 12 Months 205 79
Fair Value, 12 Months or More 224 232
Corporate securities    
Unrealized Losses    
Less Than 12 Months (20) (6)
12 Months or More (448) (455)
Fair Value    
Fair Value, Less Than 12 Months 1,895 658
Fair Value, 12 Months or More 6,017 6,260
Municipal securities    
Unrealized Losses    
Less Than 12 Months (11) (4)
12 Months or More (173) (167)
Fair Value    
Fair Value, Less Than 12 Months 959 553
Fair Value, 12 Months or More 2,365 2,237
Asset-backed securities    
Unrealized Losses    
Less Than 12 Months (1) (2)
12 Months or More (28) (33)
Fair Value    
Fair Value, Less Than 12 Months 266 197
Fair Value, 12 Months or More 519 855
Residential mortgage-backed securities    
Unrealized Losses    
Less Than 12 Months (7) (2)
12 Months or More (122) (101)
Fair Value    
Fair Value, Less Than 12 Months 397 153
Fair Value, 12 Months or More 857 814
Commercial mortgage-backed securities    
Unrealized Losses    
Less Than 12 Months (1) (2)
12 Months or More (78) (80)
Fair Value    
Fair Value, Less Than 12 Months 147 114
Fair Value, 12 Months or More 802 754
Short-term time deposits    
Unrealized Losses    
Less Than 12 Months 0 0
12 Months or More 0 0
Fair Value    
Fair Value, Less Than 12 Months 0 31
Fair Value, 12 Months or More $ 0 $ 0
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.24.2
Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Investments    
Amortized Cost    
One year or less $ 2,428 $ 2,308
One year through five years 7,877 7,738
Five years through ten years 4,166 3,905
Greater than ten years 147 155
Asset-backed securities 4,569 4,317
Amortized Cost 19,187 18,423
Fair Value    
One year or less 2,403 2,284
One year through five years 7,546 7,431
Five years through ten years 3,947 3,735
Greater than ten years 143 154
Asset-backed securities 4,344 4,117
Fair Value 18,383 17,721
Restricted Deposits    
Amortized Cost    
One year or less 395 566
One year through five years 733 527
Five years through ten years 291 298
Greater than ten years 37 34
Asset-backed securities 0 0
Amortized Cost 1,456 1,425
Fair Value    
One year or less 392 564
One year through five years 709 504
Five years through ten years 278 283
Greater than ten years 36 35
Asset-backed securities 0 0
Fair Value $ 1,415 $ 1,386
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.24.2
Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 17,605 $ 17,193
Investments:    
Equity securities 17 17
Total assets at fair value 37,420 36,317
Total liabilities at fair value   13
Accounts payable and accrued expenses: | Currency Swap    
Investments:    
Derivative liability   13
U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair value 584 395
Corporate securities    
Investments:    
Fair value 10,118 9,601
Municipal securities    
Investments:    
Fair value 4,052 3,985
Short-term time deposits    
Investments:    
Fair value 586 746
Asset-backed securities    
Investments:    
Fair value 1,720 1,638
Residential mortgage-backed securities    
Investments:    
Fair value 1,479 1,407
Commercial mortgage-backed securities    
Investments:    
Fair value 1,145 1,072
Level I    
Assets    
Cash and cash equivalents 17,605 17,193
Investments:    
Total assets at fair value 18,313 17,862
Total liabilities at fair value   0
Level I | Accounts payable and accrued expenses: | Currency Swap    
Investments:    
Derivative liability   0
Level II    
Assets    
Cash and cash equivalents 0 0
Investments:    
Total assets at fair value 19,107 18,455
Total liabilities at fair value   13
Level II | Accounts payable and accrued expenses: | Currency Swap    
Investments:    
Derivative liability   13
Level III    
Assets    
Cash and cash equivalents 0 0
Investments:    
Total assets at fair value 0 0
Total liabilities at fair value   0
Level III | Accounts payable and accrued expenses: | Currency Swap    
Investments:    
Derivative liability   0
Investments    
Investments:    
Fair value 18,383 17,721
Total investments 18,400 17,738
Investments | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair value 58 62
Investments | Corporate securities    
Investments:    
Fair value 10,080 9,564
Investments | Municipal securities    
Investments:    
Fair value 3,315 3,232
Investments | Short-term time deposits    
Investments:    
Fair value 586 746
Investments | Asset-backed securities    
Investments:    
Fair value 1,720 1,638
Investments | Residential mortgage-backed securities    
Investments:    
Fair value 1,479 1,407
Investments | Commercial mortgage-backed securities    
Investments:    
Fair value 1,145 1,072
Investments | Equity Securities    
Investments:    
Equity securities 17 17
Investments | Level I    
Investments:    
Total investments 72 77
Investments | Level I | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair value 58 62
Investments | Level I | Corporate securities    
Investments:    
Fair value 0 0
Investments | Level I | Municipal securities    
Investments:    
Fair value 0 0
Investments | Level I | Short-term time deposits    
Investments:    
Fair value 0 0
Investments | Level I | Asset-backed securities    
Investments:    
Fair value 0 0
Investments | Level I | Residential mortgage-backed securities    
Investments:    
Fair value 0 0
Investments | Level I | Commercial mortgage-backed securities    
Investments:    
Fair value 0 0
Investments | Level I | Equity Securities    
Investments:    
Equity securities 14 15
Investments | Level II    
Investments:    
Total investments 18,328 17,661
Investments | Level II | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair value 0 0
Investments | Level II | Corporate securities    
Investments:    
Fair value 10,080 9,564
Investments | Level II | Municipal securities    
Investments:    
Fair value 3,315 3,232
Investments | Level II | Short-term time deposits    
Investments:    
Fair value 586 746
Investments | Level II | Asset-backed securities    
Investments:    
Fair value 1,720 1,638
Investments | Level II | Residential mortgage-backed securities    
Investments:    
Fair value 1,479 1,407
Investments | Level II | Commercial mortgage-backed securities    
Investments:    
Fair value 1,145 1,072
Investments | Level II | Equity Securities    
Investments:    
Equity securities 3 2
Investments | Level III    
Investments:    
Total investments 0 0
Investments | Level III | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair value 0 0
Investments | Level III | Corporate securities    
Investments:    
Fair value 0 0
Investments | Level III | Municipal securities    
Investments:    
Fair value 0 0
Investments | Level III | Short-term time deposits    
Investments:    
Fair value 0 0
Investments | Level III | Asset-backed securities    
Investments:    
Fair value 0 0
Investments | Level III | Residential mortgage-backed securities    
Investments:    
Fair value 0 0
Investments | Level III | Commercial mortgage-backed securities    
Investments:    
Fair value 0 0
Investments | Level III | Equity Securities    
Investments:    
Equity securities 0 0
Restricted Deposits    
Investments:    
Fair value 1,415 1,386
Restricted Deposits | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair value 526 333
Restricted Deposits | Corporate securities    
Investments:    
Fair value 38 37
Restricted Deposits | Municipal securities    
Investments:    
Fair value 737 753
Restricted Deposits | Cash and cash equivalents    
Investments:    
Fair value 110 259
Restricted Deposits | Certificates of deposit    
Investments:    
Fair value 4 4
Restricted Deposits | Level I    
Investments:    
Fair value 636 592
Restricted Deposits | Level I | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair value 526 333
Restricted Deposits | Level I | Corporate securities    
Investments:    
Fair value 0 0
Restricted Deposits | Level I | Municipal securities    
Investments:    
Fair value 0 0
Restricted Deposits | Level I | Cash and cash equivalents    
Investments:    
Fair value 110 259
Restricted Deposits | Level I | Certificates of deposit    
Investments:    
Fair value 0 0
Restricted Deposits | Level II    
Investments:    
Fair value 779 794
Restricted Deposits | Level II | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair value 0 0
Restricted Deposits | Level II | Corporate securities    
Investments:    
Fair value 38 37
Restricted Deposits | Level II | Municipal securities    
Investments:    
Fair value 737 753
Restricted Deposits | Level II | Cash and cash equivalents    
Investments:    
Fair value 0 0
Restricted Deposits | Level II | Certificates of deposit    
Investments:    
Fair value 4 4
Restricted Deposits | Level III    
Investments:    
Fair value 0 0
Restricted Deposits | Level III | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair value 0 0
Restricted Deposits | Level III | Corporate securities    
Investments:    
Fair value 0 0
Restricted Deposits | Level III | Municipal securities    
Investments:    
Fair value 0 0
Restricted Deposits | Level III | Cash and cash equivalents    
Investments:    
Fair value 0 0
Restricted Deposits | Level III | Certificates of deposit    
Investments:    
Fair value $ 0 $ 0
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.24.2
Fair Value Measurements - Narrative (Details) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Fair Value Disclosures [Abstract]    
Aggregate carrying amount of life insurance contracts and equity investments, fair value $ 1,079 $ 1,007
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.24.2
Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details) - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]    
Balance, January 1 $ 18,000 $ 16,745
Less: Reinsurance recoverable 49 26
Balance, January 1, net 17,951 16,719
Incurred related to:    
Current year 63,383 60,335
Prior years (1,771) (1,554)
Total incurred 61,612 58,781
Paid related to:    
Current year 48,565 46,970
Prior years 12,968 11,666
Total paid 61,533 58,636
Plus: Premium deficiency reserve 85  
Balance, June 30, net 18,115 16,864
Plus: Reinsurance recoverable 58 20
Balance, June 30 18,173 16,884
Medicaid    
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]    
Balance, January 1 10,814 11,253
Less: Reinsurance recoverable 5 7
Balance, January 1, net 10,809 11,246
Incurred related to:    
Current year 39,398 40,622
Prior years (1,136) (1,153)
Total incurred 38,262 39,469
Paid related to:    
Current year 30,696 31,837
Prior years 7,918 7,890
Total paid 38,614 39,727
Plus: Premium deficiency reserve 0  
Balance, June 30, net 10,457 10,988
Plus: Reinsurance recoverable 15 5
Balance, June 30 10,472 10,993
Medicare    
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]    
Balance, January 1 3,612 3,431
Less: Reinsurance recoverable 0 0
Balance, January 1, net 3,612 3,431
Incurred related to:    
Current year 10,953 10,083
Prior years (316) (191)
Total incurred 10,637 9,892
Paid related to:    
Current year 8,093 7,726
Prior years 2,562 2,357
Total paid 10,655 10,083
Plus: Premium deficiency reserve 85  
Balance, June 30, net 3,679 3,240
Plus: Reinsurance recoverable 0 0
Balance, June 30 3,679 3,240
Commercial    
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]    
Balance, January 1 3,460 1,921
Less: Reinsurance recoverable 44 19
Balance, January 1, net 3,416 1,902
Incurred related to:    
Current year 12,274 8,857
Prior years (326) (208)
Total incurred 11,948 8,649
Paid related to:    
Current year 9,143 6,751
Prior years 2,367 1,282
Total paid 11,510 8,033
Plus: Premium deficiency reserve 0  
Balance, June 30, net 3,854 2,518
Plus: Reinsurance recoverable 43 15
Balance, June 30 3,897 2,533
Other    
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]    
Balance, January 1 114 140
Less: Reinsurance recoverable 0 0
Balance, January 1, net 114 140
Incurred related to:    
Current year 758 773
Prior years 7 (2)
Total incurred 765 771
Paid related to:    
Current year 633 656
Prior years 121 137
Total paid 754 793
Plus: Premium deficiency reserve 0  
Balance, June 30, net 125 118
Plus: Reinsurance recoverable 0 0
Balance, June 30 $ 125 $ 118
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.24.2
Medical Claims Liability - Narrative (Details) - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Mar. 31, 2024
Dec. 31, 2023
Insurance [Abstract]        
Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs $ 88 $ 319    
Short-duration insurance contracts, Incurred but not reported and expected development on reported claims 12,337      
Medicare        
Segment Reporting Information [Line Items]        
Premium deficiency reserve liability $ 335   $ 300 $ 250
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.24.2
Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Affordable Care Act [Abstract]    
Risk adjustment receivable $ 2,047 $ 893
Risk adjustment payable (3,475) (2,553)
Minimum medical loss ratio (675) (164)
Cost sharing reduction receivable 12 0
Cost sharing reduction payable $ (111) $ (114)
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.24.2
Affordable Care Act - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2024
Affordable Care Act [Abstract]      
Risk adjustment, decrease to net payable     $ 1,344
Risk adjustment and reinsurance pre-tax benefit $ 867 $ 78 $ 945
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.24.2
Debt - Schedule of Debt (Details) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Debt Instrument [Line Items]    
Total senior notes $ 15,677,000,000 $ 15,675,000,000
Finance leases and other 2,000,000 11,000,000
Debt issuance costs (111,000,000) (122,000,000)
Total debt 17,628,000,000 17,829,000,000
Less: current portion (112,000,000) (119,000,000)
 Long-term debt 17,516,000,000 17,710,000,000
Revolving Credit Agreement    
Debt Instrument [Line Items]    
Credit facility 0 150,000,000
Term Loan Facility    
Debt Instrument [Line Items]    
Credit facility 2,060,000,000 2,115,000,000
$2,500 million 4.25% Senior Notes due December 15, 2027 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,500,000,000  
Interest rate 4.25%  
Senior notes $ 2,397,000,000 2,395,000,000
$2,300 million 2.45% Senior Notes due July 15, 2028 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,300,000,000  
Interest rate 2.45%  
Senior notes $ 2,303,000,000 2,303,000,000
$3,500 million 4.625% Senior Notes due December 15, 2029 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 3,500,000,000  
Interest rate 4.625%  
Senior notes $ 3,277,000,000 3,277,000,000
$2,000 million 3.375% Senior Notes due February 15, 2030 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,000,000,000  
Interest rate 3.375%  
Senior notes $ 2,000,000,000 2,000,000,000
$2,200 million 3.00% Senior Notes due October 15, 2030 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,200,000,000  
Interest rate 3.00%  
Senior notes $ 2,200,000,000 2,200,000,000
$2,200 million 2.50% Senior Notes due March 1, 2031 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,200,000,000  
Interest rate 2.50%  
Senior notes $ 2,200,000,000 2,200,000,000
$1,300 million 2.625% Senior Notes due August 1, 2031 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 1,300,000,000  
Interest rate 2.625%  
Senior notes $ 1,300,000,000 $ 1,300,000,000
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.24.2
Stockholders' Equity - Narrative (Details)
$ in Millions
Jun. 30, 2024
USD ($)
Equity [Abstract]  
Stock repurchase program, authorized amount $ 10,000
Stock repurchase program, remaining available $ 4,378
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.24.2
Stockholders' Equity - Share Repurchase Activity (Details) - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Subsidiary, Sale of Stock [Line Items]            
Common stock repurchases $ 810 $ 151 $ 408 $ 423    
Share repurchase program, excise tax, payable $ 7   $ 3   $ 7 $ 3
Employee Stock Compensation Plan            
Subsidiary, Sale of Stock [Line Items]            
Income tax withholding (in shares) 44   71   1,346 767
Income tax withholding $ 3   $ 5   $ 103 $ 51
Common Stock            
Subsidiary, Sale of Stock [Line Items]            
Share buybacks (in shares) 10,660   6,028   11,341 10,880
Common stock repurchases (in shares) 10,704   6,099   12,687 11,647
Share buybacks $ 800   $ 400   $ 851 $ 777
Common stock repurchases $ 803   $ 405   $ 954 $ 828
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.24.2
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Net Income (Loss) Attributable to Parent [Abstract]        
Earnings attributable to Centene Corporation $ 1,146 $ 1,058 $ 2,309 $ 2,188
Shares used in computing per share amounts:        
Weighted average number of common shares outstanding (in shares) 529,602 548,932 532,385 549,850
Common stock equivalents (as determined by applying the treasury stock method) (in shares) 1,153 1,376 2,132 2,146
Weighted average number of common shares and potential dilutive common shares outstanding (in shares) 530,755 550,308 534,517 551,996
Net earnings per common share attributable to Centene Corporation:        
Basic earnings per common share (in dollars per share) $ 2.16 $ 1.93 $ 4.34 $ 3.98
Diluted earnings per common share (in dollars per share) $ 2.16 $ 1.92 $ 4.32 $ 3.96
Anti-dilutive restricted stock and restricted stock units excluded from the calculation of diluted earnings (loss) per common share (in shares) 271 1,519 267 1,611
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.24.2
Segment Information (Details)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2024
USD ($)
segment
Jun. 30, 2023
USD ($)
Segment Reporting [Abstract]        
Number of operating segments | segment     4  
Segment Reporting Information [Line Items]        
Premium and service revenues $ 35,973 $ 34,838 $ 72,310 $ 69,790
Premium tax 3,863 2,770 7,933 6,707
Total external revenues 39,836 37,608 80,243 76,497
Revenues 39,836 37,608 80,243 76,497
Medical costs 30,765 29,347 61,697 58,781
Cost of services 680 877 1,349 1,747
Gross margin 4,528 4,614 9,264 9,262
Operating Segments        
Segment Reporting Information [Line Items]        
Revenues 4,081 3,789 8,161 7,656
Eliminations        
Segment Reporting Information [Line Items]        
Revenues (4,081) (3,789) (8,161) (7,656)
Premium        
Segment Reporting Information [Line Items]        
Premium and service revenues 35,140 33,713 70,669 67,538
Service        
Segment Reporting Information [Line Items]        
Premium and service revenues 833 1,125 1,641 2,252
Premium and service revenues        
Segment Reporting Information [Line Items]        
Premium and service revenues 35,973 34,838 72,310 69,790
Medicaid        
Segment Reporting Information [Line Items]        
Revenues 24,113 24,665 49,643 50,829
Medical costs 18,767 19,459 38,262 39,469
Cost of services 22 2 43 2
Gross margin 1,461 2,434 3,405 4,651
Medicaid | Operating Segments        
Segment Reporting Information [Line Items]        
Premium tax 3,863 2,770 7,933 6,707
Total external revenues 24,113 24,665 49,643 50,829
Revenues 0 0 0 0
Medicaid | Eliminations        
Segment Reporting Information [Line Items]        
Revenues 0 0 0 0
Medicaid | Premium | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 20,229 21,895 41,667 44,122
Medicaid | Service | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 21 0 43 0
Medicaid | Premium and service revenues | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 20,250 21,895 41,710 44,122
Medicare        
Segment Reporting Information [Line Items]        
Revenues 5,978 5,665 11,913 11,541
Medical costs 5,333 4,884 10,722 9,892
Cost of services 0 0 0 0
Gross margin 645 781 1,191 1,649
Medicare | Operating Segments        
Segment Reporting Information [Line Items]        
Premium tax 0 0 0 0
Total external revenues 5,978 5,665 11,913 11,541
Revenues 0 0 0 0
Medicare | Eliminations        
Segment Reporting Information [Line Items]        
Revenues 0 0 0 0
Medicare | Premium | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 5,978 5,665 11,913 11,541
Medicare | Service | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 0 0 0 0
Medicare | Premium and service revenues | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 5,978 5,665 11,913 11,541
Commercial        
Segment Reporting Information [Line Items]        
Revenues 8,535 5,734 16,286 10,986
Medical costs 6,268 4,644 11,948 8,649
Cost of services 0 0 0 0
Gross margin 2,267 1,090 4,338 2,337
Commercial | Operating Segments        
Segment Reporting Information [Line Items]        
Premium tax 0 0 0 0
Total external revenues 8,535 5,734 16,286 10,986
Revenues 0 0 0 0
Commercial | Eliminations        
Segment Reporting Information [Line Items]        
Revenues 0 0 0 0
Commercial | Premium        
Segment Reporting Information [Line Items]        
Premium and service revenues 8,534 5,734 16,284 10,986
Commercial | Service | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 1 0 2 0
Commercial | Premium and service revenues | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 8,535 5,734 16,286 10,986
Other/Eliminations        
Segment Reporting Information [Line Items]        
Revenues 1,210 1,544 2,401 3,141
Medical costs 397 360 765 771
Cost of services 658 875 1,306 1,745
Gross margin 155 309 330 625
Other/Eliminations | Operating Segments        
Segment Reporting Information [Line Items]        
Premium tax 0 0 0 0
Total external revenues 1,210 1,544 2,401 3,141
Revenues 4,081 3,789 8,161 7,656
Other/Eliminations | Eliminations        
Segment Reporting Information [Line Items]        
Revenues (4,081) (3,789) (8,161) (7,656)
Other/Eliminations | Premium | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 399 419 805 889
Other/Eliminations | Service | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 811 1,125 1,596 2,252
Other/Eliminations | Premium and service revenues | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues $ 1,210 $ 1,544 $ 2,401 $ 3,141
EXCEL 60 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 61 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 62 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 64 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2 html 387 250 1 false 53 0 false 7 false false R1.htm 0000001 - Document - Cover Sheet http://www.centene.com/role/Cover Cover Cover 1 false false R2.htm 9952151 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 9952154 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) Statements 5 false false R6.htm 9952155 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 9952156 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) Statements 7 false false R8.htm 9952157 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 9952158 - Disclosure - Organization and Operations Sheet http://www.centene.com/role/OrganizationandOperations Organization and Operations Notes 9 false false R10.htm 9952159 - Disclosure - Acquisitions and Divestitures Sheet http://www.centene.com/role/AcquisitionsandDivestitures Acquisitions and Divestitures Notes 10 false false R11.htm 9952160 - Disclosure - Short-term and Long-term Investments, Restricted Deposits Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits Short-term and Long-term Investments, Restricted Deposits Notes 11 false false R12.htm 9952161 - Disclosure - Fair Value Measurements Sheet http://www.centene.com/role/FairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 9952162 - Disclosure - Medical Claims Liability Sheet http://www.centene.com/role/MedicalClaimsLiability Medical Claims Liability Notes 13 false false R14.htm 9952163 - Disclosure - Affordable Care Act Sheet http://www.centene.com/role/AffordableCareAct Affordable Care Act Notes 14 false false R15.htm 9952164 - Disclosure - Debt Sheet http://www.centene.com/role/Debt Debt Notes 15 false false R16.htm 9952165 - Disclosure - Stockholders' Equity Sheet http://www.centene.com/role/StockholdersEquity Stockholders' Equity Notes 16 false false R17.htm 9952166 - Disclosure - Earnings Per Share Sheet http://www.centene.com/role/EarningsPerShare Earnings Per Share Notes 17 false false R18.htm 9952167 - Disclosure - Segment Information Sheet http://www.centene.com/role/SegmentInformation Segment Information Notes 18 false false R19.htm 9952168 - Disclosure - Contingencies Sheet http://www.centene.com/role/Contingencies Contingencies Notes 19 false false R20.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 20 false false R21.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 21 false false R22.htm 9954471 - Disclosure - Organization and Operations (Policies) Sheet http://www.centene.com/role/OrganizationandOperationsPolicies Organization and Operations (Policies) Policies 22 false false R23.htm 9954472 - Disclosure - Short-term and Long-term Investments, Restricted Deposits (Tables) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables Short-term and Long-term Investments, Restricted Deposits (Tables) Tables http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits 23 false false R24.htm 9954473 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.centene.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.centene.com/role/FairValueMeasurements 24 false false R25.htm 9954474 - Disclosure - Medical Claims Liability (Tables) Sheet http://www.centene.com/role/MedicalClaimsLiabilityTables Medical Claims Liability (Tables) Tables http://www.centene.com/role/MedicalClaimsLiability 25 false false R26.htm 9954475 - Disclosure - Affordable Care Act (Tables) Sheet http://www.centene.com/role/AffordableCareActTables Affordable Care Act (Tables) Tables http://www.centene.com/role/AffordableCareAct 26 false false R27.htm 9954476 - Disclosure - Debt (Tables) Sheet http://www.centene.com/role/DebtTables Debt (Tables) Tables http://www.centene.com/role/Debt 27 false false R28.htm 9954477 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.centene.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.centene.com/role/StockholdersEquity 28 false false R29.htm 9954478 - Disclosure - Earnings Per Share (Tables) Sheet http://www.centene.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.centene.com/role/EarningsPerShare 29 false false R30.htm 9954479 - Disclosure - Segment Information (Tables) Sheet http://www.centene.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.centene.com/role/SegmentInformation 30 false false R31.htm 9954480 - Disclosure - Acquisitions and Divestitures - Divestiture (Details) Sheet http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails Acquisitions and Divestitures - Divestiture (Details) Details 31 false false R32.htm 9954481 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details) Details 32 false false R33.htm 9954482 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Narrative (Details) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails Short-term and Long-term Investments, Restricted Deposits - Narrative (Details) Details http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables 33 false false R34.htm 9954483 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details) Details 34 false false R35.htm 9954484 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details) Details 35 false false R36.htm 9954485 - Disclosure - Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 36 false false R37.htm 9954486 - Disclosure - Fair Value Measurements - Narrative (Details) Sheet http://www.centene.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements - Narrative (Details) Details 37 false false R38.htm 9954487 - Disclosure - Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details) Sheet http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details) Details 38 false false R39.htm 9954488 - Disclosure - Medical Claims Liability - Narrative (Details) Sheet http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails Medical Claims Liability - Narrative (Details) Details 39 false false R40.htm 9954489 - Disclosure - Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details) Sheet http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details) Details 40 false false R41.htm 9954490 - Disclosure - Affordable Care Act - Narrative (Details) Sheet http://www.centene.com/role/AffordableCareActNarrativeDetails Affordable Care Act - Narrative (Details) Details 41 false false R42.htm 9954491 - Disclosure - Debt - Schedule of Debt (Details) Sheet http://www.centene.com/role/DebtScheduleofDebtDetails Debt - Schedule of Debt (Details) Details 42 false false R43.htm 9954492 - Disclosure - Stockholders' Equity - Narrative (Details) Sheet http://www.centene.com/role/StockholdersEquityNarrativeDetails Stockholders' Equity - Narrative (Details) Details 43 false false R44.htm 9954493 - Disclosure - Stockholders' Equity - Share Repurchase Activity (Details) Sheet http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails Stockholders' Equity - Share Repurchase Activity (Details) Details 44 false false R45.htm 9954494 - Disclosure - Earnings Per Share (Details) Sheet http://www.centene.com/role/EarningsPerShareDetails Earnings Per Share (Details) Details http://www.centene.com/role/EarningsPerShareTables 45 false false R46.htm 9954495 - Disclosure - Segment Information (Details) Sheet http://www.centene.com/role/SegmentInformationDetails Segment Information (Details) Details http://www.centene.com/role/SegmentInformationTables 46 false false All Reports Book All Reports cnc-20240630.htm cnc-20240630.xsd cnc-20240630_cal.xml cnc-20240630_def.xml cnc-20240630_lab.xml cnc-20240630_pre.xml http://fasb.org/srt/2024 http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 true true JSON 66 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "cnc-20240630.htm": { "nsprefix": "cnc", "nsuri": "http://www.centene.com/20240630", "dts": { "inline": { "local": [ "cnc-20240630.htm" ] }, "schema": { "local": [ "cnc-20240630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "cnc-20240630_cal.xml" ] }, "definitionLink": { "local": [ "cnc-20240630_def.xml" ] }, "labelLink": { "local": [ "cnc-20240630_lab.xml" ] }, "presentationLink": { "local": [ "cnc-20240630_pre.xml" ] } }, "keyStandard": 224, "keyCustom": 26, "axisStandard": 19, "axisCustom": 0, "memberStandard": 33, "memberCustom": 19, "hidden": { "total": 5, "http://xbrl.sec.gov/dei/2024": 5 }, "contextCount": 387, "entityCount": 1, "segmentCount": 53, "elementCount": 503, "unitCount": 7, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 1202, "http://xbrl.sec.gov/dei/2024": 29, "http://xbrl.sec.gov/ecd/2024": 4, "http://fasb.org/srt/2024": 1 }, "report": { "R1": { "role": "http://www.centene.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "longName": "9952151 - Statement - CONSOLIDATED BALANCE SHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "unique": true } }, "R3": { "role": "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "longName": "9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "longName": "9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-13", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-13", "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "unique": true } }, "R5": { "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS", "longName": "9952154 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-13", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-13", "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "unique": true } }, "R6": { "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "longName": "9952155 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-50", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-61", "name": "us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "unique": true } }, "R7": { "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical", "longName": "9952156 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-13", "name": "us-gaap:OtherComprehensiveIncomeLossTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "unique": true } }, "R8": { "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "longName": "9952157 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DepreciationAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "unique": true } }, "R9": { "role": "http://www.centene.com/role/OrganizationandOperations", "longName": "9952158 - Disclosure - Organization and Operations", "shortName": "Organization and Operations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.centene.com/role/AcquisitionsandDivestitures", "longName": "9952159 - Disclosure - Acquisitions and Divestitures", "shortName": "Acquisitions and Divestitures", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits", "longName": "9952160 - Disclosure - Short-term and Long-term Investments, Restricted Deposits", "shortName": "Short-term and Long-term Investments, Restricted Deposits", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.centene.com/role/FairValueMeasurements", "longName": "9952161 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.centene.com/role/MedicalClaimsLiability", "longName": "9952162 - Disclosure - Medical Claims Liability", "shortName": "Medical Claims Liability", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InsuranceDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InsuranceDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.centene.com/role/AffordableCareAct", "longName": "9952163 - Disclosure - Affordable Care Act", "shortName": "Affordable Care Act", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "cnc:AffordableCareActDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "cnc:AffordableCareActDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.centene.com/role/Debt", "longName": "9952164 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.centene.com/role/StockholdersEquity", "longName": "9952165 - Disclosure - Stockholders' Equity", "shortName": "Stockholders' Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.centene.com/role/EarningsPerShare", "longName": "9952166 - Disclosure - Earnings Per Share", "shortName": "Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.centene.com/role/SegmentInformation", "longName": "9952167 - Disclosure - Segment Information", "shortName": "Segment Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.centene.com/role/Contingencies", "longName": "9952168 - Disclosure - Contingencies", "shortName": "Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R20": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-13", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true }, "uniqueAnchor": null }, "R21": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-13", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:Rule10b51ArrTrmntdFlag", "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-13", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:Rule10b51ArrTrmntdFlag", "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.centene.com/role/OrganizationandOperationsPolicies", "longName": "9954471 - Disclosure - Organization and Operations (Policies)", "shortName": "Organization and Operations (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables", "longName": "9954472 - Disclosure - Short-term and Long-term Investments, Restricted Deposits (Tables)", "shortName": "Short-term and Long-term Investments, Restricted Deposits (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.centene.com/role/FairValueMeasurementsTables", "longName": "9954473 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "cnc:FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "cnc:FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.centene.com/role/MedicalClaimsLiabilityTables", "longName": "9954474 - Disclosure - Medical Claims Liability (Tables)", "shortName": "Medical Claims Liability (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.centene.com/role/AffordableCareActTables", "longName": "9954475 - Disclosure - Affordable Care Act (Tables)", "shortName": "Affordable Care Act (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.centene.com/role/DebtTables", "longName": "9954476 - Disclosure - Debt (Tables)", "shortName": "Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.centene.com/role/StockholdersEquityTables", "longName": "9954477 - Disclosure - Stockholders' Equity (Tables)", "shortName": "Stockholders' Equity (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.centene.com/role/EarningsPerShareTables", "longName": "9954478 - Disclosure - Earnings Per Share (Tables)", "shortName": "Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.centene.com/role/SegmentInformationTables", "longName": "9954479 - Disclosure - Segment Information (Tables)", "shortName": "Segment Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "longName": "9954480 - Disclosure - Acquisitions and Divestitures - Divestiture (Details)", "shortName": "Acquisitions and Divestitures - Divestiture (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GainLossOnSaleOfBusiness", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-84", "name": "us-gaap:DerivativeAssetNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "unique": true } }, "R32": { "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "longName": "9954481 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details)", "shortName": "Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails", "longName": "9954482 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Narrative (Details)", "shortName": "Short-term and Long-term Investments, Restricted Deposits - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "longName": "9954483 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details)", "shortName": "Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails", "longName": "9954484 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details)", "shortName": "Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-107", "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-107", "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "longName": "9954485 - Disclosure - Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "shortName": "Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.centene.com/role/FairValueMeasurementsNarrativeDetails", "longName": "9954486 - Disclosure - Fair Value Measurements - Narrative (Details)", "shortName": "Fair Value Measurements - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-3", "name": "cnc:LifeInsuranceContractsAndEquityInvestmentsFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "cnc:LifeInsuranceContractsAndEquityInvestmentsFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "longName": "9954487 - Disclosure - Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details)", "shortName": "Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-58", "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "unique": true } }, "R39": { "role": "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails", "longName": "9954488 - Disclosure - Medical Claims Liability - Narrative (Details)", "shortName": "Medical Claims Liability - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "cnc:AmountsRecordedAsAnAdjustmentToPremiumRevenuesRelatedToMinimumHBRAndReturnOfPremiumPrograms", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "cnc:AmountsRecordedAsAnAdjustmentToPremiumRevenuesRelatedToMinimumHBRAndReturnOfPremiumPrograms", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails", "longName": "9954489 - Disclosure - Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details)", "shortName": "Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-3", "name": "cnc:AffordableCareActRiskAdjustmentReceivable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "cnc:AffordableCareActRiskAdjustmentReceivable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.centene.com/role/AffordableCareActNarrativeDetails", "longName": "9954490 - Disclosure - Affordable Care Act - Narrative (Details)", "shortName": "Affordable Care Act - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-1", "name": "cnc:AffordableCareActRiskAdjustmentNetPayableIncreaseDecrease", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "cnc:AffordableCareActRiskAdjustmentNetPayableIncreaseDecrease", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.centene.com/role/DebtScheduleofDebtDetails", "longName": "9954491 - Disclosure - Debt - Schedule of Debt (Details)", "shortName": "Debt - Schedule of Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-3", "name": "cnc:SeniorNotesTotal", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "cnc:SeniorNotesTotal", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.centene.com/role/StockholdersEquityNarrativeDetails", "longName": "9954492 - Disclosure - Stockholders' Equity - Narrative (Details)", "shortName": "Stockholders' Equity - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-3", "name": "srt:StockRepurchaseProgramAuthorizedAmount1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "srt:StockRepurchaseProgramAuthorizedAmount1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails", "longName": "9954493 - Disclosure - Stockholders' Equity - Share Repurchase Activity (Details)", "shortName": "Stockholders' Equity - Share Repurchase Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-13", "name": "us-gaap:TreasuryStockValueAcquiredCostMethod", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-284", "name": "us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "unique": true } }, "R45": { "role": "http://www.centene.com/role/EarningsPerShareDetails", "longName": "9954494 - Disclosure - Earnings Per Share (Details)", "shortName": "Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-13", "name": "us-gaap:IncomeLossFromContinuingOperations", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-13", "name": "us-gaap:IncomeLossFromContinuingOperations", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.centene.com/role/SegmentInformationDetails", "longName": "9954495 - Disclosure - Segment Information (Details)", "shortName": "Segment Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20240630.htm", "first": true, "unique": true } } }, "tag": { "cnc_A1300Million2625SeniorNotesDueAugust2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20240630", "localname": "A1300Million2625SeniorNotesDueAugust2031Member", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$1,300 million 2.625% Senior Notes due August 1, 2031", "label": "$1,300 Million 2.625% Senior Notes due August 2031 [Member]", "documentation": "$1,300 Million 2.625% Senior Notes due August 2031" } } }, "auth_ref": [] }, "cnc_A2200Million250SeniorNotesDueMarch2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20240630", "localname": "A2200Million250SeniorNotesDueMarch2031Member", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$2,200 million 2.50% Senior Notes due March 1, 2031", "label": "$2,200 Million 2.50% Senior Notes due March 2031 [Member]", "documentation": "$2,200 Million 2.50% Senior Notes due March 2031" } } }, "auth_ref": [] }, "cnc_A2200Million300SeniorNotesDueOctober2030Member": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20240630", "localname": "A2200Million300SeniorNotesDueOctober2030Member", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$2,200 million 3.00% Senior Notes due October 15, 2030", "label": "$2,200 Million 3.00% Senior Notes Due October 2030 [Member]", "documentation": "$2,200 Million 3.00% Senior Notes Due October 2030" } } }, "auth_ref": [] }, "cnc_A2200Million375SeniorNotesDueFebruary2030Member": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20240630", "localname": "A2200Million375SeniorNotesDueFebruary2030Member", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$2,000 million 3.375% Senior Notes due February 15, 2030", "label": "$2,200 Million 3.75% Senior Notes Due February 2030 [Member]", "documentation": "$2,200 Million 3.75% Senior Notes Due February 2030" } } }, "auth_ref": [] }, "cnc_A2300Million245SeniorNotsDueJuly2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20240630", "localname": "A2300Million245SeniorNotsDueJuly2028Member", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$2,300 million 2.45% Senior Notes due July 15, 2028", "label": "$2,300 Million 2.45% Senior Nots due July 2028 [Member]", "documentation": "$2,300 Million 2.45% Senior Nots due July 2028" } } }, "auth_ref": [] }, "cnc_A3500Million4625SeniorNotesDueDecember2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20240630", "localname": "A3500Million4625SeniorNotesDueDecember2029Member", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$3,500 million 4.625% Senior Notes due December 15, 2029", "label": "$3,500 Million 4.625% Senior Notes due December 2029 [Member]", "documentation": "$3,500 Million 4.625% Senior Notes due December 2029" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued expenses", "label": "Accounts Payable and Accrued Liabilities, Current", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r78", "r79" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAndAccruedLiabilitiesMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued expenses:", "label": "Accounts Payable and Accrued Liabilities [Member]", "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive (loss)", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r23", "r24", "r93", "r192", "r604", "r651", "r652" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Earnings (Loss)", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r1", "r16", "r24", "r496", "r499", "r548", "r647", "r648", "r926", "r927", "r928", "r937", "r938", "r939", "r940" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r860" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r88" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-in Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r662", "r937", "r938", "r939", "r940", "r1017", "r1082" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r873" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r873" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r873" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r873" ] }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails": { "parentTag": "us-gaap_TreasuryStockValueAcquiredCostMethod", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax withholding", "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation", "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock compensation expense", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r51", "r52", "r440" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "cnc_AffordableCareActAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.centene.com/20240630", "localname": "AffordableCareActAbstract", "lang": { "en-us": { "role": { "terseLabel": "Affordable Care Act [Abstract]", "label": "Affordable Care Act [Abstract]", "documentation": "Affordable Care Act [Abstract]" } } }, "auth_ref": [] }, "cnc_AffordableCareActCostSharingReductionReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20240630", "localname": "AffordableCareActCostSharingReductionReceivable", "crdr": "debit", "presentation": [ "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost sharing reduction receivable", "label": "Affordable Care Act, Cost Sharing Reduction Receivable", "documentation": "Affordable Care Act, Cost Sharing Reduction Receivable" } } }, "auth_ref": [] }, "cnc_AffordableCareActCostSharingReductionsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20240630", "localname": "AffordableCareActCostSharingReductionsPayable", "crdr": "credit", "presentation": [ "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Cost sharing reduction payable", "label": "Affordable Care Act Cost Sharing Reductions, Payable", "documentation": "Affordable Care Act Cost Sharing Reductions, Payable" } } }, "auth_ref": [] }, "cnc_AffordableCareActDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.centene.com/20240630", "localname": "AffordableCareActDisclosureTextBlock", "presentation": [ "http://www.centene.com/role/AffordableCareAct" ], "lang": { "en-us": { "role": { "terseLabel": "Affordable Care Act", "label": "Affordable Care Act Disclosure [Text Block]", "documentation": "Affordable Care Act Disclosure [Text Block]" } } }, "auth_ref": [] }, "cnc_AffordableCareActMinimumMedicalLossRatio": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20240630", "localname": "AffordableCareActMinimumMedicalLossRatio", "crdr": "credit", "presentation": [ "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Minimum medical loss ratio", "label": "Affordable Care Act Minimum Medical Loss Ratio", "documentation": "Affordable Care Act, Minimum Medical Loss Ratio" } } }, "auth_ref": [] }, "cnc_AffordableCareActReinsurancePayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20240630", "localname": "AffordableCareActReinsurancePayable", "crdr": "credit", "presentation": [ "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Risk adjustment payable", "label": "Affordable Care Act Reinsurance Payable", "documentation": "Affordable Care Act Reinsurance, Payable" } } }, "auth_ref": [] }, "cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20240630", "localname": "AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://www.centene.com/role/AffordableCareActNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Risk adjustment and reinsurance pre-tax benefit", "label": "Affordable Care Act, Risk Adjustment And Reinsurance, Pre-Tax Expense (Benefit)", "documentation": "Affordable Care Act, Risk Adjustment And Reinsurance, Pre-Tax Expense (Benefit)" } } }, "auth_ref": [] }, "cnc_AffordableCareActRiskAdjustmentNetPayableIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20240630", "localname": "AffordableCareActRiskAdjustmentNetPayableIncreaseDecrease", "crdr": "debit", "presentation": [ "http://www.centene.com/role/AffordableCareActNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Risk adjustment, decrease to net payable", "label": "Affordable Care Act, Risk Adjustment, Net Payable Increase (Decrease)", "documentation": "Affordable Care Act, Risk Adjustment, Net Payable Increase (Decrease)" } } }, "auth_ref": [] }, "cnc_AffordableCareActRiskAdjustmentReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20240630", "localname": "AffordableCareActRiskAdjustmentReceivable", "crdr": "debit", "presentation": [ "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk adjustment receivable", "label": "Affordable Care Act, Risk Adjustment Receivable", "documentation": "Affordable Care Act, Risk Adjustment Receivable" } } }, "auth_ref": [] }, "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table", "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r906" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r832", "r842", "r852", "r884" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r835", "r845", "r855", "r887" ] }, "ecd_AggtPnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtPnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Pension Adjustments Service Cost", "label": "Aggregate Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r907" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r873" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r880" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r836", "r846", "r856", "r880", "r888", "r892", "r900" ] }, "us-gaap_AllOtherSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllOtherSegmentsMember", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "verboseLabel": "Other/Eliminations", "label": "Other Operating Segment [Member]", "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items." } } }, "auth_ref": [ "r261", "r280", "r281", "r282", "r283", "r284", "r287", "r767", "r768" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r898" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of acquired intangible assets", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r10", "r359", "r360", "r774" ] }, "cnc_AmountsRecordedAsAnAdjustmentToPremiumRevenuesRelatedToMinimumHBRAndReturnOfPremiumPrograms": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20240630", "localname": "AmountsRecordedAsAnAdjustmentToPremiumRevenuesRelatedToMinimumHBRAndReturnOfPremiumPrograms", "crdr": "credit", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs", "label": "Amounts Recorded As An Adjustment to Premium Revenues Related to Minimum HBR and Return of Premium Programs", "documentation": "Amounts Recorded As An Adjustment To Premium Revenues Related To Minimum HBR and Return Of Premium Programs" } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Anti-dilutive restricted stock and restricted stock units excluded from the calculation of diluted earnings (loss) per common share (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r252" ] }, "us-gaap_AssetBackedSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetBackedSecuritiesMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset-backed securities", "label": "Asset-Backed Securities [Member]", "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans." } } }, "auth_ref": [ "r781", "r801", "r951", "r957", "r958" ] }, "us-gaap_AssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetImpairmentCharges", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 }, "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment", "label": "Asset Impairment Charges", "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill." } } }, "auth_ref": [ "r10", "r38" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r129", "r145", "r185", "r224", "r256", "r264", "r282", "r286", "r329", "r375", "r376", "r378", "r379", "r380", "r381", "r382", "r384", "r385", "r487", "r492", "r533", "r598", "r703", "r767", "r768", "r800", "r823", "r981", "r982", "r1037" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r179", "r194", "r224", "r329", "r375", "r376", "r378", "r379", "r380", "r381", "r382", "r384", "r385", "r487", "r492", "r533", "r800", "r981", "r982", "r1037" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets at fair value", "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r507", "r508", "r789" ] }, "us-gaap_AssetsFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsFairValueDisclosureAbstract", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "crdr": "credit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "parentTag": "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Unrealized Gains", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax", "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r300" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "parentTag": "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Gross Unrealized Losses", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax", "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r301" ] }, "us-gaap_AvailableForSaleSecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesAbstract", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments:", "label": "Debt Securities, Available-for-Sale [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized Losses", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Five years through ten years", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r954" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Five years through ten years", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r307", "r593" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "One year through five years", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r953" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "One year through five years", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r306", "r592" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Greater than ten years", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r955" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Greater than ten years", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r308", "r594" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortized Cost", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "One year or less", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r952" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "One year or less", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r305", "r591" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset-backed securities", "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping." } } }, "auth_ref": [ "r950", "r951" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset-backed securities", "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping." } } }, "auth_ref": [ "r304", "r590", "r950" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r895" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r896" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r891" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r891" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r891" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r891" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r891" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r891" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r894" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r893" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r892" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r892" ] }, "us-gaap_BankTimeDepositsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BankTimeDepositsMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term time deposits", "label": "Bank Time Deposits [Member]", "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest." } } }, "auth_ref": [ "r140" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.centene.com/role/OrganizationandOperationsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.centene.com/role/OrganizationandOperations" ], "lang": { "en-us": { "role": { "verboseLabel": "Organization and Operations", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r111" ] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 }, "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "periodEndLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r30", "r181", "r757" ] }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1019", "r1020" ] }, "us-gaap_CashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents [Member]", "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, cash equivalents and restricted cash and cash equivalents, beginning of period", "periodEndLabel": "Cash, cash equivalents and restricted cash and cash equivalents, end of period", "totalLabel": "Total cash, cash equivalents and restricted cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r30", "r108", "r221" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "The following table provides a reconciliation of cash, cash equivalents and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above:", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase in cash, cash equivalents and restricted cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r0", "r108" ] }, "us-gaap_CertificatesOfDepositMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CertificatesOfDepositMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Certificates of deposit", "label": "Certificates of Deposit [Member]", "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured." } } }, "auth_ref": [ "r14", "r814", "r815", "r816", "r817" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r871" ] }, "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year", "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]" } } }, "auth_ref": [ "r868" ] }, "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested", "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r866" ] }, "cnc_CircleHealthMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20240630", "localname": "CircleHealthMember", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Circle Health", "label": "Circle Health [Member]", "documentation": "Circle Health" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r155", "r189", "r190", "r191", "r224", "r243", "r247", "r249", "r251", "r258", "r259", "r329", "r375", "r378", "r379", "r380", "r384", "r385", "r414", "r415", "r417", "r420", "r427", "r533", "r655", "r656", "r657", "r658", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r691", "r712", "r729", "r745", "r746", "r747", "r748", "r749", "r910", "r933", "r941" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r872" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r872" ] }, "us-gaap_CommercialMortgageBackedSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommercialMortgageBackedSecuritiesMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Commercial mortgage-backed securities", "netLabel": "Commercial mortgage-backed securities", "terseLabel": "Commercial mortgage-backed securities", "label": "Commercial Mortgage-Backed Securities [Member]", "documentation": "Securities collateralized by commercial real estate mortgage loans." } } }, "auth_ref": [ "r789", "r791", "r792", "r951", "r957", "r958", "r987" ] }, "cnc_CommercialSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20240630", "localname": "CommercialSegmentMember", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial", "label": "Commercial Segment [Member]", "documentation": "Commercial Segment" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r84", "r132", "r600", "r690" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.centene.com/role/Contingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r114", "r371", "r372", "r755", "r972", "r976" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical", "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r810", "r811", "r812", "r814", "r815", "r816", "r817", "r937", "r938", "r940", "r1017", "r1080", "r1082" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in dollars per share)", "verboseLabel": "Par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r87" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r87", "r691" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r87" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding (in shares)", "periodStartLabel": "Balance (in shares)", "periodEndLabel": "Balance (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r17", "r87", "r691", "r709", "r1082", "r1083" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $0.001 par value; authorized 800,000 shares; 619,495 issued and 526,001 outstanding at June\u00a030, 2024, and 615,291 issued and 534,484 outstanding at December\u00a031, 2023", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r87", "r603", "r800" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r877" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r876" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r878" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r875" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive earnings attributable to Centene Corporation", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r25", "r203", "r205", "r213", "r586", "r615", "r617" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Comprehensive loss attributable to noncontrolling interests", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r7", "r56", "r60", "r203", "r205", "r212", "r585", "r615", "r616" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive earnings", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r60", "r123", "r203", "r205", "r211", "r584", "r615" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Domain]", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r32", "r33", "r65", "r66", "r292", "r754" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Axis]", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r32", "r33", "r65", "r66", "r292", "r653", "r754" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Axis]", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r32", "r33", "r65", "r66", "r292", "r754", "r912" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r32", "r33", "r65", "r66", "r292" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Domain]", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r32", "r33", "r65", "r66", "r292", "r754" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]", "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r143", "r157", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r225", "r256", "r266", "r280", "r281", "r282", "r283", "r284", "r286", "r287", "r288", "r375", "r376", "r377", "r378", "r380", "r381", "r382", "r383", "r384", "r767", "r768", "r920", "r921", "r981", "r982" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]", "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r143", "r157", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r225", "r256", "r266", "r280", "r281", "r282", "r283", "r284", "r286", "r287", "r288", "r375", "r376", "r377", "r378", "r380", "r381", "r382", "r383", "r384", "r767", "r768", "r920", "r921", "r981", "r982" ] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Unearned revenue", "label": "Contract with Customer, Liability, Current", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r429", "r430", "r433" ] }, "us-gaap_CorporateDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CorporateDebtSecuritiesMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate securities", "verboseLabel": "Corporate securities", "label": "Corporate Debt Securities [Member]", "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment." } } }, "auth_ref": [ "r781", "r783", "r789", "r801", "r808", "r1077" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of services", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r97", "r98", "r580" ] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostsAndExpenses", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Costs and Expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r103" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditFacilityAxis", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r374", "r979" ] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditFacilityDomain", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r374", "r979", "r980" ] }, "us-gaap_CurrencySwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CurrencySwapMember", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency Swap", "label": "Currency Swap [Member]", "documentation": "Swap involving the exchange of principal and interest in one currency for another currency." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_DebtAndCapitalLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtAndCapitalLeaseObligations", "crdr": "credit", "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.centene.com/role/DebtScheduleofDebtDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total debt", "label": "Debt and Lease Obligation", "documentation": "Amount of short-term and long-term debt and lease obligation." } } }, "auth_ref": [ "r130", "r131" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.centene.com/role/Debt" ], "lang": { "en-us": { "role": { "verboseLabel": "Debt", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r115", "r222", "r364", "r365", "r366", "r367", "r368", "r373", "r374", "r386", "r392", "r393", "r394", "r395", "r396", "r397", "r402", "r409", "r410", "r412", "r542" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r20", "r78", "r79", "r130", "r131", "r225", "r387", "r388", "r389", "r390", "r391", "r393", "r398", "r399", "r400", "r401", "r403", "r404", "r405", "r406", "r407", "r408", "r775", "r776", "r777", "r778", "r779", "r799", "r934", "r973", "r974", "r975", "r1035", "r1036" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt, face amount", "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r387", "r542", "r543", "r776", "r777", "r799" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r81", "r388" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r225", "r387", "r388", "r389", "r390", "r391", "r393", "r398", "r399", "r400", "r401", "r403", "r404", "r405", "r406", "r407", "r408", "r411", "r775", "r776", "r777", "r778", "r779", "r799", "r934", "r1035", "r1036" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r20", "r225", "r387", "r388", "r389", "r390", "r391", "r393", "r398", "r399", "r400", "r401", "r403", "r404", "r405", "r406", "r407", "r408", "r775", "r776", "r777", "r778", "r779", "r799", "r934", "r973", "r974", "r975", "r1035", "r1036" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentTable", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "Disclosure of information about long-term debt instrument or arrangement." } } }, "auth_ref": [ "r20", "r43", "r44", "r67", "r119", "r120", "r225", "r387", "r388", "r389", "r390", "r391", "r393", "r398", "r399", "r400", "r401", "r403", "r404", "r405", "r406", "r407", "r408", "r411", "r775", "r776", "r777", "r778", "r779", "r799", "r934", "r1035", "r1036" ] }, "us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss", "crdr": "debit", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest income", "label": "Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss", "documentation": "Amount, after allowance for credit loss, of accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r303", "r338", "r339", "r340" ] }, "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "parentTag": "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost", "weight": 1.0, "order": 4.0 }, "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Amortized Cost", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss", "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r966" ] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger", "crdr": "debit", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, 12 Months or More", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r151", "r343", "r772" ] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss", "crdr": "debit", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "12 Months or More", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss", "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r151", "r343" ] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "crdr": "debit", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Less Than 12 Months", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r151", "r343", "r772" ] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "crdr": "debit", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less Than 12 Months", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss", "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r151", "r343" ] }, "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0, "order": 3.0 }, "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 2.0 }, "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "totalLabel": "Fair Value", "verboseLabel": "Fair value", "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest", "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r966" ] }, "cnc_DebtSecuritiesAvailableForSaleNumberOfPositions": { "xbrltype": "integerItemType", "nsuri": "http://www.centene.com/20240630", "localname": "DebtSecuritiesAvailableForSaleNumberOfPositions", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total investment positions", "label": "Debt Securities, Available -for-Sale, Number of Positions", "documentation": "Debt Securities, Available -for-Sale, Number of Positions" } } }, "auth_ref": [] }, "us-gaap_DebtSecuritiesAvailableForSaleTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesAvailableForSaleTable", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule Of Investments And Restricted Deposits By Type [Table]", "terseLabel": "Debt Securities, Available-for-sale [Table]", "label": "Debt Securities, Available-for-Sale [Table]", "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r304", "r305", "r306", "r307", "r308" ] }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of available-for-sale investments with gross unrealized losses by investment type and length of time", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]", "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r149", "r772", "r967" ] }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Positions from which gross unrealized losses were generated", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions", "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r150", "r342" ] }, "us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesAvailableforsaleAmortizedCostAbstract", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Securities", "label": "Debt Securities, Available-for-Sale, Amortized Cost [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r10", "r153", "r936" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liability", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r468", "r469", "r599" ] }, "us-gaap_DepositsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepositsMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Deposits", "label": "Deposits [Member]", "documentation": "Amounts held on account by the entity representing a liability to the depositor. Deposits may take various forms (for example, demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits) and may be categorized in multiple ways (such as, foreign and domestic, interest and noninterest bearing)." } } }, "auth_ref": [ "r139" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Depreciation", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation expense", "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r10", "r39" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization, Nonproduction", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r10", "r39" ] }, "us-gaap_DerivativeAssetNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeAssetNotionalAmount", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notional amount", "label": "Derivative Asset, Notional Amount", "documentation": "Nominal or face amount used to calculate payments on the derivative asset." } } }, "auth_ref": [ "r734", "r737", "r739", "r742", "r1014", "r1015", "r1016" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r680", "r682", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r704", "r705", "r706", "r707", "r717", "r718", "r719", "r720", "r723", "r724", "r725", "r726", "r734", "r735", "r740", "r743", "r810", "r812", "r1024", "r1025", "r1026", "r1027", "r1028", "r1029", "r1031", "r1032" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r61", "r62", "r63", "r127", "r680", "r682", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r704", "r705", "r706", "r707", "r717", "r718", "r719", "r720", "r723", "r724", "r725", "r726", "r734", "r735", "r740", "r743", "r759", "r810", "r812", "r1024", "r1025", "r1026", "r1027", "r1028", "r1029", "r1031", "r1032" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilities", "crdr": "credit", "calculation": { "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liability", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r195", "r196", "r507", "r508", "r521", "r532", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r704", "r706", "r707", "r735", "r736", "r738", "r740", "r741", "r743", "r744", "r759", "r1021", "r1022", "r1023", "r1081" ] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Classification [Axis]", "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r177" ] }, "us-gaap_DisposalGroupClassificationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupClassificationDomain", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Classification [Domain]", "label": "Disposal Group Classification [Domain]", "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations", "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]", "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations." } } }, "auth_ref": [ "r11", "r18" ] }, "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group, Held-for-sale, Not Discontinued Operations", "label": "Disposal Group, Held-for-Sale, Not Discontinued Operations [Member]", "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations." } } }, "auth_ref": [ "r4", "r18", "r177" ] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Name [Domain]", "label": "Disposal Group Name [Domain]", "documentation": "Name of disposal group." } } }, "auth_ref": [ "r784", "r785" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r827" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r859" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year", "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]" } } }, "auth_ref": [ "r870" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share [Abstract]", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic earnings per common share (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r214", "r231", "r232", "r233", "r234", "r235", "r236", "r241", "r243", "r249", "r250", "r251", "r255", "r482", "r485", "r504", "r505", "r587", "r618", "r760" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Net earnings per common share attributable to Centene Corporation:", "label": "Earnings Per Share, Basic [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasicOtherDisclosuresAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted average number of common shares outstanding:", "terseLabel": "Shares used in computing per share amounts:", "label": "Earnings Per Share, Basic, Other Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted earnings per common share (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r214", "r231", "r232", "r233", "r234", "r235", "r236", "r243", "r249", "r250", "r251", "r255", "r482", "r485", "r504", "r505", "r587", "r618", "r760" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.centene.com/role/EarningsPerShare" ], "lang": { "en-us": { "role": { "verboseLabel": "Earnings Per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r240", "r252", "r253", "r254" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r534" ] }, "cnc_EmployeeStockCompensationPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20240630", "localname": "EmployeeStockCompensationPlanMember", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Compensation Plan", "label": "Employee Stock Compensation Plan [Member]", "documentation": "Employee Stock Compensation Plan" } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Option", "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r825" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r825" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r825" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r909" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r825" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r825" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r825" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r825" ] }, "ecd_EqtyAwrdsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Footnote", "label": "Equity Awards Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r864" ] }, "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table", "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]" } } }, "auth_ref": [ "r905" ] }, "ecd_EqtyAwrdsAdjsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments", "label": "Equity Awards Adjustments [Member]" } } }, "auth_ref": [ "r905" ] }, "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table", "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r905" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Equity [Abstract]", "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r17", "r174", "r206", "r207", "r208", "r226", "r227", "r228", "r230", "r235", "r237", "r239", "r257", "r331", "r332", "r362", "r428", "r474", "r475", "r479", "r480", "r481", "r483", "r484", "r485", "r495", "r496", "r497", "r498", "r499", "r500", "r503", "r535", "r537", "r538", "r539", "r540", "r541", "r544", "r546", "r548", "r613", "r647", "r648", "r649", "r662", "r729" ] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityMethodInvestments", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "parentTag": "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private equity investments", "label": "Equity Method Investments", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r256", "r274", "r286", "r328", "r923", "r963" ] }, "us-gaap_EquitySecuritiesFvNi": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquitySecuritiesFvNi", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "parentTag": "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue", "weight": 1.0, "order": 2.0 }, "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity securities", "label": "Equity Securities, FV-NI, Current", "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current." } } }, "auth_ref": [ "r186", "r531", "r758" ] }, "us-gaap_EquitySecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquitySecuritiesMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Securities", "label": "Equity Securities [Member]", "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants." } } }, "auth_ref": [ "r37", "r801", "r818", "r819", "r820", "r1084" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r874" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r832", "r842", "r852", "r884" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r829", "r839", "r849", "r881" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r880" ] }, "us-gaap_ExternalCreditRatingByGroupingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ExternalCreditRatingByGroupingAxis", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "External Credit Rating by Grouping [Axis]", "label": "External Credit Rating by Grouping [Axis]", "documentation": "Information by external rating classified as investment grade or non investment grade." } } }, "auth_ref": [ "r146", "r147", "r148", "r494", "r965" ] }, "us-gaap_ExternalCreditRatingByGroupingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ExternalCreditRatingByGroupingDomain", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "External Credit Rating by Grouping [Domain]", "label": "External Credit Rating by Grouping [Domain]", "documentation": "External credit rating classified as investment grade or non-investment grade." } } }, "auth_ref": [ "r64" ] }, "us-gaap_ExternalCreditRatingInvestmentGradeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ExternalCreditRatingInvestmentGradeMember", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "External Credit Rating, Investment Grade", "label": "External Credit Rating, Investment Grade [Member]", "documentation": "External credit-rating that could be used to describe the current status of the payment and performance risk of credit derivatives and guarantee obligations that connote investment grade." } } }, "auth_ref": [ "r64" ] }, "cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.centene.com/20240630", "localname": "FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions", "label": "Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Input Definitions [Table Text Block]", "documentation": "Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r507", "r508", "r521", "r789" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Class [Domain]", "label": "Asset Class [Domain]", "documentation": "Class of asset." } } }, "auth_ref": [ "r512", "r513", "r514", "r515", "r516", "r517", "r522", "r791" ] }, "us-gaap_FairValueByAssetClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByAssetClassAxis", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Class [Axis]", "label": "Asset Class [Axis]", "documentation": "Information by class of asset." } } }, "auth_ref": [ "r512", "r513", "r514", "r515", "r516", "r517", "r522", "r791" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r400", "r434", "r435", "r436", "r437", "r438", "r439", "r506", "r508", "r509", "r510", "r511", "r520", "r521", "r523", "r552", "r553", "r554", "r776", "r777", "r781", "r782", "r783", "r789", "r792" ] }, "us-gaap_FairValueByLiabilityClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByLiabilityClassAxis", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability Class [Axis]", "label": "Liability Class [Axis]", "documentation": "Information by class of liability." } } }, "auth_ref": [ "r512", "r513", "r514", "r515", "r516", "r517", "r522" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Fair Value Disclosures [Abstract]", "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.centene.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r516", "r518", "r519", "r520", "r523", "r524", "r525", "r526", "r527", "r581", "r789", "r793" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level I", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r400", "r434", "r439", "r508", "r521", "r552", "r781", "r782", "r783", "r789" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level II", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r400", "r434", "r439", "r508", "r509", "r521", "r553", "r776", "r777", "r781", "r782", "r783", "r789" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level III", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r400", "r434", "r435", "r436", "r437", "r438", "r439", "r508", "r509", "r510", "r511", "r521", "r554", "r776", "r777", "r781", "r782", "r783", "r789", "r792" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value by Liability Class [Domain]", "label": "Fair Value by Liability Class [Domain]", "documentation": "Represents classes of liabilities measured and disclosed at fair value." } } }, "auth_ref": [ "r512", "r513", "r514", "r515", "r516", "r517", "r522" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r400", "r434", "r435", "r436", "r437", "r438", "r439", "r506", "r508", "r509", "r510", "r511", "r520", "r521", "r523", "r552", "r553", "r554", "r776", "r777", "r781", "r782", "r783", "r789", "r792" ] }, "cnc_FinanceLeaseLiabilityAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20240630", "localname": "FinanceLeaseLiabilityAndOther", "crdr": "credit", "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails_1": { "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance leases and other", "label": "Finance Lease Liability And Other", "documentation": "Finance Lease Liability And Other" } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancialInstrumentAxis", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Investments And Restricted Deposits By Type [Axis]", "verboseLabel": "Financial Instrument [Axis]", "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r333", "r334", "r335", "r336", "r337", "r341", "r344", "r345", "r411", "r425", "r501", "r528", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r614", "r772", "r789", "r791", "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r801", "r913", "r914", "r915", "r916", "r917", "r918", "r919", "r959", "r960", "r961", "r962", "r1018", "r1021", "r1022", "r1023", "r1030", "r1033" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r836", "r846", "r856", "r888" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r836", "r846", "r856", "r888" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r836", "r846", "r856", "r888" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r836", "r846", "r856", "r888" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r836", "r846", "r856", "r888" ] }, "cnc_FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20240630", "localname": "FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$2,500 million 4.25% Senior Notes due December 15, 2027", "label": "Four Point Two Five Percent Senior Notes, Due In Twenty Twenty Seven [Member]", "documentation": "Four Point Two Five Percent Senior Notes, Due In Twenty Twenty Seven [Member]" } } }, "auth_ref": [] }, "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year", "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]" } } }, "auth_ref": [ "r869" ] }, "us-gaap_GainLossOnSaleOfBusiness": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainLossOnSaleOfBusiness", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "(Gain) loss on divestitures, net", "negatedTerseLabel": "Gain (loss) on divestitures", "label": "Gain (Loss) on Disposition of Business", "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant." } } }, "auth_ref": [ "r491", "r932" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "netLabel": "Goodwill", "label": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r183", "r346", "r582", "r768", "r773", "r790", "r800", "r968", "r969" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Goodwill impairment", "label": "Goodwill, Impairment Loss", "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r10", "r347", "r353", "r357", "r773", "r790" ] }, "us-gaap_GoodwillImpairmentLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillImpairmentLossNetOfTax", "crdr": "debit", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill, impairment, net of tax", "label": "Goodwill, Impairment Loss, Net of Tax", "documentation": "Amount, after tax, of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GrossProfit", "crdr": "credit", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross margin", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r94", "r99", "r144", "r224", "r329", "r375", "r376", "r378", "r379", "r380", "r381", "r382", "r384", "r385", "r533", "r762", "r767", "r943", "r945", "r946", "r947", "r948", "r981" ] }, "us-gaap_HealthCarePremiumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HealthCarePremiumMember", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Premium", "label": "Health Care, Premium [Member]", "documentation": "Money received from insurance for service provided for maintenance, diagnosis and treatment of physical and mental health." } } }, "auth_ref": [ "r986" ] }, "us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "label": "Debt Securities, Held-to-Maturity, Unrealized Loss Position, Fair Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperations", "crdr": "credit", "presentation": [ "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Earnings attributable to Centene Corporation", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent." } } }, "auth_ref": [ "r55", "r96", "r110", "r231", "r232", "r233", "r234", "r235", "r248", "r251", "r485" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Earnings before income tax", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r95", "r137", "r144", "r588", "r609", "r762", "r767", "r943", "r945", "r946", "r947", "r948" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Name [Axis]", "label": "Disposal Group Name [Axis]", "documentation": "Information by name of disposal group." } } }, "auth_ref": [ "r784", "r785" ] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Disposal Groups, Including Discontinued Operations [Table]", "label": "Disposal Groups, Including Discontinued Operations [Table]", "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r13", "r18", "r22", "r69", "r70", "r71", "r72", "r73", "r74", "r75", "r76", "r77", "r113" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax expense", "negatedLabel": "Income tax benefit", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r152", "r154", "r238", "r239", "r256", "r272", "r286", "r470", "r471", "r476", "r619", "r786" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes paid", "label": "Income Taxes Paid, Net", "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax." } } }, "auth_ref": [ "r31", "r220", "r472", "r473" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable and accrued expenses", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Unearned revenue", "label": "Increase (Decrease) in Contract with Customer, Liability", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r579", "r931" ] }, "us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInHealthCareInsuranceLiabilities", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Medical claims liabilities", "label": "Increase (Decrease) in Health Care Insurance Liabilities", "documentation": "The increase (decrease) in health care insurance liability balances during the period." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Other long-term liabilities", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherOperatingAssets", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Other assets", "label": "Increase (Decrease) in Other Operating Assets", "documentation": "Amount of increase (decrease) in operating assets classified as other." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in assets and liabilities", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPremiumsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInPremiumsReceivable", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Premium and trade receivables", "label": "Increase (Decrease) in Premiums Receivable", "documentation": "The change in the premium receivable balance on the balance sheet." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.centene.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Common stock equivalents (as determined by applying the treasury stock method) (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r244", "r245", "r246", "r251", "r441" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r836", "r846", "r856", "r880", "r888", "r892", "r900" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r898" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r828", "r904" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r828", "r904" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r828", "r904" ] }, "us-gaap_InsuranceAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InsuranceAbstract", "lang": { "en-us": { "role": { "terseLabel": "Insurance [Abstract]", "label": "Insurance [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InsuranceDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InsuranceDisclosureTextBlock", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiability" ], "lang": { "en-us": { "role": { "terseLabel": "Medical Claims Liability", "label": "Insurance Disclosure [Text Block]", "documentation": "The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items." } } }, "auth_ref": [ "r596", "r597", "r637", "r638" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r358", "r970", "r971" ] }, "us-gaap_InterestExpenseNonoperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseNonoperating", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Interest expense", "label": "Interest Expense, Nonoperating", "documentation": "Amount of interest expense classified as nonoperating." } } }, "auth_ref": [ "r268", "r929" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Interest paid", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r215", "r218", "r219" ] }, "us-gaap_IntersegmentEliminationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntersegmentEliminationMember", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Eliminations", "label": "Intersegment Eliminations [Member]", "documentation": "Eliminating entries used in operating segment consolidation." } } }, "auth_ref": [ "r143", "r256", "r266", "r280", "r281", "r282", "r283", "r284", "r286", "r287", "r767" ] }, "us-gaap_InvestmentIncomeNonoperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentIncomeNonoperating", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Investment and other income", "label": "Investment Income, Nonoperating", "documentation": "The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations." } } }, "auth_ref": [ "r102" ] }, "cnc_InvestmentSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20240630", "localname": "InvestmentSecuritiesMember", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment Securities", "label": "Investment Securities [Member]", "documentation": "Investment Securities" } } }, "auth_ref": [] }, "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Contractual maturities of short-term and long-term investments and restricted deposits", "label": "Investments Classified by Contractual Maturity Date [Table Text Block]", "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments." } } }, "auth_ref": [] }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Investments, Debt and Equity Securities [Abstract]", "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "auth_ref": [] }, "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20240630", "localname": "InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total, Amortized Cost", "label": "Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost", "documentation": "Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost" } } }, "auth_ref": [] }, "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20240630", "localname": "InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "parentTag": "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total, Fair Value", "label": "Investments, Debt Securities, Equity Securities And Other, Fair Value", "documentation": "Investments, Debt Securities, Equity Securities And Other, Fair Value" } } }, "auth_ref": [] }, "us-gaap_InvestmentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total investments", "label": "Investments, Fair Value Disclosure", "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method." } } }, "auth_ref": [ "r1019", "r1020", "r1030" ] }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits" ], "lang": { "en-us": { "role": { "verboseLabel": "Short-term and Long-term Investments, Restricted Deposits", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "documentation": "The entire disclosure for investments in certain debt and equity securities." } } }, "auth_ref": [ "r141", "r156", "r294", "r295", "r529", "r530", "r1039" ] }, "us-gaap_InvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentsMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments", "label": "Investments [Member]", "documentation": "Assets held for their financial return, rather than for the entity's operations." } } }, "auth_ref": [] }, "cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration": { "xbrltype": "durationItemType", "nsuri": "http://www.centene.com/20240630", "localname": "InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments recorded at fair value that carry rating of AAA Plus, weighted average (in years)", "label": "Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration", "documentation": "Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r20", "r78", "r79", "r80", "r82", "r83", "r84", "r85", "r224", "r329", "r375", "r376", "r378", "r379", "r380", "r381", "r382", "r384", "r385", "r488", "r492", "r493", "r533", "r689", "r761", "r823", "r981", "r1037", "r1038" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities, redeemable noncontrolling interests and stockholders' equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r92", "r134", "r607", "r800", "r935", "r964", "r1034" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r80", "r180", "r224", "r329", "r375", "r376", "r378", "r379", "r380", "r381", "r382", "r384", "r385", "r488", "r492", "r493", "r533", "r800", "r981", "r1037", "r1038" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "calculation": { "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities at fair value", "label": "Liabilities, Fair Value Disclosure", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r508", "r1019" ] }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 }, "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medical claims liability", "periodStartLabel": "Balance, January 1", "periodEndLabel": "Balance, June 30", "label": "Liability for Claims and Claims Adjustment Expense", "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date." } } }, "auth_ref": [ "r804", "r807", "r1041", "r1050" ] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Paid related to:", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1", "crdr": "credit", "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current year", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year", "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs." } } }, "auth_ref": [ "r642", "r804" ] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1", "crdr": "credit", "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prior years", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years", "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs." } } }, "auth_ref": [ "r642", "r804" ] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "crdr": "debit", "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total incurred", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims", "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process." } } }, "auth_ref": [ "r804", "r1048" ] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Incurred related to:", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "crdr": "credit", "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, January 1, net", "periodEndLabel": "Balance, June 30, net", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net", "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims." } } }, "auth_ref": [ "r640", "r643", "r1041" ] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]", "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20240630", "localname": "LifeInsuranceContractsAndEquityInvestmentsFairValue", "crdr": "debit", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate carrying amount of life insurance contracts and equity investments, fair value", "label": "Life Insurance Contracts And Equity Investments, Fair Value", "documentation": "Life Insurance Contracts And Equity Investments, Fair Value" } } }, "auth_ref": [] }, "us-gaap_LifeInsuranceCorporateOrBankOwnedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LifeInsuranceCorporateOrBankOwnedAmount", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "parentTag": "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Life insurance contracts", "label": "Life Insurance, Corporate or Bank Owned, Amount", "documentation": "This item represents the amount that could be realized under a life insurance contract or contracts owned by the Entity as of the date of the statement of financial position. Such Entity-owned life insurance policies are commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI)." } } }, "auth_ref": [ "r330", "r924" ] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCredit", "crdr": "credit", "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails_1": { "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit facility", "label": "Long-Term Line of Credit", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r20", "r131", "r1042" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails": { "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0, "order": 1.0 }, "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of long-term debt", "negatedLabel": "Less: current portion", "label": "Long-Term Debt, Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r187" ] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 }, "http://www.centene.com/role/DebtScheduleofDebtDetails": { "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Long-term debt", "terseLabel": "Long-term debt", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r188" ] }, "us-gaap_LongTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermInvestments", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "Long-term investments", "label": "Long-Term Investments", "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle)." } } }, "auth_ref": [ "r182" ] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r20", "r973", "r974", "r975" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r20", "r40", "r973", "r974", "r975" ] }, "cnc_MagellanRxMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20240630", "localname": "MagellanRxMember", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Magellan Rx", "label": "Magellan Rx [Member]", "documentation": "Magellan Rx" } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r872" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r872" ] }, "cnc_MedicaidSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20240630", "localname": "MedicaidSegmentMember", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medicaid", "label": "Medicaid Segment [Member]", "documentation": "Medicaid Segment" } } }, "auth_ref": [] }, "cnc_MedicareSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20240630", "localname": "MedicareSegmentMember", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medicare", "label": "Medicare Segment [Member]", "documentation": "Medicare Segment" } } }, "auth_ref": [] }, "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestitures" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisitions and Divestitures", "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]", "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings." } } }, "auth_ref": [ "r68", "r122" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "Nonredeemable noncontrolling interest", "label": "Equity, Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r91", "r133", "r224", "r329", "r375", "r378", "r379", "r380", "r384", "r385", "r533", "r606", "r693" ] }, "us-gaap_MinorityInterestDecreaseFromRedemptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MinorityInterestDecreaseFromRedemptions", "crdr": "debit", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchase of redeemable noncontrolling interest", "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests", "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests)." } } }, "auth_ref": [ "r57", "r121", "r124" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r891" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r899" ] }, "us-gaap_MunicipalBondsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MunicipalBondsMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Municipal securities", "verboseLabel": "Municipal securities", "label": "Municipal Bonds [Member]", "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments." } } }, "auth_ref": [] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r873" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r217" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities:", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r217" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from investing activities:", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r108", "r109", "r110" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from operating activities:", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net earnings attributable to Centene Corporation", "terseLabel": "Net earnings (loss)", "label": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r100", "r110", "r138", "r178", "r201", "r204", "r208", "r224", "r229", "r231", "r232", "r233", "r234", "r235", "r238", "r239", "r248", "r329", "r375", "r376", "r378", "r379", "r380", "r381", "r382", "r384", "r385", "r482", "r485", "r505", "r533", "r612", "r711", "r727", "r728", "r821", "r981" ] }, "us-gaap_NetIncomeLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net earnings per common share attributable to Centene Corporation:", "verboseLabel": "Net Income (Loss) Attributable to Parent [Abstract]", "label": "Net Income (Loss) Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Loss attributable to noncontrolling interests", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r59", "r125", "r201", "r204", "r235", "r238", "r239", "r611", "r928" ] }, "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Net earnings (loss)", "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest", "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity." } } }, "auth_ref": [ "r21", "r125", "r126" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.centene.com/role/OrganizationandOperationsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Accounting Guidance Not Yet Adopted", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r872" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r836", "r846", "r856", "r880", "r888" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r863" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r862" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r880" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r899" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r899" ] }, "us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NoncontrollingInterestDecreaseFromDeconsolidation", "crdr": "debit", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Divestiture of noncontrolling interest", "label": "Noncontrolling Interest, Decrease from Deconsolidation", "documentation": "The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest." } } }, "auth_ref": [ "r15", "r45" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling Interest", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r53", "r428", "r937", "r938", "r939", "r940", "r1082" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Other income (expense):", "label": "Nonoperating Income (Expense) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NumberOfOperatingSegments", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of operating segments", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r768", "r944" ] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpensesAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Expenses:", "label": "Operating Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Earnings from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r144", "r762", "r943", "r945", "r946", "r947", "r948" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r280", "r281", "r282", "r283", "r284", "r287", "r767", "r768" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "Other current assets", "label": "Other Assets, Current", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r193", "r800" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other long-term assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r184" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "lang": { "en-us": { "role": { "verboseLabel": "Foreign currency translation adjustments, net of tax", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r2", "r613" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive earnings (loss)", "terseLabel": "Other comprehensive earnings (loss), net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r17", "r19", "r202", "r205", "r210", "r235", "r535", "r536", "r541", "r583", "r613", "r926", "r927" ] }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Reclassification adjustment, net of tax", "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax", "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities." } } }, "auth_ref": [ "r6", "r93", "r200", "r327" ] }, "us-gaap_OtherComprehensiveIncomeLossTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossTax", "crdr": "debit", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive earning (loss), tax", "label": "Other Comprehensive Income (Loss), Tax", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss)." } } }, "auth_ref": [ "r3", "r206", "r210", "r470", "r477", "r478", "r535", "r539", "r541", "r583", "r613" ] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Change in unrealized gain (loss) on investments", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax", "documentation": "Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r197", "r199", "r327" ] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Change in unrealized gain (loss) on investments, net of tax", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r197", "r199", "r327" ] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Change in unrealized gain (loss) on investments, tax effect", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax", "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r3", "r198" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other long-term liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r83" ] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Other adjustments, net", "label": "Other Noncash Income (Expense)", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r110" ] }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherOperatingActivitiesCashFlowStatement", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Other operating activities, net", "label": "Other Operating Activities, Cash Flow Statement", "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities)." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r872" ] }, "us-gaap_OtherRestrictedAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherRestrictedAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted deposits", "label": "Other Restricted Assets, Noncurrent", "documentation": "Amount of noncurrent assets that are pledged or subject to withdrawal restrictions, classified as other." } } }, "auth_ref": [ "r752", "r753" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r834", "r844", "r854", "r886" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r837", "r847", "r857", "r889" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r837", "r847", "r857", "r889" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r861" ] }, "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForLossesAndLossAdjustmentExpense", "crdr": "credit", "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total paid", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid", "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process." } } }, "auth_ref": [ "r8", "r804", "r1049" ] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Common stock repurchases", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r106" ] }, "us-gaap_PaymentsToAcquireInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireInvestments", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of investments", "label": "Payments to Acquire Investments", "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period." } } }, "auth_ref": [ "r104" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Capital expenditures", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r105" ] }, "us-gaap_PaymentsToMinorityShareholders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToMinorityShareholders", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchase of noncontrolling interest", "label": "Payments to Noncontrolling Interests", "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest." } } }, "auth_ref": [ "r29" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r871" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r871" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r863" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r880" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r873" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r862" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameAxis", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Axis]", "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1010", "r1011", "r1012", "r1013" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameDomain", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Domain]", "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1010", "r1011", "r1012", "r1013" ] }, "ecd_PnsnAdjsPrrSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnAdjsPrrSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Prior Service Cost", "label": "Pension Adjustments Prior Service Cost [Member]" } } }, "auth_ref": [ "r864" ] }, "ecd_PnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Service Cost", "label": "Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r908" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Benefits Adjustments, Footnote", "label": "Pension Benefits Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r863" ] }, "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PolicyholderBenefitsAndClaimsIncurredNet", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medical costs", "label": "Policyholder Benefits and Claims Incurred, Net", "documentation": "Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred." } } }, "auth_ref": [ "r1044" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value (in dollars per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r86", "r414" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares authorized (in shares)", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r86", "r691" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares issued (in shares)", "label": "Preferred Stock, Shares Issued", "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt." } } }, "auth_ref": [ "r86", "r414" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares outstanding (in shares)", "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r86", "r691", "r709", "r1082", "r1083" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at June\u00a030, 2024 and December\u00a031, 2023", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r86", "r602", "r800" ] }, "cnc_PremiumDeficiencyReserveLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20240630", "localname": "PremiumDeficiencyReserveLiability", "crdr": "credit", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Premium deficiency reserve liability", "label": "Premium Deficiency Reserve Liability", "documentation": "Premium Deficiency Reserve Liability" } } }, "auth_ref": [] }, "cnc_PremiumDeficiencyReserveLiabilityIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20240630", "localname": "PremiumDeficiencyReserveLiabilityIncreaseDecrease", "crdr": "credit", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plus: Premium deficiency reserve", "label": "Premium Deficiency Reserve Liability Increase (Decrease)", "documentation": "Premium Deficiency Reserve Liability Increase (Decrease)" } } }, "auth_ref": [] }, "cnc_PremiumTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20240630", "localname": "PremiumTaxExpense", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Premium tax expense", "label": "Premium Tax Expense", "documentation": "Premium tax expense, similar assessments and provider pass through payments." } } }, "auth_ref": [] }, "cnc_PremiumTaxRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20240630", "localname": "PremiumTaxRevenue", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 1.0 }, "http://www.centene.com/role/SegmentInformationDetails": { "parentTag": "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Premium tax", "label": "Premium Tax Revenue", "documentation": "Premium tax revenue, similar assessments and provider pass through payments." } } }, "auth_ref": [] }, "us-gaap_PremiumsAndOtherReceivablesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PremiumsAndOtherReceivablesNet", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Premium and trade receivables", "label": "Premiums and Other Receivables, Net", "documentation": "Carrying amount as of the balance sheet date, net of allowance for doubtful accounts, of all premiums and other types of receivables due from other persons or entities." } } }, "auth_ref": [ "r1043" ] }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromDivestitureOfBusinesses", "crdr": "debit", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of business", "label": "Proceeds from Divestiture of Businesses", "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period." } } }, "auth_ref": [ "r27" ] }, "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Divestiture proceeds, net of divested cash", "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested", "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity." } } }, "auth_ref": [ "r27" ] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from common stock issuances", "label": "Proceeds from Issuance of Common Stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r5" ] }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOfLongTermDebt", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from long-term debt", "label": "Proceeds from Issuance of Long-Term Debt", "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r28", "r655" ] }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Other financing activities, net", "label": "Proceeds from (Payments for) Other Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities classified as other." } } }, "auth_ref": [ "r911", "r930" ] }, "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Sales and maturities of investments", "label": "Proceeds from Sale, Maturity and Collection of Investments", "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period." } } }, "auth_ref": [ "r26" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]", "documentation": "Information by product and service, or group of similar products and similar services." } } }, "auth_ref": [ "r158", "r159", "r160", "r161", "r162", "r163", "r173", "r289", "r580", "r631", "r632", "r633", "r634", "r635", "r636", "r646", "r756", "r780", "r802", "r803", "r805", "r807", "r809", "r922", "r977", "r978", "r985", "r1045", "r1051", "r1052", "r1053", "r1054", "r1055", "r1056", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1078", "r1079" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]", "documentation": "Product or service, or a group of similar products or similar services." } } }, "auth_ref": [ "r158", "r159", "r160", "r161", "r162", "r163", "r173", "r289", "r580", "r631", "r632", "r633", "r634", "r635", "r636", "r646", "r756", "r780", "r802", "r803", "r805", "r807", "r809", "r922", "r977", "r978", "r985", "r1045", "r1051", "r1052", "r1053", "r1054", "r1055", "r1056", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1078", "r1079" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Net earnings", "terseLabel": "Net earnings", "verboseLabel": "Net earnings", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r178", "r201", "r204", "r216", "r224", "r229", "r235", "r238", "r239", "r329", "r375", "r376", "r378", "r379", "r380", "r381", "r382", "r384", "r385", "r482", "r485", "r486", "r489", "r490", "r505", "r533", "r588", "r610", "r661", "r711", "r727", "r728", "r787", "r788", "r822", "r928", "r981" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Property, software and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r12", "r547", "r595", "r608", "r800" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r861" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r861" ] }, "cnc_RatedSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20240630", "localname": "RatedSecuritiesMember", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rated Securities", "label": "Rated Securities [Member]", "documentation": "Rated Securities [Member]" } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r829", "r839", "r849", "r881" ] }, "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemable noncontrolling interests", "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount", "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity." } } }, "auth_ref": [ "r41", "r42", "r116", "r117" ] }, "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments", "crdr": "debit", "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Less: Reinsurance recoverable", "periodEndLabel": "Plus: Reinsurance recoverable", "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments", "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer." } } }, "auth_ref": [ "r640", "r643", "r644", "r804", "r807", "r1040", "r1046", "r1047" ] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments and repurchases of long-term debt", "label": "Repayments of Long-Term Debt", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r107", "r658" ] }, "us-gaap_ResidentialMortgageBackedSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ResidentialMortgageBackedSecuritiesMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Residential mortgage-backed securities", "label": "Residential Mortgage-Backed Securities [Member]", "documentation": "Securities collateralized by residential real estate mortgage loans." } } }, "auth_ref": [ "r789", "r791", "r792", "r949", "r951", "r956", "r957", "r958", "r987" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r830", "r840", "r850", "r882" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r831", "r841", "r851", "r883" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r838", "r848", "r858", "r890" ] }, "us-gaap_RestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "periodEndLabel": "Restricted cash and cash equivalents, included in restricted deposits", "label": "Restricted Cash and Cash Equivalents", "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r30", "r128", "r181", "r221", "r601" ] }, "cnc_RestrictedCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20240630", "localname": "RestrictedCashEquivalentsMember", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash equivalents", "label": "Restricted Cash Equivalents [Member]", "documentation": "Restricted Cash Equivalents [Member]" } } }, "auth_ref": [] }, "cnc_RestrictedCertificatesOfDepositMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20240630", "localname": "RestrictedCertificatesOfDepositMember", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted certificates of deposit", "label": "Restricted Certificates Of Deposit [Member]", "documentation": "Restricted certificates of deposit [member]" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r89", "r121", "r605", "r650", "r652", "r659", "r692", "r800" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r174", "r226", "r227", "r228", "r230", "r235", "r237", "r239", "r331", "r332", "r362", "r474", "r475", "r479", "r480", "r481", "r483", "r484", "r485", "r495", "r497", "r498", "r500", "r503", "r544", "r546", "r647", "r649", "r662", "r1082" ] }, "cnc_ReturnofPremiumPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20240630", "localname": "ReturnofPremiumPayable", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Return of premium payable", "label": "Return of Premium Payable", "documentation": "Return of Premium Payable" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.centene.com/role/SegmentInformationDetails": { "parentTag": "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax", "weight": 1.0, "order": 1.0 }, "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Premium and service revenues", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r142", "r143", "r256", "r265", "r266", "r280", "r286", "r289", "r291", "r292", "r431", "r432", "r580" ] }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "crdr": "credit", "calculation": { "http://www.centene.com/role/SegmentInformationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total external revenues", "label": "Revenue from Contract with Customer, Including Assessed Tax", "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise." } } }, "auth_ref": [ "r142", "r143", "r256", "r265", "r266", "r280", "r286", "r289", "r291", "r292", "r431", "r432", "r580" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Revenues", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total revenues", "terseLabel": "Revenues", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r142", "r143", "r209", "r224", "r256", "r265", "r266", "r280", "r286", "r289", "r291", "r292", "r329", "r375", "r376", "r378", "r379", "r380", "r381", "r382", "r384", "r385", "r533", "r588", "r767", "r981" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenuesAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues:", "label": "Revenues [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Credit Agreement", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r899" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r899" ] }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule Of Investments And Restricted Deposits By Type [Line Items]", "terseLabel": "Debt Securities, Available-for-sale [Line Items]", "label": "Debt Securities, Available-for-Sale [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r304", "r305", "r306", "r307", "r308" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://www.centene.com/role/DebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Debt", "label": "Schedule of Debt [Table Text Block]", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.centene.com/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Calculation of Basic and Diluted Net Earnings Per Common Share", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r942" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r1019", "r1020" ] }, "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of change in medical claims liability", "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]", "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims." } } }, "auth_ref": [ "r639" ] }, "cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.centene.com/20240630", "localname": "ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "presentation": [ "http://www.centene.com/role/AffordableCareActTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of net receivables (payables) related to the Affordable Care Act Programs", "label": "Schedule Of Receivables (Payables) Related To The Affordable Care Act Programs [Table Text Block]", "documentation": "Schedule of Receivables (Payables) Related to the Affordable Care Act Programs" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment." } } }, "auth_ref": [ "r34", "r35", "r36" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.centene.com/role/SegmentInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Information", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r34", "r35", "r36" ] }, "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfTreasuryStockByClassTextBlock", "presentation": [ "http://www.centene.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Share Repurchase Activity", "label": "Class of Treasury Stock [Table Text Block]", "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock." } } }, "auth_ref": [ "r46", "r47", "r48", "r49" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r824" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r826" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentDomain", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r142", "r143", "r144", "r145", "r256", "r261", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r286", "r287", "r288", "r292", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r361", "r369", "r370", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r764", "r767", "r768", "r773", "r806", "r1045", "r1051", "r1052", "r1053", "r1054", "r1055", "r1056", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1078", "r1079" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.centene.com/role/SegmentInformation" ], "lang": { "en-us": { "role": { "verboseLabel": "Segment Information", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r145", "r256", "r260", "r261", "r262", "r263", "r264", "r276", "r278", "r279", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r292", "r763", "r765", "r766", "r767", "r769", "r770", "r771" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting Information [Line Items]", "verboseLabel": "Segment Reporting Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative expenses", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r101" ] }, "us-gaap_SeniorNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SeniorNotes", "crdr": "credit", "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails": { "parentTag": "cnc_SeniorNotesTotal", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior notes", "label": "Senior Notes", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders." } } }, "auth_ref": [ "r131", "r1042" ] }, "us-gaap_SeniorNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SeniorNotesMember", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Notes", "label": "Senior Notes [Member]", "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors." } } }, "auth_ref": [] }, "cnc_SeniorNotesTotal": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20240630", "localname": "SeniorNotesTotal", "crdr": "credit", "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails_1": { "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0, "order": 3.0 }, "http://www.centene.com/role/DebtScheduleofDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total senior notes", "label": "Senior Notes, Total", "documentation": "Senior Notes, Total" } } }, "auth_ref": [] }, "us-gaap_ServiceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ServiceMember", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Service", "label": "Service [Member]", "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service." } } }, "auth_ref": [ "r780" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r9" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Award Types", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467" ] }, "us-gaap_ShareRepurchaseProgramExciseTaxPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareRepurchaseProgramExciseTaxPayable", "crdr": "credit", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share repurchase program, excise tax, payable", "label": "Share Repurchase Program, Excise Tax, Payable", "documentation": "Amount of excise tax payable on share purchased under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership." } } }, "auth_ref": [ "r983" ] }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "calculation": { "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails": { "parentTag": "us-gaap_TreasuryStockSharesAcquired", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax withholding (in shares)", "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.centene.com/20240630", "localname": "ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term and long-term investments and restricted deposits by investment type", "label": "Short Term And Long Term Investments And Restricted Deposits By Investment Type [Table Text Block]", "documentation": "Short-term and long-term investments and restricted deposits by investment type" } } }, "auth_ref": [] }, "us-gaap_ShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortTermInvestments", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term investments", "label": "Short-Term Investments", "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current." } } }, "auth_ref": [ "r135", "r136", "r925" ] }, "us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet", "crdr": "credit", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-duration insurance contracts, Incurred but not reported and expected development on reported claims", "label": "Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net", "documentation": "Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense." } } }, "auth_ref": [ "r645", "r646", "r807" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r142", "r143", "r144", "r145", "r176", "r256", "r261", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r286", "r287", "r288", "r292", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r361", "r363", "r369", "r370", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r764", "r767", "r768", "r773", "r806", "r1045", "r1051", "r1052", "r1053", "r1054", "r1055", "r1056", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1078", "r1079" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r155", "r189", "r190", "r191", "r224", "r243", "r247", "r249", "r251", "r258", "r259", "r329", "r375", "r378", "r379", "r380", "r384", "r385", "r414", "r415", "r417", "r420", "r427", "r533", "r655", "r656", "r657", "r658", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r691", "r712", "r729", "r745", "r746", "r747", "r748", "r749", "r910", "r933", "r941" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r17", "r87", "r90", "r91", "r174", "r206", "r207", "r208", "r226", "r227", "r228", "r230", "r235", "r237", "r239", "r257", "r331", "r332", "r362", "r428", "r474", "r475", "r479", "r480", "r481", "r483", "r484", "r485", "r495", "r496", "r497", "r498", "r499", "r500", "r503", "r535", "r537", "r538", "r539", "r540", "r541", "r544", "r546", "r548", "r613", "r647", "r648", "r649", "r662", "r729" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical", "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "verboseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r226", "r227", "r228", "r257", "r546", "r580", "r654", "r673", "r683", "r684", "r685", "r686", "r687", "r688", "r691", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r704", "r705", "r706", "r707", "r708", "r710", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r729", "r813" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Comprehensive Income [Abstract]", "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r226", "r227", "r228", "r257", "r293", "r546", "r580", "r654", "r673", "r683", "r684", "r685", "r686", "r687", "r688", "r691", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r704", "r705", "r706", "r707", "r708", "r710", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r729", "r813" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r833", "r843", "r853", "r885" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued for employee benefit plans (in shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r17", "r86", "r87", "r121" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued for employee benefit plans", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r50", "r86", "r87", "r121" ] }, "srt_StockRepurchaseProgramAuthorizedAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "StockRepurchaseProgramAuthorizedAmount1", "crdr": "credit", "presentation": [ "http://www.centene.com/role/StockholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock repurchase program, authorized amount", "label": "Share Repurchase Program, Authorized, Amount", "documentation": "Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership." } } }, "auth_ref": [ "r984" ] }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "crdr": "credit", "presentation": [ "http://www.centene.com/role/StockholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock repurchase program, remaining available", "label": "Share Repurchase Program, Remaining Authorized, Amount", "documentation": "Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total Centene stockholders' equity", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r87", "r90", "r91", "r112", "r693", "r709", "r730", "r731", "r800", "r823", "r935", "r964", "r1034", "r1082" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders' equity", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r53", "r54", "r58", "r174", "r175", "r207", "r226", "r227", "r228", "r230", "r235", "r237", "r331", "r332", "r362", "r428", "r474", "r475", "r479", "r480", "r481", "r483", "r484", "r485", "r495", "r496", "r497", "r498", "r499", "r500", "r503", "r535", "r537", "r541", "r545", "r548", "r648", "r649", "r660", "r693", "r709", "r730", "r731", "r750", "r822", "r935", "r964", "r1034", "r1082" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "verboseLabel": "Stockholders' equity:", "terseLabel": "Stockholders' equity", "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.centene.com/role/StockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders' Equity", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r118", "r223", "r413", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r426", "r428", "r502", "r732", "r733", "r751" ] }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]", "label": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]", "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group by type of sale. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity." } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsidiarySaleOfStockLineItems", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsidiary, Sale of Stock [Line Items]", "label": "Subsidiary, Sale of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental disclosures of cash flow information:", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense", "crdr": "debit", "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current year", "label": "Current Year Claims and Claims Adjustment Expense", "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs." } } }, "auth_ref": [ "r641", "r804" ] }, "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense", "crdr": "debit", "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prior years", "label": "Prior Year Claims and Claims Adjustment Expense", "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs." } } }, "auth_ref": [ "r641", "r804" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r879" ] }, "cnc_TermLoanCreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20240630", "localname": "TermLoanCreditAgreementMember", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan Facility", "label": "Term Loan Credit Agreement [Member]", "documentation": "Term Loan Credit Agreement [Member]" } } }, "auth_ref": [] }, "cnc_TotalPremiumAndServiceMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20240630", "localname": "TotalPremiumAndServiceMember", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Premium and service revenues", "label": "Total Premium and Service [Member]", "documentation": "Total Premium and Service" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r871" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r878" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r898" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r900" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments [Domain]", "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r411", "r425", "r501", "r528", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r614", "r789", "r791", "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r801", "r913", "r914", "r915", "r916", "r917", "r918", "r919", "r959", "r960", "r961", "r962", "r1018", "r1021", "r1022", "r1023", "r1030", "r1033" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r901" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r902" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Expiration Date", "label": "Trading Arrangement Expiration Date" } } }, "auth_ref": [ "r902" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r900" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r900" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r903" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r901" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockCommonMember", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury Stock", "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r46" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockCommonShares", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "verboseLabel": "Treasury stock (in shares)", "periodStartLabel": "Treasury stock (in shares)", "periodEndLabel": "Treasury stock (in shares)", "label": "Treasury Stock, Common, Shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r46" ] }, "us-gaap_TreasuryStockCommonValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockCommonValue", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "negatedLabel": "Treasury stock, at cost (93,494 and 80,807 shares, respectively)", "label": "Treasury Stock, Common, Value", "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r46", "r49", "r90" ] }, "us-gaap_TreasuryStockSharesAcquired": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockSharesAcquired", "calculation": { "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock repurchases (in shares)", "totalLabel": "Common stock repurchases (in shares)", "label": "Treasury Stock, Shares, Acquired", "documentation": "Number of shares that have been repurchased during the period and are being held in treasury." } } }, "auth_ref": [ "r17", "r87", "r121" ] }, "cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation": { "xbrltype": "sharesItemType", "nsuri": "http://www.centene.com/20240630", "localname": "TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation", "calculation": { "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails": { "parentTag": "us-gaap_TreasuryStockSharesAcquired", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share buybacks (in shares)", "label": "Treasury Stock, Shares, Acquired, Excluding Shares Withheld For Tax Withholding Obligation", "documentation": "Treasury Stock, Shares, Acquired, Excluding Shares Withheld For Tax Withholding Obligation" } } }, "auth_ref": [] }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockValueAcquiredCostMethod", "crdr": "debit", "calculation": { "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Common stock repurchases", "totalLabel": "Common stock repurchases", "label": "Treasury Stock, Value, Acquired, Cost Method", "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method." } } }, "auth_ref": [ "r17", "r46", "r121" ] }, "cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20240630", "localname": "TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes", "crdr": "debit", "calculation": { "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails": { "parentTag": "us-gaap_TreasuryStockValueAcquiredCostMethod", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share buybacks", "label": "Treasury Stock, Value, Acquired, Cost Method, Excluding Shares Withheld For Tax Purposes", "documentation": "Treasury Stock, Value, Acquired, Cost Method, Excluding Shares Withheld For Tax Purposes" } } }, "auth_ref": [] }, "us-gaap_USTreasuryAndGovernmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "USTreasuryAndGovernmentMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. Treasury securities and obligations of U.S. government corporations and agencies", "label": "US Treasury and Government [Member]", "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac)." } } }, "auth_ref": [ "r589", "r781", "r801", "r808", "r1077" ] }, "us-gaap_UnamortizedDebtIssuanceExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnamortizedDebtIssuanceExpense", "crdr": "debit", "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails_1": { "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Debt issuance costs", "label": "Unamortized Debt Issuance Expense", "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset." } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r897" ] }, "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year", "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]" } } }, "auth_ref": [ "r867" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.centene.com/role/EarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average number of common shares and potential dilutive common shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r242", "r251" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.centene.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average number of common shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r241", "r251" ] }, "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested", "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r865" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-12" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-14" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-15" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-5" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478353/942-405-50-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(2)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3A", "Subparagraph": "(3)", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "320", "Publisher": "FASB", "URI": "https://asc.fasb.org/320/tableOfContent" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "(12)(c)", "Section": "S99", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "(16)(c)", "Paragraph": "3A", "Section": "S99", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-2" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-3" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-18" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-21" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-24" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205-20/tableOfContent" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-11" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3A" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4A" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5D" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/470/tableOfContent" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3A", "Subparagraph": "(14)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3A", "Subparagraph": "(15)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/805/tableOfContent" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-23" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479024/942-230-45-1" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479024/942-230-45-1" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/942-320/tableOfContent" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-29" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-29" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-29" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-7" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1403", "Paragraph": "b", "Publisher": "SEC" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "a", "Publisher": "SEC" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column A", "Publisher": "SEC" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column B", "Publisher": "SEC" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column C", "Publisher": "SEC" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column D", "Publisher": "SEC" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column E", "Publisher": "SEC" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column F", "Publisher": "SEC" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iii)(A)", "Publisher": "SEC" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iii)(B)", "Publisher": "SEC" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iii)(A)", "Publisher": "SEC" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iii)(B)", "Publisher": "SEC" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iii)(C)", "Publisher": "SEC" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 11", "Section": "L", "Publisher": "SEC" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-17A" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/260/tableOfContent" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-28A" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/280/tableOfContent" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/320/tableOfContent" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-10" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2A" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "325", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481612/325-30-25-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-3A" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-3B" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-5" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480454/718-10-45-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-11" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1B" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-1A" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "940", "SubTopic": "820", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/944/tableOfContent" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479838/944-20-50-7" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(4)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(4)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(cc)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-4" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478600/954-210-50-2" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r756": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r757": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r758": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r759": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22" }, "r760": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r761": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r762": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r763": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r764": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r765": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r766": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r767": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r768": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r769": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r770": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r771": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r772": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8" }, "r773": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24" }, "r774": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40" }, "r775": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r776": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r777": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r778": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E" }, "r779": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F" }, "r780": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r781": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r782": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r783": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r784": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r785": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r786": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r787": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r788": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K" }, "r789": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r790": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r791": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "101", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101" }, "r792": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r793": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r794": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r795": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r796": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r797": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r798": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r799": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r800": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r801": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4" }, "r802": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2" }, "r803": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r804": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-7" }, "r805": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r806": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r807": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E" }, "r808": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-17" }, "r809": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18" }, "r810": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r811": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r812": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r813": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r814": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r815": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r816": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r817": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r818": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7" }, "r819": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7" }, "r820": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7" }, "r821": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r822": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r823": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r824": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r825": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r826": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r827": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r828": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r829": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r830": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r831": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r832": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r833": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r834": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r835": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r836": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r837": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r838": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r839": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r840": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r841": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r842": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r843": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r844": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r845": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r846": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r847": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r848": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r849": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r850": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r851": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r852": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r853": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r854": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r855": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r856": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r857": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r858": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r859": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r860": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r861": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r862": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r863": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r864": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "ii" }, "r865": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "i" }, "r866": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "ii" }, "r867": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iii" }, "r868": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iv" }, "r869": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "v" }, "r870": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "vi" }, "r871": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r872": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r873": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r874": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r875": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r876": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r877": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r878": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r879": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r880": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r881": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r882": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r883": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r884": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r885": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r886": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r887": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r888": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r889": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r890": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r891": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r892": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r893": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r894": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r895": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r896": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r897": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r898": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r899": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r900": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r901": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r902": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r903": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r904": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r905": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Number": "229", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1" }, "r906": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "A", "Number": "229" }, "r907": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Number": "229" }, "r908": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "i", "Number": "229" }, "r909": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r910": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r911": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r912": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r913": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r914": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(1)", "Publisher": "SEC" }, "r915": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(2)", "Publisher": "SEC" }, "r916": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(3)", "Publisher": "SEC" }, "r917": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r918": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r919": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r920": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(ii)", "Publisher": "SEC" }, "r921": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iii)", "Publisher": "SEC" }, "r922": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 2", "Publisher": "SEC" }, "r923": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r924": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r925": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r926": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r927": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r928": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r929": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r930": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r931": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r932": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r933": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r934": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r935": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r936": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r937": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r938": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r939": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r940": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r941": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55" }, "r942": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r943": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r944": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18" }, "r945": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r946": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r947": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r948": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r949": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r950": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r951": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r952": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r953": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r954": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r955": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r956": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r957": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r958": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r959": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9" }, "r960": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r961": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r962": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r963": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r964": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r965": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5" }, "r966": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1" }, "r967": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4" }, "r968": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r969": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r970": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r971": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r972": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r973": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r974": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r975": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r976": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r977": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r978": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r979": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r980": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r981": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r982": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r983": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1" }, "r984": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4" }, "r985": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r986": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r987": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r988": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r989": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r990": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r991": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r992": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r993": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r994": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r995": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r996": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r997": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r998": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r999": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1000": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1001": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1002": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1003": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1004": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1005": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1006": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1007": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1008": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1009": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1010": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1011": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1012": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1013": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1014": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r1015": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r1016": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B" }, "r1017": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r1018": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r1019": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1020": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1021": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1022": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1023": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1024": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1025": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1026": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1027": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1028": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1029": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1030": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r1031": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r1032": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r1033": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r1034": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r1035": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r1036": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r1037": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1038": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1039": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "940", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/940-320/tableOfContent" }, "r1040": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479838/944-20-50-5" }, "r1041": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(13)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1042": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1043": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1044": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r1045": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r1046": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477409/944-310-45-6" }, "r1047": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-2" }, "r1048": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3" }, "r1049": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3" }, "r1050": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(cc)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3" }, "r1051": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1052": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1053": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r1054": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r1055": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r1056": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1057": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1058": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1059": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1060": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1061": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1062": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1063": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1064": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1065": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1066": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1067": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1068": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1069": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1070": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1071": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1072": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1073": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1074": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1075": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1076": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1077": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-1" }, "r1078": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1079": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1080": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r1081": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r1082": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1083": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1084": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" } } } ZIP 67 0001071739-24-000157-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001071739-24-000157-xbrl.zip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�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cnc-20240630_htm.xml IDEA: XBRL DOCUMENT 0001071739 2024-01-01 2024-06-30 0001071739 2024-07-24 0001071739 2024-06-30 0001071739 2023-12-31 0001071739 us-gaap:HealthCarePremiumMember 2024-04-01 2024-06-30 0001071739 us-gaap:HealthCarePremiumMember 2023-04-01 2023-06-30 0001071739 us-gaap:HealthCarePremiumMember 2024-01-01 2024-06-30 0001071739 us-gaap:HealthCarePremiumMember 2023-01-01 2023-06-30 0001071739 us-gaap:ServiceMember 2024-04-01 2024-06-30 0001071739 us-gaap:ServiceMember 2023-04-01 2023-06-30 0001071739 us-gaap:ServiceMember 2024-01-01 2024-06-30 0001071739 us-gaap:ServiceMember 2023-01-01 2023-06-30 0001071739 2024-04-01 2024-06-30 0001071739 2023-04-01 2023-06-30 0001071739 2023-01-01 2023-06-30 0001071739 us-gaap:CommonStockMember 2023-12-31 0001071739 us-gaap:CommonStockMember 2024-06-30 0001071739 us-gaap:CommonStockMember 2024-03-31 0001071739 us-gaap:TreasuryStockCommonMember 2023-12-31 0001071739 us-gaap:TreasuryStockCommonMember 2024-03-31 0001071739 us-gaap:TreasuryStockCommonMember 2024-06-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001071739 us-gaap:RetainedEarningsMember 2023-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2023-12-31 0001071739 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001071739 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001071739 2024-01-01 2024-03-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001071739 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001071739 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001071739 us-gaap:RetainedEarningsMember 2024-03-31 0001071739 us-gaap:NoncontrollingInterestMember 2024-03-31 0001071739 2024-03-31 0001071739 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001071739 us-gaap:NoncontrollingInterestMember 2024-04-01 2024-06-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001071739 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001071739 us-gaap:TreasuryStockCommonMember 2024-04-01 2024-06-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001071739 us-gaap:RetainedEarningsMember 2024-06-30 0001071739 us-gaap:NoncontrollingInterestMember 2024-06-30 0001071739 us-gaap:CommonStockMember 2023-06-30 0001071739 us-gaap:CommonStockMember 2023-03-31 0001071739 us-gaap:CommonStockMember 2022-12-31 0001071739 us-gaap:TreasuryStockCommonMember 2023-06-30 0001071739 us-gaap:TreasuryStockCommonMember 2022-12-31 0001071739 us-gaap:TreasuryStockCommonMember 2023-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001071739 us-gaap:RetainedEarningsMember 2022-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2022-12-31 0001071739 2022-12-31 0001071739 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001071739 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001071739 2023-01-01 2023-03-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001071739 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001071739 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001071739 us-gaap:RetainedEarningsMember 2023-03-31 0001071739 us-gaap:NoncontrollingInterestMember 2023-03-31 0001071739 2023-03-31 0001071739 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001071739 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001071739 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001071739 us-gaap:TreasuryStockCommonMember 2023-04-01 2023-06-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001071739 us-gaap:RetainedEarningsMember 2023-06-30 0001071739 us-gaap:NoncontrollingInterestMember 2023-06-30 0001071739 2023-06-30 0001071739 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember cnc:MagellanRxMember 2024-01-01 2024-06-30 0001071739 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember cnc:CircleHealthMember 2023-01-01 2023-12-31 0001071739 us-gaap:CurrencySwapMember 2023-08-31 0001071739 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember cnc:CircleHealthMember 2024-01-12 2024-01-12 0001071739 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember cnc:CircleHealthMember 2024-01-01 2024-06-30 0001071739 us-gaap:USTreasuryAndGovernmentMember 2024-06-30 0001071739 us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001071739 us-gaap:CorporateDebtSecuritiesMember 2024-06-30 0001071739 us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001071739 cnc:RestrictedCertificatesOfDepositMember 2024-06-30 0001071739 cnc:RestrictedCertificatesOfDepositMember 2023-12-31 0001071739 cnc:RestrictedCashEquivalentsMember 2024-06-30 0001071739 cnc:RestrictedCashEquivalentsMember 2023-12-31 0001071739 us-gaap:BankTimeDepositsMember 2024-06-30 0001071739 us-gaap:BankTimeDepositsMember 2023-12-31 0001071739 us-gaap:MunicipalBondsMember 2024-06-30 0001071739 us-gaap:MunicipalBondsMember 2023-12-31 0001071739 us-gaap:AssetBackedSecuritiesMember 2024-06-30 0001071739 us-gaap:AssetBackedSecuritiesMember 2023-12-31 0001071739 us-gaap:ResidentialMortgageBackedSecuritiesMember 2024-06-30 0001071739 us-gaap:ResidentialMortgageBackedSecuritiesMember 2023-12-31 0001071739 us-gaap:CommercialMortgageBackedSecuritiesMember 2024-06-30 0001071739 us-gaap:CommercialMortgageBackedSecuritiesMember 2023-12-31 0001071739 cnc:RatedSecuritiesMember cnc:InvestmentSecuritiesMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2024-01-01 2024-06-30 0001071739 us-gaap:CommercialMortgageBackedSecuritiesMember 2024-01-01 2024-06-30 0001071739 us-gaap:InvestmentsMember 2024-06-30 0001071739 us-gaap:DepositsMember 2024-06-30 0001071739 us-gaap:InvestmentsMember 2023-12-31 0001071739 us-gaap:DepositsMember 2023-12-31 0001071739 us-gaap:FairValueInputsLevel1Member 2024-06-30 0001071739 us-gaap:FairValueInputsLevel2Member 2024-06-30 0001071739 us-gaap:FairValueInputsLevel3Member 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:USTreasuryAndGovernmentMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:MunicipalBondsMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:MunicipalBondsMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:BankTimeDepositsMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:BankTimeDepositsMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:BankTimeDepositsMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:BankTimeDepositsMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:AssetBackedSecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:AssetBackedSecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:AssetBackedSecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:CommercialMortgageBackedSecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:CommercialMortgageBackedSecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:CommercialMortgageBackedSecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:CommercialMortgageBackedSecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:EquitySecuritiesMember 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member 2024-06-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CashAndCashEquivalentsMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CashAndCashEquivalentsMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CashAndCashEquivalentsMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:CashAndCashEquivalentsMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:USTreasuryAndGovernmentMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:CorporateDebtSecuritiesMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CertificatesOfDepositMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CertificatesOfDepositMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CertificatesOfDepositMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:CertificatesOfDepositMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:MunicipalBondsMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:MunicipalBondsMember 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member 2024-06-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member 2024-06-30 0001071739 us-gaap:FairValueInputsLevel1Member 2023-12-31 0001071739 us-gaap:FairValueInputsLevel2Member 2023-12-31 0001071739 us-gaap:FairValueInputsLevel3Member 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:MunicipalBondsMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:MunicipalBondsMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:BankTimeDepositsMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:BankTimeDepositsMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:BankTimeDepositsMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:BankTimeDepositsMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:AssetBackedSecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:AssetBackedSecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:AssetBackedSecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:CommercialMortgageBackedSecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:CommercialMortgageBackedSecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:CommercialMortgageBackedSecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:CommercialMortgageBackedSecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:EquitySecuritiesMember 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member 2023-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CashAndCashEquivalentsMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CashAndCashEquivalentsMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CashAndCashEquivalentsMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:CashAndCashEquivalentsMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CertificatesOfDepositMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CertificatesOfDepositMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CertificatesOfDepositMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:CertificatesOfDepositMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:MunicipalBondsMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:MunicipalBondsMember 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member 2023-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0001071739 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel1Member us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-12-31 0001071739 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel2Member us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-12-31 0001071739 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel3Member us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-12-31 0001071739 us-gaap:CurrencySwapMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-12-31 0001071739 cnc:MedicaidSegmentMember 2023-12-31 0001071739 cnc:MedicareSegmentMember 2023-12-31 0001071739 cnc:CommercialSegmentMember 2023-12-31 0001071739 us-gaap:AllOtherSegmentsMember 2023-12-31 0001071739 cnc:MedicaidSegmentMember 2024-01-01 2024-06-30 0001071739 cnc:MedicareSegmentMember 2024-01-01 2024-06-30 0001071739 cnc:CommercialSegmentMember 2024-01-01 2024-06-30 0001071739 us-gaap:AllOtherSegmentsMember 2024-01-01 2024-06-30 0001071739 cnc:MedicaidSegmentMember 2024-06-30 0001071739 cnc:MedicareSegmentMember 2024-06-30 0001071739 cnc:CommercialSegmentMember 2024-06-30 0001071739 us-gaap:AllOtherSegmentsMember 2024-06-30 0001071739 cnc:MedicaidSegmentMember 2022-12-31 0001071739 cnc:MedicareSegmentMember 2022-12-31 0001071739 cnc:CommercialSegmentMember 2022-12-31 0001071739 us-gaap:AllOtherSegmentsMember 2022-12-31 0001071739 cnc:MedicaidSegmentMember 2023-01-01 2023-06-30 0001071739 cnc:MedicareSegmentMember 2023-01-01 2023-06-30 0001071739 cnc:CommercialSegmentMember 2023-01-01 2023-06-30 0001071739 us-gaap:AllOtherSegmentsMember 2023-01-01 2023-06-30 0001071739 cnc:MedicaidSegmentMember 2023-06-30 0001071739 cnc:MedicareSegmentMember 2023-06-30 0001071739 cnc:CommercialSegmentMember 2023-06-30 0001071739 us-gaap:AllOtherSegmentsMember 2023-06-30 0001071739 cnc:MedicareSegmentMember 2024-03-31 0001071739 cnc:FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember us-gaap:SeniorNotesMember 2024-06-30 0001071739 cnc:FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember us-gaap:SeniorNotesMember 2023-12-31 0001071739 cnc:A2300Million245SeniorNotsDueJuly2028Member us-gaap:SeniorNotesMember 2024-06-30 0001071739 cnc:A2300Million245SeniorNotsDueJuly2028Member us-gaap:SeniorNotesMember 2023-12-31 0001071739 cnc:A3500Million4625SeniorNotesDueDecember2029Member us-gaap:SeniorNotesMember 2024-06-30 0001071739 cnc:A3500Million4625SeniorNotesDueDecember2029Member us-gaap:SeniorNotesMember 2023-12-31 0001071739 cnc:A2200Million375SeniorNotesDueFebruary2030Member us-gaap:SeniorNotesMember 2024-06-30 0001071739 cnc:A2200Million375SeniorNotesDueFebruary2030Member us-gaap:SeniorNotesMember 2023-12-31 0001071739 cnc:A2200Million300SeniorNotesDueOctober2030Member us-gaap:SeniorNotesMember 2024-06-30 0001071739 cnc:A2200Million300SeniorNotesDueOctober2030Member us-gaap:SeniorNotesMember 2023-12-31 0001071739 cnc:A2200Million250SeniorNotesDueMarch2031Member us-gaap:SeniorNotesMember 2024-06-30 0001071739 cnc:A2200Million250SeniorNotesDueMarch2031Member us-gaap:SeniorNotesMember 2023-12-31 0001071739 cnc:A1300Million2625SeniorNotesDueAugust2031Member us-gaap:SeniorNotesMember 2024-06-30 0001071739 cnc:A1300Million2625SeniorNotesDueAugust2031Member us-gaap:SeniorNotesMember 2023-12-31 0001071739 cnc:TermLoanCreditAgreementMember 2024-06-30 0001071739 cnc:TermLoanCreditAgreementMember 2023-12-31 0001071739 us-gaap:RevolvingCreditFacilityMember 2024-06-30 0001071739 us-gaap:RevolvingCreditFacilityMember 2023-12-31 0001071739 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001071739 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001071739 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001071739 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001071739 cnc:EmployeeStockCompensationPlanMember 2024-04-01 2024-06-30 0001071739 cnc:EmployeeStockCompensationPlanMember 2023-04-01 2023-06-30 0001071739 cnc:EmployeeStockCompensationPlanMember 2024-01-01 2024-06-30 0001071739 cnc:EmployeeStockCompensationPlanMember 2023-01-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicaidSegmentMember 2024-04-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicareSegmentMember 2024-04-01 2024-06-30 0001071739 us-gaap:HealthCarePremiumMember cnc:CommercialSegmentMember 2024-04-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember us-gaap:AllOtherSegmentsMember 2024-04-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicaidSegmentMember 2024-04-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicareSegmentMember 2024-04-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:CommercialSegmentMember 2024-04-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember us-gaap:AllOtherSegmentsMember 2024-04-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicaidSegmentMember 2024-04-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicareSegmentMember 2024-04-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:CommercialSegmentMember 2024-04-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember us-gaap:AllOtherSegmentsMember 2024-04-01 2024-06-30 0001071739 cnc:TotalPremiumAndServiceMember 2024-04-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicaidSegmentMember 2024-04-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicareSegmentMember 2024-04-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:CommercialSegmentMember 2024-04-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2024-04-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember 2024-04-01 2024-06-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicaidSegmentMember 2024-04-01 2024-06-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicareSegmentMember 2024-04-01 2024-06-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:CommercialSegmentMember 2024-04-01 2024-06-30 0001071739 us-gaap:IntersegmentEliminationMember us-gaap:AllOtherSegmentsMember 2024-04-01 2024-06-30 0001071739 us-gaap:IntersegmentEliminationMember 2024-04-01 2024-06-30 0001071739 cnc:MedicaidSegmentMember 2024-04-01 2024-06-30 0001071739 cnc:MedicareSegmentMember 2024-04-01 2024-06-30 0001071739 cnc:CommercialSegmentMember 2024-04-01 2024-06-30 0001071739 us-gaap:AllOtherSegmentsMember 2024-04-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicaidSegmentMember 2023-04-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicareSegmentMember 2023-04-01 2023-06-30 0001071739 us-gaap:HealthCarePremiumMember cnc:CommercialSegmentMember 2023-04-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember us-gaap:AllOtherSegmentsMember 2023-04-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicaidSegmentMember 2023-04-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicareSegmentMember 2023-04-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:CommercialSegmentMember 2023-04-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember us-gaap:AllOtherSegmentsMember 2023-04-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicaidSegmentMember 2023-04-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicareSegmentMember 2023-04-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:CommercialSegmentMember 2023-04-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember us-gaap:AllOtherSegmentsMember 2023-04-01 2023-06-30 0001071739 cnc:TotalPremiumAndServiceMember 2023-04-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicaidSegmentMember 2023-04-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicareSegmentMember 2023-04-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:CommercialSegmentMember 2023-04-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2023-04-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember 2023-04-01 2023-06-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicaidSegmentMember 2023-04-01 2023-06-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicareSegmentMember 2023-04-01 2023-06-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:CommercialSegmentMember 2023-04-01 2023-06-30 0001071739 us-gaap:IntersegmentEliminationMember us-gaap:AllOtherSegmentsMember 2023-04-01 2023-06-30 0001071739 us-gaap:IntersegmentEliminationMember 2023-04-01 2023-06-30 0001071739 cnc:MedicaidSegmentMember 2023-04-01 2023-06-30 0001071739 cnc:MedicareSegmentMember 2023-04-01 2023-06-30 0001071739 cnc:CommercialSegmentMember 2023-04-01 2023-06-30 0001071739 us-gaap:AllOtherSegmentsMember 2023-04-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicaidSegmentMember 2024-01-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicareSegmentMember 2024-01-01 2024-06-30 0001071739 us-gaap:HealthCarePremiumMember cnc:CommercialSegmentMember 2024-01-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember us-gaap:AllOtherSegmentsMember 2024-01-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicaidSegmentMember 2024-01-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicareSegmentMember 2024-01-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:CommercialSegmentMember 2024-01-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember us-gaap:AllOtherSegmentsMember 2024-01-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicaidSegmentMember 2024-01-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicareSegmentMember 2024-01-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:CommercialSegmentMember 2024-01-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember us-gaap:AllOtherSegmentsMember 2024-01-01 2024-06-30 0001071739 cnc:TotalPremiumAndServiceMember 2024-01-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicaidSegmentMember 2024-01-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicareSegmentMember 2024-01-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:CommercialSegmentMember 2024-01-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2024-01-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember 2024-01-01 2024-06-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicaidSegmentMember 2024-01-01 2024-06-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicareSegmentMember 2024-01-01 2024-06-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:CommercialSegmentMember 2024-01-01 2024-06-30 0001071739 us-gaap:IntersegmentEliminationMember us-gaap:AllOtherSegmentsMember 2024-01-01 2024-06-30 0001071739 us-gaap:IntersegmentEliminationMember 2024-01-01 2024-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicaidSegmentMember 2023-01-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicareSegmentMember 2023-01-01 2023-06-30 0001071739 us-gaap:HealthCarePremiumMember cnc:CommercialSegmentMember 2023-01-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember us-gaap:AllOtherSegmentsMember 2023-01-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicaidSegmentMember 2023-01-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicareSegmentMember 2023-01-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:CommercialSegmentMember 2023-01-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember us-gaap:AllOtherSegmentsMember 2023-01-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicaidSegmentMember 2023-01-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicareSegmentMember 2023-01-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:CommercialSegmentMember 2023-01-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember us-gaap:AllOtherSegmentsMember 2023-01-01 2023-06-30 0001071739 cnc:TotalPremiumAndServiceMember 2023-01-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicaidSegmentMember 2023-01-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicareSegmentMember 2023-01-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember cnc:CommercialSegmentMember 2023-01-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2023-01-01 2023-06-30 0001071739 us-gaap:OperatingSegmentsMember 2023-01-01 2023-06-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicaidSegmentMember 2023-01-01 2023-06-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicareSegmentMember 2023-01-01 2023-06-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:CommercialSegmentMember 2023-01-01 2023-06-30 0001071739 us-gaap:IntersegmentEliminationMember us-gaap:AllOtherSegmentsMember 2023-01-01 2023-06-30 0001071739 us-gaap:IntersegmentEliminationMember 2023-01-01 2023-06-30 shares iso4217:USD iso4217:USD shares iso4217:GBP pure cnc:position cnc:segment 0001071739 --12-31 2024 Q2 false 10-Q true 2024-06-30 false 001-31826 CENTENE CORPORATION DE 42-1406317 7700 Forsyth Boulevard St. Louis, MO 63105 314 725-4477 Common Stock $0.001 Par Value CNC NYSE Yes Yes Large Accelerated Filer false false false 526030000 17605000000 17193000000 16587000000 15532000000 2609000000 2459000000 1605000000 5572000000 38406000000 40756000000 16870000000 16286000000 1415000000 1386000000 2041000000 2019000000 17558000000 17558000000 5755000000 6101000000 1092000000 535000000 83137000000 84641000000 18173000000 18000000000 12232000000 16420000000 1615000000 1462000000 597000000 715000000 112000000 119000000 32729000000 36716000000 17516000000 17710000000 665000000 641000000 4770000000 3618000000 55680000000 58685000000 16000000 19000000 0.001 0.001 10000000 10000000 0 0 0 0 0 0 0.001 0.001 800000000 800000000 619495000 526001000 615291000 534484000 1000000 1000000 20461000000 20304000000 -646000000 -652000000 14352000000 12043000000 93494000 80807000 6817000000 5856000000 27351000000 25840000000 90000000 97000000 27441000000 25937000000 83137000000 84641000000 35140000000 33713000000 70669000000 67538000000 833000000 1125000000 1641000000 2252000000 35973000000 34838000000 72310000000 69790000000 3863000000 2770000000 7933000000 6707000000 39836000000 37608000000 80243000000 76497000000 30765000000 29347000000 61697000000 58781000000 680000000 877000000 1349000000 1747000000 2894000000 3016000000 6112000000 6027000000 133000000 146000000 268000000 288000000 173000000 179000000 346000000 362000000 3962000000 2854000000 8123000000 6865000000 0 18000000 13000000 38000000 38607000000 36437000000 77908000000 74108000000 1229000000 1171000000 2335000000 2389000000 463000000 425000000 1008000000 778000000 176000000 181000000 354000000 361000000 1516000000 1415000000 2989000000 2806000000 370000000 360000000 685000000 621000000 1146000000 1055000000 2304000000 2185000000 0 -3000000 -5000000 -3000000 1146000000 1058000000 2309000000 2188000000 2.16 1.93 4.34 3.98 2.16 1.92 4.32 3.96 529602000 548932000 532385000 549850000 530755000 550308000 534517000 551996000 1146000000 1055000000 2304000000 2185000000 -26000000 -142000000 -107000000 111000000 -6000000 -34000000 -21000000 27000000 -20000000 -108000000 -86000000 84000000 -4000000 -2000000 -92000000 -4000000 0 23000000 0 46000000 -16000000 -83000000 6000000 134000000 1130000000 972000000 2310000000 2319000000 0 -3000000 -5000000 -3000000 1130000000 975000000 2315000000 2322000000 0.001 0.001 0.001 0.001 0.001 0.001 615291000 1000000 20304000000 -652000000 12043000000 80807000 -5856000000 97000000 25937000000 1163000000 -4000000 1159000000 -12000000 22000000 22000000 3882000 14000000 14000000 1983000 151000000 151000000 70000000 70000000 3000000 3000000 619173000 1000000 20388000000 -630000000 13206000000 82790000 -6007000000 90000000 27048000000 1146000000 0 1146000000 -5000000 -16000000 -16000000 322000 11000000 11000000 10704000 810000000 810000000 62000000 62000000 619495000 1000000 20461000000 -646000000 14352000000 93494000 -6817000000 90000000 27441000000 0.001 0.001 0.001 0.001 0.001 0.001 607847000 1000000 20060000000 -1132000000 9341000000 57093000 -4213000000 124000000 24181000000 1130000000 0 1130000000 61000000 217000000 217000000 6508000 12000000 12000000 5548000 423000000 423000000 61000000 61000000 12000000 12000000 614355000 1000000 20121000000 -915000000 10471000000 62641000 -4636000000 124000000 25166000000 1058000000 -3000000 1055000000 -34000000 -83000000 -83000000 388000 9000000 9000000 6099000 408000000 408000000 56000000 56000000 3000000 24000000 27000000 614743000 1000000 20183000000 -998000000 11529000000 68740000 -5044000000 97000000 25768000000 2304000000 2185000000 614000000 650000000 132000000 117000000 13000000 38000000 40000000 -160000000 103000000 172000000 11000000 -68000000 1059000000 319000000 404000000 325000000 173000000 139000000 -118000000 1895000000 -1704000000 618000000 1838000000 2081000000 4000000 0 1719000000 6815000000 337000000 440000000 3434000000 3199000000 2497000000 2293000000 959000000 669000000 -315000000 -677000000 350000000 1281000000 565000000 1322000000 954000000 828000000 25000000 21000000 0 85000000 -4000000 0 -1148000000 -933000000 7000000 -7000000 263000000 5198000000 17452000000 12330000000 17715000000 17528000000 352000000 348000000 610000000 592000000 17605000000 17170000000 110000000 358000000 17715000000 17528000000 Organization and Operations <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Annual Report on Form 10-K for the fiscal year ended December 31, 2023. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2023 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain 2023 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2024 presentation. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Guidance Not Yet Adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (FASB) issued an Accounting Standards Update (ASU) which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant expenses. The amendments will require public entities to disclose significant segment expenses that are regularly provided to the chief operating decision-maker and included within segment profit and loss. The new standard is effective for annual periods beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. The Company is currently evaluating the effect of the new disclosure requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued an ASU which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The new standard is effective for annual periods beginning after December 15, 2024. The Company is currently evaluating the effect of the new disclosure requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the SEC adopted the final rule under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors. This rule will require disclosure of material climate-related risks and material direct greenhouse gas emissions from operations owned or controlled (Scope 1) and/or material indirect greenhouse gas emissions from purchased energy consumed in owned or controlled operations (Scope 2). Additionally, the rules require disclosure in the notes to the financial statements of the effects of severe weather events and other natural conditions, subject to certain materiality thresholds. The disclosure requirements will begin phasing in for reports and registration statements including financial information with respect to annual periods beginning in 2025. In April 2024, the SEC voluntarily stayed the final rule pending the completion of judicial review by the Court of Appeals for the Eighth Circuit. The Company is monitoring the development of litigation related to the SEC's rule, and is currently evaluating the effect of the new disclosure requirements.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Annual Report on Form 10-K for the fiscal year ended December 31, 2023. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2023 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain 2023 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2024 presentation. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Guidance Not Yet Adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (FASB) issued an Accounting Standards Update (ASU) which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant expenses. The amendments will require public entities to disclose significant segment expenses that are regularly provided to the chief operating decision-maker and included within segment profit and loss. The new standard is effective for annual periods beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. The Company is currently evaluating the effect of the new disclosure requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued an ASU which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The new standard is effective for annual periods beginning after December 15, 2024. The Company is currently evaluating the effect of the new disclosure requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the SEC adopted the final rule under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors. This rule will require disclosure of material climate-related risks and material direct greenhouse gas emissions from operations owned or controlled (Scope 1) and/or material indirect greenhouse gas emissions from purchased energy consumed in owned or controlled operations (Scope 2). Additionally, the rules require disclosure in the notes to the financial statements of the effects of severe weather events and other natural conditions, subject to certain materiality thresholds. The disclosure requirements will begin phasing in for reports and registration statements including financial information with respect to annual periods beginning in 2025. In April 2024, the SEC voluntarily stayed the final rule pending the completion of judicial review by the Court of Appeals for the Eighth Circuit. The Company is monitoring the development of litigation related to the SEC's rule, and is currently evaluating the effect of the new disclosure requirements.</span></div> Acquisitions and Divestitures<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Magellan Specialty Health Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2024, the Company recorded an additional gain on the previously reported divestiture of Magellan Specialty Health of $83 million for achievement of contingent consideration related to the sale and finalization of working capital adjustments, which is included in investment and other income in the Consolidated Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Circle Health Group Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 28, 2023, the Company signed a definitive agreement to sell Circle Health Group (Circle Health), one of the U.K.'s largest independent hospital operators, which is included in the Other segment. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the signed definitive agreement in the third quarter of 2023, and subsequently updated in the fourth quarter of 2023, the Company recorded impairment charges related to goodwill associated with the pending divestiture totaling $292 million, or $258 million after-tax.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to manage the foreign exchange risk on the sale price associated with the pending divestiture of Circle Health, in August 2023 the Company entered into a foreign currency swap agreement for a notional amount of $931 million, to sell £740 million. The swap agreement was formally designated and qualified as a cash flow hedge. The swap expired on the earlier of the divestiture closing date or March 28, 2024. The gain or loss due to changes in the fair value of the foreign currency swap was recorded in other comprehensive income until the Circle Health divestiture closed, at which time the gain or loss was recorded in earnings to the same line in the Consolidated Statement of Operations as the gain or loss on sale.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2024, the Company completed the divestiture for $931 million. Upon closing the divestiture, the Company settled the foreign currency swap and recorded a corresponding gain of $20 million, which includes the cumulative translation adjustment previously recorded in accumulated other comprehensive income in the Consolidated Balance Sheet. The gain is included in investment and other income in the Consolidated Statements of Operations. During the six months ended June 30, 2024, the Company realized a net tax benefit of approximately $40 million on the loss recognized on the divestiture.</span></div> 83000000 292000000 258000000 931000000 740000000 931000000 20000000 -40000000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Short-term and Long-term Investments, Restricted Deposits</span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.431%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of </span></div><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government corporations and agencies</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">591 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">584 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">403 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">395 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,554 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,118 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,984 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,601 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted certificates of deposit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,229 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,052 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,135 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,985 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,741 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,720 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,665 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,638 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,606 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,479 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,503 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,407 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,222 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,145 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,149 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,072 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">833 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">833 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance contracts</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,739 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(896)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,894 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,872 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(860)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,131 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investments are debt securities classified as available-for-sale with the exception of equity securities, certain private equity investments and life insurance contracts. Private equity investments include direct investments in private equity securities as well as private equity funds. The Company's investment policies are designed to provide liquidity, preserve capital and maximize total return on invested assets with a focus on high credit quality securities. The Company limits the size of investment in any single issuer other than U.S. treasury securities and obligations of U.S. government corporations and agencies. As of June 30, 2024, 99% of the Company's investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations. At June 30, 2024, the Company held certificates of deposit, equity securities, private equity investments and life insurance contracts, which did not carry a credit rating. Accrued interest income on available-for-sale debt securities was $168 million and $153 million at June 30, 2024 and December 31, 2023, respectively, and is included in other current assets in the Consolidated Balance Sheets.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's residential mortgage-backed securities are primarily issued by the Federal National Mortgage Association, Government National Mortgage Association or Federal Home Loan Mortgage Corporation, which carry implicit or explicit guarantees of the U.S. government. The Company's commercial mortgage-backed securities are primarily senior tranches with a weighted average rating of AA+ and a weighted average duration of 3 years at June 30, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government corporations and agencies</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,895 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,017 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,260 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,365 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,237 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,869 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(856)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,784 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,152 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2024, the gross unrealized losses were generated from 4,626 positions out of a total of 6,830 positions. The change in fair value of available-for-sale debt securities is primarily a result of movement in interest rates subsequent to the purchase of the security.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes. If the security meets this criterion, the decline in fair value is recorded in earnings. The Company does not intend to sell these securities prior to maturity and it is not likely that the Company will be required to sell these securities prior to maturity; therefore, the Company did not record an impairment for these securities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company monitors available-for-sale debt securities for credit losses. Certain investments have experienced a decline in fair value due to changes in credit quality, market interest rates and/or general economic conditions. The Company recognizes an allowance when evidence demonstrates that the decline in fair value is credit related. Evidence of a credit-related loss may include rating agency actions, adverse conditions specifically related to the security or failure of the issuer of the security to make scheduled payments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year or less</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,428 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,308 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,284 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,877 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,546 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,738 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,431 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,166 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,905 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,735 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,344 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,317 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,117 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,187 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,383 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,456 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,423 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,721 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from contractual maturities due to call or prepayment options. Equity securities, private equity investments and life insurance contracts are excluded from the table above because they do not have a contractual maturity. The Company has an option to redeem substantially all of the securities included in the greater than ten years category listed above at amortized cost.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.431%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of </span></div><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government corporations and agencies</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">591 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">584 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">403 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">395 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,554 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,118 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,984 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,601 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted certificates of deposit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,229 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,052 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,135 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,985 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,741 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,720 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,665 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,638 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,606 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,479 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,503 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,407 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,222 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,145 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,149 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,072 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">833 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">833 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance contracts</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,739 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(896)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,894 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,872 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(860)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,131 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 591000000 0 7000000 584000000 403000000 0 8000000 395000000 10554000000 32000000 468000000 10118000000 9984000000 78000000 461000000 9601000000 4000000 0 0 4000000 4000000 0 0 4000000 110000000 0 0 110000000 259000000 0 0 259000000 586000000 0 0 586000000 746000000 0 0 746000000 4229000000 7000000 184000000 4052000000 4135000000 21000000 171000000 3985000000 1741000000 8000000 29000000 1720000000 1665000000 8000000 35000000 1638000000 1606000000 2000000 129000000 1479000000 1503000000 7000000 103000000 1407000000 1222000000 2000000 79000000 1145000000 1149000000 5000000 82000000 1072000000 17000000 17000000 17000000 17000000 890000000 890000000 833000000 833000000 189000000 189000000 174000000 174000000 21739000000 51000000 896000000 20894000000 20872000000 119000000 860000000 20131000000 0.99 168000000 153000000 P3Y <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government corporations and agencies</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,895 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,017 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,260 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,365 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,237 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,869 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(856)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,784 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,152 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0 205000000 7000000 224000000 0 79000000 8000000 232000000 20000000 1895000000 448000000 6017000000 6000000 658000000 455000000 6260000000 11000000 959000000 173000000 2365000000 4000000 553000000 167000000 2237000000 1000000 266000000 28000000 519000000 2000000 197000000 33000000 855000000 7000000 397000000 122000000 857000000 2000000 153000000 101000000 814000000 1000000 147000000 78000000 802000000 2000000 114000000 80000000 754000000 0 0 0 0 0 31000000 0 0 40000000 3869000000 856000000 10784000000 16000000 1785000000 844000000 11152000000 4626 6830 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year or less</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,428 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,308 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,284 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,877 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,546 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,738 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,431 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,166 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,905 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,735 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,344 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,317 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,117 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,187 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,383 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,456 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,423 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,721 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 2428000000 2403000000 395000000 392000000 2308000000 2284000000 566000000 564000000 7877000000 7546000000 733000000 709000000 7738000000 7431000000 527000000 504000000 4166000000 3947000000 291000000 278000000 3905000000 3735000000 298000000 283000000 147000000 143000000 37000000 36000000 155000000 154000000 34000000 35000000 4569000000 4344000000 0 0 4317000000 4117000000 0 0 19187000000 18383000000 1456000000 1415000000 18423000000 17721000000 1425000000 1386000000 Fair Value Measurements <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level Input:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Input Definition:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at June 30, 2024, for assets and liabilities measured at fair value on a recurring basis ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,605 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,605 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,080 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,080 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,315 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,315 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,720 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,720 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,328 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,400 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">737 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">737 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,313 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,107 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,420 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at December 31, 2023, for assets and liabilities measured at fair value on a recurring basis ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,193 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,193 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,564 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,564 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,232 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,232 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,407 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,407 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,661 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,738 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,862 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,455 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,317 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency swap agreement</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes matrix-pricing services to estimate fair value for securities which are not actively traded on the measurement date. The Company designates these securities as Level II fair value measurements. In addition, the aggregate carrying amount of the Company's private equity investments and life insurance contracts, which approximates fair value, was $1,079 million and $1,007 million as of June 30, 2024 and December 31, 2023, respectively.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level Input:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Input Definition:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.</span></td></tr></table></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at June 30, 2024, for assets and liabilities measured at fair value on a recurring basis ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,605 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,605 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,080 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,080 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,315 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,315 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,720 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,720 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,328 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,400 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">737 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">737 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,313 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,107 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,420 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at December 31, 2023, for assets and liabilities measured at fair value on a recurring basis ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,193 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,193 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,564 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,564 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,232 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,232 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,407 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,407 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,661 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,738 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,862 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,455 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,317 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency swap agreement</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div> 17605000000 0 0 17605000000 58000000 0 0 58000000 0 10080000000 0 10080000000 0 3315000000 0 3315000000 0 586000000 0 586000000 0 1720000000 0 1720000000 0 1479000000 0 1479000000 0 1145000000 0 1145000000 14000000 3000000 0 17000000 72000000 18328000000 0 18400000000 110000000 0 0 110000000 526000000 0 0 526000000 0 38000000 0 38000000 0 4000000 0 4000000 0 737000000 0 737000000 636000000 779000000 0 1415000000 18313000000 19107000000 0 37420000000 17193000000 0 0 17193000000 62000000 0 0 62000000 0 9564000000 0 9564000000 0 3232000000 0 3232000000 0 746000000 0 746000000 0 1638000000 0 1638000000 0 1407000000 0 1407000000 0 1072000000 0 1072000000 15000000 2000000 0 17000000 77000000 17661000000 0 17738000000 259000000 0 0 259000000 333000000 0 0 333000000 0 37000000 0 37000000 0 4000000 0 4000000 0 753000000 0 753000000 592000000 794000000 0 1386000000 17862000000 18455000000 0 36317000000 0 13000000 0 13000000 0 13000000 0 13000000 1079000000 1007000000 Medical Claims Liability<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the change in medical claims liability for the six months ended June 30, 2024 ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1, 2024</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,814 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,612 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,460 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2024, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,809 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,612 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,416 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,951 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,398 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,953 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,274 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,383 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,136)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(326)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,771)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,262 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,637 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,948 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,612 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,696 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,093 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,143 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,565 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,918 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,562 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,367 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,968 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,614 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,655 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,510 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,533 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2024, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,457 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,679 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,854 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,115 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2024</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,472 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,679 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,897 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,173 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the change in medical claims liability for the six months ended June 30, 2023 ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.356%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1, 2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,253 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,431 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,745 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2023, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,246 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,431 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,902 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,719 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,622 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,083 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,857 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,335 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,153)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,554)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,469 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,892 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,649 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">771 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,781 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,837 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,726 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,751 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,970 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,890 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,357 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,666 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,727 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,083 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,033 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,636 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2023, net</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,988 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,240 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,518 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,864 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2023</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,993 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,240 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,884 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance recoverables related to medical claims are included in premium and trade receivables. Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. Additionally, as a result of development within "Incurred related to: Prior years," the Company recorded $88 million and $319 million as a reduction to premium revenue in the six months ended June 30, 2024 and 2023, respectively, for minimum health benefits ratio (HBR) and other return of premium programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incurred but not reported (IBNR) plus expected development on reported claims as of June 30, 2024 was $12,337 million. Total IBNR plus expected development on reported claims represents estimates for claims incurred but not reported, development on reported claims and estimates for the costs necessary to process unpaid claims at the end of each period. The Company estimates its liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice. These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services and other relevant factors.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews actual and anticipated experience compared to the assumptions used to establish medical costs. The Company establishes premium deficiency reserves if actual and anticipated experience indicates that existing policy liabilities together with the present value of future gross premiums will not be sufficient to cover the present value of future benefits, settlement and maintenance costs. For purposes of determining premium deficiencies, contracts are grouped in a manner consistent with the method of acquiring, servicing and measuring the profitability of such contracts and expected investment income is excluded. In December 2023, the Company recorded a premium deficiency reserve of $250 million related to the 2024 Medicare Advantage contract year, which was increased to $300 million in the first quarter of 2024 and to $335 million in the second quarter of 2024 consistent with the intra-year flow of seasonality.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the change in medical claims liability for the six months ended June 30, 2024 ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1, 2024</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,814 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,612 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,460 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2024, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,809 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,612 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,416 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,951 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,398 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,953 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,274 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,383 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,136)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(326)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,771)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,262 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,637 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,948 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,612 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,696 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,093 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,143 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,565 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,918 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,562 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,367 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,968 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,614 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,655 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,510 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,533 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2024, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,457 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,679 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,854 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,115 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2024</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,472 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,679 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,897 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,173 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the change in medical claims liability for the six months ended June 30, 2023 ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.356%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1, 2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,253 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,431 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,745 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2023, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,246 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,431 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,902 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,719 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,622 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,083 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,857 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,335 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,153)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,554)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,469 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,892 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,649 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">771 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,781 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,837 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,726 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,751 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,970 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,890 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,357 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,666 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,727 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,083 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,033 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,636 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2023, net</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,988 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,240 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,518 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,864 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2023</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,993 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,240 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,884 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 10814000000 3612000000 3460000000 114000000 18000000000 5000000 0 44000000 0 49000000 10809000000 3612000000 3416000000 114000000 17951000000 39398000000 10953000000 12274000000 758000000 63383000000 -1136000000 -316000000 -326000000 7000000 -1771000000 38262000000 10637000000 11948000000 765000000 61612000000 30696000000 8093000000 9143000000 633000000 48565000000 7918000000 2562000000 2367000000 121000000 12968000000 38614000000 10655000000 11510000000 754000000 61533000000 0 85000000 0 0 85000000 10457000000 3679000000 3854000000 125000000 18115000000 15000000 0 43000000 0 58000000 10472000000 3679000000 3897000000 125000000 18173000000 11253000000 3431000000 1921000000 140000000 16745000000 7000000 0 19000000 0 26000000 11246000000 3431000000 1902000000 140000000 16719000000 40622000000 10083000000 8857000000 773000000 60335000000 -1153000000 -191000000 -208000000 -2000000 -1554000000 39469000000 9892000000 8649000000 771000000 58781000000 31837000000 7726000000 6751000000 656000000 46970000000 7890000000 2357000000 1282000000 137000000 11666000000 39727000000 10083000000 8033000000 793000000 58636000000 10988000000 3240000000 2518000000 118000000 16864000000 5000000 0 15000000 0 20000000 10993000000 3240000000 2533000000 118000000 16884000000 -88000000 -319000000 12337000000 250000000 300000000 335000000 Affordable Care Act <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Affordable Care Act established risk spreading premium stabilization programs as well as a minimum annual medical loss ratio (MLR) and cost sharing reductions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's net receivables (payables) for each of the programs are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment receivable</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,047 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,475)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,553)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimum medical loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(675)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost sharing reduction receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost sharing reduction payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2024, the Centers for Medicare and Medicaid Services (CMS) announced the final risk adjustment transfers for the 2023 benefit year. Based on the Company's estimate of the final settlement, the risk adjustment net payable was decreased by $1,344 million in the first half of 2024. After consideration of minimum MLR and other related impacts, the net pre-tax benefit recognized was $945 million in the six months ended June 30, 2024 ($78 million in the first quarter of 2024 and $867 million in the second quarter of 2024).</span></div> <div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's net receivables (payables) for each of the programs are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment receivable</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,047 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,475)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,553)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimum medical loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(675)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost sharing reduction receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost sharing reduction payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2047000000 893000000 3475000000 2553000000 675000000 164000000 12000000 0 111000000 114000000 -1344000000 -945000000 -78000000 -867000000 Debt <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,500 million 4.25% Senior Notes due December 15, 2027</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,395 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,300 million 2.45% Senior Notes due July 15, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,500 million 4.625% Senior Notes due December 15, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 3.375% Senior Notes due February 15, 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 3.00% Senior Notes due October 15, 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 2.50% Senior Notes due March 1, 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,300 million 2.625% Senior Notes due August 1, 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,677 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,675 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Facility</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,115 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,628 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,829 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,516 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,710 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,500 million 4.25% Senior Notes due December 15, 2027</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,395 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,300 million 2.45% Senior Notes due July 15, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,500 million 4.625% Senior Notes due December 15, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 3.375% Senior Notes due February 15, 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 3.00% Senior Notes due October 15, 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 2.50% Senior Notes due March 1, 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,300 million 2.625% Senior Notes due August 1, 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,677 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,675 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Facility</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,115 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,628 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,829 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,516 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,710 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2500000000 0.0425 2397000000 2395000000 2300000000 0.0245 2303000000 2303000000 3500000000 0.04625 3277000000 3277000000 2000000000 0.03375 2000000000 2000000000 2200000000 0.0300 2200000000 2200000000 2200000000 0.0250 2200000000 2200000000 1300000000 0.02625 1300000000 1300000000 15677000000 15675000000 2060000000 2115000000 0 150000000 2000000 11000000 111000000 122000000 17628000000 17829000000 112000000 119000000 17516000000 17710000000 Stockholders' Equity <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Board of Directors has authorized a stock repurchase program of the Company's common stock from time to time on the open market or through privately negotiated transactions. The Company is authorized to repurchase up to $10,000 million, inclusive of past authorizations. As of June 30, 2024, the Company had a remaining amount of $4,378 million available under the stock repurchase program.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents the Company's share repurchase activity ($ in millions, shares in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.361%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share buybacks</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,660 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,028 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,341 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,880 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax withholding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,704 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,099 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,687 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">954 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,647 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Excludes share repurchase excise tax of approximately $7 million and $3 million accrued as of June 30, 2024 and 2023, respectively.</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares repurchased for income tax withholding are shares withheld in connection with employee stock plans to meet applicable tax withholding requirements. These shares are typically included in the Company's treasury stock.</span></div> 10000000000 4378000000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents the Company's share repurchase activity ($ in millions, shares in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.361%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share buybacks</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,660 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,028 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,341 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,880 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax withholding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,704 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,099 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,687 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">954 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,647 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Excludes share repurchase excise tax of approximately $7 million and $3 million accrued as of June 30, 2024 and 2023, respectively.</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 10660000 800000000 6028000 400000000 11341000 851000000 10880000 777000000 44000 3000000 71000 5000000 1346000 103000000 767000 51000000 10704000 803000000 6099000 405000000 12687000 954000000 11647000 828000000 7000000 3000000 Earnings Per Share <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to Centene Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,146 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,309 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,188 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing per share amounts:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529,602 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,932 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532,385 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549,850 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents (as determined by applying the treasury stock method)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,153 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,376 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,132 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares and potential dilutive common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530,755 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550,308 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534,517 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551,996 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings per common share attributable to Centene Corporation:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.16 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.93 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.34 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.98 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.96 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted earnings per common share for the three months ended June 30, 2024 and 2023 excludes 271 thousand shares and 1,519 thousand shares, respectively, related to anti-dilutive stock options, restricted stock and restricted stock units.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted earnings per common share for the six months ended June 30, 2024 and 2023 excludes 267 thousand shares and 1,611 thousand shares, respectively, related to anti-dilutive stock options, restricted stock and restricted stock units.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to Centene Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,146 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,309 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,188 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing per share amounts:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529,602 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,932 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532,385 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549,850 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents (as determined by applying the treasury stock method)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,153 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,376 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,132 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares and potential dilutive common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530,755 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550,308 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534,517 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551,996 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings per common share attributable to Centene Corporation:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.16 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.93 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.34 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.98 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.96 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div> 1146000000 1058000000 2309000000 2188000000 529602000 548932000 532385000 549850000 1153000 1376000 2132000 2146000 530755000 550308000 534517000 551996000 2.16 1.93 4.34 3.98 2.16 1.92 4.32 3.96 271000 1519000 267000 1611000 Segment Information <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in four segments: (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment and (4) an Other segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicaid, Medicare and Commercial segments represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies, among others. The Company's international businesses, Operose Health Group (Operose Health) and Circle Health, were divested in December 2023 and January 2024, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors used in determining the reportable business segments include the nature of operating activities, the existence of separate senior management teams and the type of information presented to the Company's chief operating decision-maker to evaluate all results of operations. The Company does not report total assets by segment since this is not a metric used to allocate resources or evaluate segment performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the three months ended June 30, 2024, is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,229 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,978 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,534 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,140 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">833 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,250 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,978 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,535 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,973 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,863 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,863 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,113 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,978 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,535 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,836 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,081 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,081 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,081)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,081)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,113 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,978 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,535 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,836 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,767 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,333 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,268 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,765 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,461 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,267 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,528 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin represents premium and service revenues less medical costs and cost of services.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the three months ended June 30, 2023, is as follows ($ in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,895 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,665 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,734 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,713 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,895 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,665 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,734 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,544 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,838 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,770 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,770 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,665 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,665 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,734 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,544 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,608 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,789 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,789 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,789)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,789)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,665 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,665 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,734 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,544 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,608 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,459 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,884 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,644 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,347 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,434 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,090 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,614 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin represents premium and service revenues less medical costs and cost of services.</span></div></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the six months ended June 30, 2024, is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,667 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,913 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,284 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,669 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,641 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,710 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,913 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,286 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,401 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,310 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,933 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,933 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,643 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,913 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,286 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,401 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,243 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,161 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,161 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,643 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,913 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,286 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,401 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,243 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,262 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,722 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,948 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,697 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,405 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,191 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,338 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,264 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin represents premium and service revenues less medical costs and cost of services.</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the six months ended June 30, 2023, is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,122 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,541 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,986 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,538 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,252 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,252 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,122 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,541 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,986 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,141 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,790 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,707 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,707 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,829 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,541 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,986 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,141 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,497 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,656 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,656 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,656)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,656)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,829 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,541 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,986 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,141 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,497 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,469 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,892 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,649 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">771 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,781 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,745 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,747 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,651 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,649 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,337 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,262 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin represents premium and service revenues less medical costs and cost of services.</span></div></td></tr></table></div> 4 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the three months ended June 30, 2024, is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,229 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,978 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,534 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,140 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">833 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,250 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,978 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,535 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,973 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,863 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,863 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,113 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,978 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,535 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,836 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,081 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,081 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,081)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,081)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,113 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,978 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,535 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,836 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,767 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,333 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,268 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,765 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,461 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,267 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,528 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin represents premium and service revenues less medical costs and cost of services.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the three months ended June 30, 2023, is as follows ($ in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,895 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,665 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,734 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,713 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,895 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,665 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,734 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,544 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,838 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,770 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,770 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,665 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,665 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,734 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,544 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,608 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,789 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,789 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,789)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,789)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,665 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,665 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,734 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,544 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,608 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,459 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,884 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,644 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,347 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,434 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,090 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,614 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin represents premium and service revenues less medical costs and cost of services.</span></div></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the six months ended June 30, 2024, is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,667 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,913 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,284 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,669 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,641 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,710 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,913 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,286 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,401 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,310 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,933 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,933 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,643 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,913 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,286 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,401 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,243 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,161 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,161 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,643 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,913 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,286 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,401 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,243 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,262 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,722 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,948 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,697 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,405 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,191 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,338 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,264 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin represents premium and service revenues less medical costs and cost of services.</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the six months ended June 30, 2023, is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,122 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,541 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,986 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,538 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,252 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,252 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,122 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,541 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,986 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,141 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,790 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,707 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,707 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,829 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,541 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,986 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,141 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,497 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,656 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,656 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,656)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,656)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,829 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,541 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,986 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,141 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,497 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,469 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,892 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,649 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">771 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,781 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,745 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,747 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,651 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,649 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,337 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,262 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin represents premium and service revenues less medical costs and cost of services.</span></div></td></tr></table></div> 20229000000 5978000000 8534000000 399000000 35140000000 21000000 0 1000000 811000000 833000000 20250000000 5978000000 8535000000 1210000000 35973000000 3863000000 0 0 0 3863000000 24113000000 5978000000 8535000000 1210000000 39836000000 0 0 0 4081000000 4081000000 0 0 0 -4081000000 -4081000000 24113000000 5978000000 8535000000 1210000000 39836000000 18767000000 5333000000 6268000000 397000000 30765000000 22000000 0 0 658000000 680000000 1461000000 645000000 2267000000 155000000 4528000000 21895000000 5665000000 5734000000 419000000 33713000000 0 0 0 1125000000 1125000000 21895000000 5665000000 5734000000 1544000000 34838000000 2770000000 0 0 0 2770000000 24665000000 5665000000 5734000000 1544000000 37608000000 0 0 0 3789000000 3789000000 0 0 0 -3789000000 -3789000000 24665000000 5665000000 5734000000 1544000000 37608000000 19459000000 4884000000 4644000000 360000000 29347000000 2000000 0 0 875000000 877000000 2434000000 781000000 1090000000 309000000 4614000000 41667000000 11913000000 16284000000 805000000 70669000000 43000000 0 2000000 1596000000 1641000000 41710000000 11913000000 16286000000 2401000000 72310000000 7933000000 0 0 0 7933000000 49643000000 11913000000 16286000000 2401000000 80243000000 0 0 0 8161000000 8161000000 0 0 0 -8161000000 -8161000000 49643000000 11913000000 16286000000 2401000000 80243000000 38262000000 10722000000 11948000000 765000000 61697000000 43000000 0 0 1306000000 1349000000 3405000000 1191000000 4338000000 330000000 9264000000 44122000000 11541000000 10986000000 889000000 67538000000 0 0 0 2252000000 2252000000 44122000000 11541000000 10986000000 3141000000 69790000000 6707000000 0 0 0 6707000000 50829000000 11541000000 10986000000 3141000000 76497000000 0 0 0 7656000000 7656000000 0 0 0 -7656000000 -7656000000 50829000000 11541000000 10986000000 3141000000 76497000000 39469000000 9892000000 8649000000 771000000 58781000000 2000000 0 0 1745000000 1747000000 4651000000 1649000000 2337000000 625000000 9262000000 Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is routinely subjected to legal and regulatory proceedings in the normal course of business. These matters can include, without limitation:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">periodic compliance and other reviews and investigations by various federal and state regulatory agencies with respect to requirements applicable to the Company's business, including, without limitation, those related to payment of out-of-network claims, compliance with CMS Medicare and Marketplace regulations, including risk adjustment and broker compensation, compliance with the False Claims Act, the calculation of minimum MLR and rebates related thereto, submissions to state agencies related to payments or state false claims acts, pre-authorization penalties, timely review of grievances and appeals, timely and accurate payment of claims, cybersecurity issues, including those related to the Company's or the Company's third-party vendors' information systems, and the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and other federal and state fraud, waste and abuse laws;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation arising out of general business activities, such as tax matters, disputes related to healthcare benefits coverage or reimbursement, putative securities class actions, and medical malpractice, privacy, real estate, intellectual property, vendor disputes and employment-related claims; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disputes regarding reinsurance arrangements, claims arising out of the acquisition or divestiture of various assets, class actions and claims relating to the performance of contractual and non-contractual obligations to providers, members, employer groups, vendors and others, including, but not limited to, the alleged failure to properly pay claims and challenges to the manner in which the Company processes claims, claims related to network adequacy and claims alleging that the Company has engaged in unfair business practices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, these matters may result in awards of damages, fines or penalties, which could be substantial, and/or could require changes to the Company's business. The Company intends to vigorously defend itself against legal and regulatory proceedings to which it is currently a party; however, these proceedings are subject to many uncertainties. In some of the cases pending against the Company, substantial non-economic or punitive damages are being sought. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records reserves and accrues costs for certain legal proceedings and regulatory matters to the extent that it determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect the Company's best estimate of the probable loss for such matters, the recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to, they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; involve a large number of parties, claimants or regulatory bodies; are in the early stages of the proceedings; involve a number of separate proceedings and/or a wide range of potential outcomes; or result in a change of business practices. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this report, amounts accrued for legal proceedings and regulatory matters were not material, except for the reserve estimate as previously disclosed in the Company's 2023 Annual Report on Form 10-K with respect to claims or potential claims involving services provided by Envolve Pharmacy Solutions, Inc. (Envolve), as the Company's pharmacy benefits management (PBM) subsidiary. The Company has reached no-fault settlement agreements related to services previously provided by Envolve with the vast majority of states impacted. Such agreements have provided for payment amounts consistent with the initial reserve estimate established in the second quarter of 2021 related to this issue. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that in a particular quarter or annual period the Company's financial condition, results of operations, cash flow and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of or development in legal and/or regulatory proceedings. The Company believes that the ultimate outcome of any of the regulatory and legal proceedings that are currently pending against it should not have a material adverse effect on financial condition, results of operations, cash flow or liquidity.</span></div> false false false false